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The mammalian testis is divided into two distinct compartments which carry out its 
principal functions. Spermatogenesis occurs within the seminiferous tubules and 
androgen biosynthesis primarily occurs in the interstitial space. Both these processes 
are entirely dependent upon the two major testicular somatic cell populations - the 
Sertoli and Leydig cells respectively. In human males, testicular spermatogenic and 
endocrine function declines during the ageing process. Of particular significance is the 
reported age-related decrease in Leydig cell androgen production as androgens have 
been suggested to play a crucial role in supporting lifelong general health in men, with 
low circulating testosterone linked to an increased risk of developing chronic age-
related cardiometabolic diseases. However, the relationship between ageing, testicular 
function and disease is not fully understood, impeding the development of novel 
therapeutic strategies to treat age-related testicular dysfunction. 
In one set of studies undertaken herein, a series of novel mouse models of premature 
ageing were utilised to begin to dissect the process of age-related testicular 
degeneration. Firstly, a novel knockout-first conditional allele of a previously reported 
premature-ageing model driven by Cisd2 (CDGSH Iron Sulphur Domain 2) deficiency 
was validated and the testicular phenotype characterised and compared to that of 
naturally aged mice at 18-months of age. Histological analyses revealed premature 
testicular atrophy at 6-months of age in CISD2 deficient mice, consistent with 
observations of the naturally aged testis. Circulating testosterone was significantly 
lower in CISD2-deficient mice compared to wild-type controls at 6-months of age and 
the luteinising hormone/testosterone ratio was significantly elevated, indicative of 
compensated Leydig cell failure. mRNA expression of key genes involved in androgen 
production were also significantly reduced in the CISD2-deficient testis, pointing to 
Leydig cell dysfunction in this model of premature aging. Next, Cre/LoxP technology 
was used to delete Cisd2 from specific testicular cell populations to determine which 
cell types control/support Leydig cell function during the ageing process. Testosterone 
production was unaffected when Cisd2 was disrupted in either the Leydig cell 
population or Sertoli cell population. These observations suggest that disruption to the 
testicular microenvironment in which Leydig cells reside, rather than intrinsic Leydig 
cell ageing, may play a significant role in age-associated Leydig cell dysfunction. 
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A second set of studies were carried out to investigate the role of leukemia inhibitory 
factor (LIF) signalling in the maintenance of testicular function. LIF is a pleiotropic 
cytokine belonging to the interleukin-6 family. In the rodent testis, LIF is expressed in 
fetal life and adulthood; the peritubular myoid cells thought to be the main site of 
production. Given their anatomical location within the testis, LIF produced by 
peritubular myoid cells may act on both intratubular and interstitial cells to influence 
spermatogenesis and steroidogenesis respectively. Indeed, LIFR is expressed in germ 
cells, Sertoli cells, Leydig cells as well as testicular macrophages suggesting that LIF 
may be a key paracrine regulator of testicular function. However, the precise role of 
LIF/LIFR signalling in the testis is largely unknown. As such, models of testicular 
cell-specific Lifr deletion were generated using Cre/LoxP technology. Analysis of 
these novel models of conditional LIFR ablation revealed that LIFR is dispensable in 
germ cells for normal spermatogenesis. However, LIFR ablation from Sertoli cells 
resulted in a progressive degenerative phenotype, characterised by abnormal germ cell 
loss, sperm stasis, seminiferous tubule distention and subsequent atrophy of the 
seminiferous tubules.  
In a final set of studies, a rat model of Leydig cell ablation-regeneration was used to 
determine the regenerative capacity of human adipose-derived perivascular stem cells 
(hAd-PSC) as a potential therapy for testicular dysfunction. Following ethane 
dimethanesulphonate (EDS) mediated Leydig cell ablation, primary hAd-PSCs, 
cultured with or without LH, IGF-1, PDGFBB, T3 and ITS supplement, were 
transplanted into the rat testis and Leydig cell regeneration was monitored via serial 
measurements of circulating luteinising hormone (LH) and testosterone. Overall, hAd-
PSCs had no impact on the recovery of circulating testosterone levels. However, when 
pre-cultured with the cocktail of hormone/growth factor supplements, the LH spike 
induced by the removal of testosterone negative feedback was dampened, suggesting 
the transplanted cells may promote Leydig cell regeneration. Whether these cells 
differentiate into Leydig cells, or simply provide paracrine support to the regenerating 
Leydig cells remains to be determined. Although Ad-PSCs may enhance regeneration 
kinetics, the transplanted cells were undetectable in the testis 5 weeks post 





In males, the testicles have two main functions; to produce sperm via the process of 
spermatogenesis, and to produce the hormone testosterone. Both these functions rely 
on specific types of cells in the testis. The Sertoli cells provide important support to 
the developing sperm cells, and the Leydig cells are responsible for producing 
testosterone. As males age, the testicles become less efficient at producing sperm and 
testosterone. Reduced testosterone production in ageing men is particularly important 
because, further to its role in the reproductive system, testosterone is also required to 
keep other parts of the body healthy and low levels of testosterone have been linked to 
an increased risk of developing health problem such as diabetes and cardiovascular 
disease. However, the reasons why the testicles become less efficient during ageing 
and disease are not fully understood, making the development of new treatments to 
promote testicle function difficult. 
To try and better understand what causes age-related testicular decline, the studies 
described in this thesis utilised a series of new mouse models of premature testicular 
ageing which were designed to limit ‘ageing’ to specific cells in the testicles. These 
models enabled the contribution of the different cell populations to the overall function 
of the testicles to be assessed. It was found that ageing of the Leydig cells themselves 
wasn’t responsible for the decline in testosterone production but instead, changes to 
the local environment inside the testicle might be the reason they become less efficient 
as they age. 
In a second set of experiments, signalling of a molecule known as leukemia inhibitory 
factor (LIF) was manipulated to see how it might regulate testicular function. This 
molecule is present in the testicle throughout life and is thought to be important, but 
its function has not been established. By disrupting LIF signalling in developing sperm 
cells and/or Sertoli cells, it was found that LIF signalling in the developing sperm cells 
is not needed for the production of mature sperm. In contrast, LIF signalling in Sertoli 
cells is needed to maintain normal spermatogenesis. These were the first experiments 
describing how LIF signalling may support testicle function. 
A final set of experiments were carried out to try and find a new treatment to promote 
testicle function. Stem cells from human fat tissue were injected into the testicles of 
rats that had had their Leydig cells destroyed by a toxic chemical. The results showed 
that the stem cells might help restore testosterone production, but they do not survive 
long-term in the testicles which may limit their use as a therapy.
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 Literature Review 
1.1 Testicular Development 
1.1.1 The Male Genetic ‘Switch’ 
Establishment of the phenotypic male begins with the commitment of the bipotential 
gonad to form a testis. This process relies on the presence of a Y chromosome, which 
harbours the crucial Sry (Sex-determining Region, Y chromosome) gene (Sinclair et 
al., 1990). In the absence of SRY (i.e. in XX females, or XY individuals with 
mutated/deleted Sry), ovaries rather than testes develop (Jager et al., 1990, Hawkins 
et al., 1992, Kato et al., 2013). Conversely, transgenic Sry expression in genetically 
female mice results in testis development (Koopman et al., 1991). In the mouse, Sry is 
expressed in pre-Sertoli cells, derived from the coelomic epithelium (Karl and Capel, 
1998), from embryonic day (e) 10.5 to 12.5, reaching a peak at e11.5 throughout the 
length of the gonad (Bullejos and Koopman, 2001, Sekido et al., 2004, Wilhelm et al., 
2005). A crucial function of SRY appears to be up-regulation of Sox9 (SRY box-9) 
(Sekido et al., 2004, Wilhelm et al., 2005, Hiramatsu et al., 2009), a key transcription 
factor required for Sertoli cell differentiation and subsequent testicular development 
as evidenced by sex reversal in Sox9 gain of function XX and loss of function XY 
gonads (Vidal et al., 2001, Barrionuevo et al., 2006, Lavery et al., 2011). SOX9 
upregulates the expression of Fgf9 (Fibroblast Growth Factor-9) and together FGF9 
and SOX9 act to inhibit the expression of pro-ovarian genes including Wnt4 
(Wingless-related MMTV integration site 4). Recent research has highlighted a large 
number of target genes either activated or repressed by SRY and SOX9 (Li et al., 
2014), but ultimately the development of the bipotential gonad into a testis or ovary 
depends on the balance of Fgf9 and Wnt4 expression (Kim et al., 2006). A schematic 
overview of testicular development is presented in Figure 1.1. 




Figure 1.1 Overview of Testicular Development in the Mouse. Sry (Sex-determining 
Region, Y chromosome) is expressed in pre-Sertoli cells from e10.5 and functions to 
upregulate Sox9 (SRY-Box 9), inducing Sertoli cell differentiation and subsequent testicular 
development. Testis cords begin to form at embryonic day (e) 11.5 representing the first 
morphological change associated with testicular development. From e12.5, fetal Leydig cells 
appear in the interstitium and are required for subsequent masculinisation and development 
of the male reproductive tract. This figure has been adapted from Svingen and Koopman 
(2013) in accordance with Creative Commons Licensing (Attribution-NonCommercial 3.0 
Unported). 
1.1.2 Formation of the Testis 
Formation of the testis cords between e11.5 and 12.5 represents the first major 
morphological change associated with testis development (Nel-Themaat et al., 2009) 
and is dependent on migration of endothelial cells from the mesonephros (Buehr et al., 
1993, Merchant-Larios et al., 1993, Tilmann and Capel, 1999, Cool et al., 2008, 
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Combes et al., 2009). Testis cords comprise Sertoli cells and germ cells surrounded by 
a layer of peritubular myoid cells and are the precursor to the spermatogenic 
seminiferous tubules of the adult testis. Migrating endothelial cells contribute to the 
formation of the testicular vasculature, a process which is critical for formation of 
seminiferous cords (Brennan et al., 2003, Yao et al., 2006, Coveney et al., 2008, 
Combes et al., 2009, Cool et al., 2011).  
Concomitant with the establishment of the testicular vasculature and formation of the 
seminiferous cords, fetal Leydig cells appear in the interstitial compartment of the 
mouse testis at e12.5-13.0 (Greco and Payne, 1994, Baker et al., 1999, Yao et al., 
2002). Fetal Leydig cells develop from a heterogeneous population of interstitial 
precursors derived from both the coelomic epithelium and cells of the gonad-
mesonephros border (DeFalco et al., 2011, Liu et al., 2016) under the influence of 
various signalling molecules including Sertoli cell-derived desert hedgehog (DHH) 
and platelet derived growth factor (PDGF). In mice, disruption of Dhh (Yao et al., 
2002) and platelet derived growth factor receptor-alpha (Pdgfra) (Brennan et al., 2003) 
results in defective fetal Leydig cell development. Conversely, constitutive activation 
of the hedgehog pathway in SF1-positive somatic cells of the mouse ovary results in 
the development of functional fetal Leydig cells as evidenced by the virilisation of XX 
embryos (Barsoum et al., 2009), highlighting the importance of fetal Leydig cells in 
the process of masculinisation (see section 1.1.3). Notch-Hes1 (Hairy Enhancer of 
Split-1) signalling has also been implicated in the regulation of fetal Leydig cell 
development. Pharmacological and genetic blockade of Notch signalling results in 
increased fetal Leydig cell numbers, while constitutive Notch activation impairs 
Leydig cell development and results in increased undifferentiated mesenchymal cells 
(Tang et al., 2008). Additionally, abnormal testis cords are noted in both loss and gain 
of function models, suggesting interstitial cells of the fetal gonad may influence cord 
formation. Indeed, fetal Leydig cells produce activin-A, a member of the transforming 
growth factor beta (TGF-β) protein family, which acts on Sertoli cells to promote their 
proliferation and expansion of the testis cords (Archambeault and Yao, 2010). The 
expression of leukemia inhibitory factor (LIF) and its receptor (LIFR) coincides with 
the development of the fetal Leydig cell population. Interestingly, Lif is upregulated in 
the embryonic testis as a result of bis (2-ethylhexyl) phthalate (DEHP) exposure and 
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LIF promotes fetal Leydig cell aggregation (Lin et al., 2008), a common feature of 
phthalate-induced testicular dysgenesis (Mahood et al., 2005, Lara et al., 2017, van 
den Driesche et al., 2017). However, a precise role for LIF/LIFR signalling in 
testicular development has not been established. 
1.1.3 Masculinisation 
Following commitment of the bipotential gonad to testis development, concerted 
action of Leydig cell-derived insulin-like factor 3 (INSL3)(Kubota et al., 2001, Nef 
and Parada, 1999), Sertoli cell-derived anti-Müllerian hormone (AMH) (Behringer et 
al., 1994, Munsterberg and Lovell-Badge, 1991) as well as the adequate production 
and action of androgen (Lyon and Hawkes, 1970, Geissler et al., 1994, Caron et al., 
1997, Ahmed et al., 2000, Hu et al., 2002, Yeh et al., 2002, Notini et al., 2005, 
Hannema et al., 2006, Welsh et al., 2008) is required for masculinisation and 
development of the male reproductive tract. Androgens produced by the fetal testis 
function to stabilise the Wolffian ducts and promote proper development of the male 
reproductive tract and external genitalia (e.g. testis descent/penile morphogenesis), as 
well as masculinisation of other aspects of the fetus including the brain (Sato et al., 
2004, Welsh et al., 2008, Welsh et al., 2009b). Studies in rats have identified a critical 
window, between e15.5 to e18.5, in which androgens are crucial for the 
masculinisation process (Welsh et al., 2008). Such a window is thought to exist during 
human fetal development between gestational weeks 8-12. Insufficient androgen 
production/action during this developmental window can give rise to malformations 
of the male reproductive system such as cryptorchidism (incomplete descent of the 
testes into the scrotum) and hypospadias (malformations of the penis). These 
developmental disorders, as well as adult onset of testicular germ cell cancer and 
reduced sperm counts are thought to comprise a testicular dysgenesis syndrome which 
share a common fetal origin (Boisen et al., 2001, Skakkebaek et al., 2001, Hughes et 
al., 2006). In fact, an unfavourable environment in utero has been associated with 
lower adult testosterone levels, suggesting aspects of adult Leydig cell function may 
be ‘programmed’ during fetal life (Cicognani et al., 2002, Vanbillemont et al., 2010). 
In this regard, a recent study by Kilcoyne et al. (2014) suggests that insufficient 
androgen action on adult Leydig cell stem/progenitor cells during embryonic 
development may negatively impact the function of the adult Leydig cell population. 
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1.2 Structure and Function of the Adult Testis 
The mammalian testis is a complex multicellular organ, separated into two distinct 
compartments (Figure 1.2) that carry out its principal functions: spermatogenesis and 
steroidogenesis. 
 
Figure 1.2 Structure of the Adult Testis. Cross Section of an adult mouse testis (left) and 
schematic representation (right) of the various cellular components of the adult testis. The 
testis can be divided into two distinct compartments; the tubular compartment is the site of 
spermatogenesis and consists of seminiferous tubules in which Sertoli (SC) and germ cells are 
present (a = spermatogonia; b = spermatocyte; c and d = round/elongating spermatids; e = 
elongate spermatids). The interstitial compartment, between the seminiferous tubules, is 
where the testosterone producing Leydig cells (LC) are found. PTM = peritubular myoid cell; 
SLC = stem Leydig cell; BV = blood vessel. 
1.2.1 Leydig Cells 
Leydig cells; the androgen producing cells found in the testis interstitium (Figure 1.2), 
were first described by Franz von Leydig in 1850 (Schneider, 2012). In rodents, two 
populations of Leydig cells (fetal and adult) arise during development (Lording and de 
Kretser, 1972, Tapanainen et al., 1984, Zirkin and Ewing, 1987, Shima et al., 2015). 
Regression of the fetal Leydig cell population, at least functionally, occurs between 
birth and postnatal day (d) 10-20 (O'Shaughnessy et al., 2002b, Wu et al., 2010). 
Whether fetal Leydig cell death occurs prior to replacement by the adult Leydig cell 
population is not entirely clear. For example, Yokoi et al. (1998) reported Leydig cell 
death in the perinatal rat testis based on immuno-detection of terminal 
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deoxynucleotidyl transferase whereas no apoptotic cells are detected in the testis 
interstitium during postnatal development in the mouse (Faria et al., 2003). In line with 
the latter, fetal Leydig cells are reported to persist in the adult testis (Mendis-
Handagama et al., 1987, Kerr and Knell, 1988, Kaftanovskaya et al., 2015, Shima et 
al., 2015). In contrast to rodents, Leydig cell development in humans has been 
described as a ‘tri-phasic’ process evidenced by increases in testosterone and INSL3 
production 2-3 months after birth (Forest et al., 1973, Prince, 1990, Prince, 2001, Bay 
et al., 2007). Leydig cell development has been extensively characterised using rodent 
models thus development of the adult Leydig cell population is described in the 
following section with reference primarily to the rat and mouse. 
 Adult Leydig Cell Development 
Adult Leydig cells begin to populate the testis during pubertal development however, 
the specific mechanisms regulating adult Leydig cell differentiation are not entirely 
understood. Early studies of ethane dimethanesulphonate (EDS) mediated adult 
Leydig cell ablation and regeneration in the rat proposed that, much like the 
development of fetal Leydig cells (see section 1.1.2), adult Leydig cells arise from an 
interstitial stem cell population (Kerr et al., 1985, Jackson et al., 1986). Indeed, 
numerous studies have since confirmed that adult Leydig cells arise from a spindle-
shaped mesenchymal stem cell pool which is established in the testis interstitium 
during fetal life (Siril Ariyaratne et al., 2000, Davidoff et al., 2004, Ge et al., 2006, 
O'Shaughnessy et al., 2008, Stanley et al., 2012, Jiang et al., 2014, Kilcoyne et al., 
2014, Li et al., 2016, Liu et al., 2016, Zang et al., 2017). However, it is not clear 
whether this stem cell population is common to both fetal and adult Leydig cells. For 
example, common signalling molecules including DHH and PDGF-A are involved in 
the development of both fetal and adult Leydig cell populations supporting the 
hypothesis of a common precursor to both populations (Clark et al., 2000, Gnessi et 
al., 2000, Yao et al., 2002, Brennan et al., 2003, Park et al., 2007, Barsoum et al., 
2013). However, divergence in the development and/or function also exists between 
fetal and adult Leydig cells. For instance, whilst fetal Leydig cells develop 
independently of luteinising hormone (LH) signalling, proper establishment of the 
adult population does not occur in the absence of LH stimulation (Shan et al., 1995, 
O’Shaughnessy et al., 1998, Baker and O'Shaughnessy, 2001, Zhang et al., 2001, Ma 
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et al., 2004). Additionally, fetal, but not adult, Leydig cells express the melanocortin 
type 2 receptor and are thus sensitive to adrenocorticotrophic hormone which 
stimulates fetal Leydig cell steroidogenesis (O’Shaughnessy et al., 2003, Johnston et 
al., 2007). Whether these discrepancies refute a common ontogeny for fetal and adult 
Leydig cells, or simply reflect temporal differences in the regulation of Leydig cell 
development/function remains to be established. Interestingly, there is evidence to 
suggest that two separate subsets of Leydig cells exist in the adult mouse testis which 
show differential phenotypic responses to perturbations in paracrine signalling (Payne 
et al., 1980, Welsh et al., 2012). Increasing our understanding of the regulatory 
mechanism(s) governing the development and function of the adult Leydig cell 
population will aid the development of novel regenerative therapies to replace poorly 
functioning aged Leydig cells. 
 Stem Leydig Cells 
Development of the adult Leydig cell population progresses through four distinct 
stages (stem – progenitor –immature – adult; Figure 1.3) relating to alterations in cell 
morphology, gene expression and steroidogenic activity (O'Shaughnessy and Murphy, 
1991, Ge and Hardy, 1998, Ge et al., 2005, Dong et al., 2007). The precise origin of 
stem Leydig cells is a topic of contentious debate, with evidence of peritubular (Siril 
Ariyaratne et al., 2000) and/or perivascular (Davidoff et al., 2004) origins reported in 
the literature. Ge et al. (2006) described a population of spindle-shaped cells in the d7 
rat testis interstitium, primarily in association with the peritubular region, which were 
negative for the Leydig cell lineage markers 3β-hydroxysteroid dehydrogenase 
(HSD3b) and luteinising hormone/chorionic gonadotrophin receptor (LHCGR). These 
cells were isolated based on negative selection for LHCGR and positive selection for 
PDGFRa and were further shown to express the stem cell markers leukemia inhibitory 
factor receptor (LIFR) and c-Kit. The authors went on to demonstrate these cells are 
capable of long term self-renewal in vitro and can differentiate into testosterone-
producing Leydig cells in vitro and in vivo, suggesting that this cell population may, 
in the rat testis, represent the elusive stem Leydig cells. More recently, using a green 
fluorescent protein-tagged nestin (Nes-GFP) mouse, Jiang et al. (2014) isolated a 
population of cells from the postnatal mouse testis with similar characteristics and also 
suggested that cluster of differentiation-51 (CD51) may be a putative surface marker 
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of stem Leydig cells in the postnatal mouse testis. Indeed, Zang et al. (2017) went on 
to show that CD51-positive cells isolated from 12-week old mouse testes display stem 
cell characteristics and are able to differentiate into functional Leydig-like cells both 
in vitro and in vivo. Using a linage tracing approach, Kilcoyne et al. (2014) suggested 
that the orphan nuclear receptor chicken ovalbumin upstream promoter transcription 
factor-II (COUP-TFII) is a marker of adult Leydig stem/progenitor cells. COUP-TFII 
is essential for the development of adult Leydig cells during pubertal development. 
Using an inducible gene ablation approach, Qin et al. (2008) demonstrated that COUP-
TFII deficiency resulted in arrested Leydig cell development at the progenitor stage. 
 
Figure 1.3 Stages of Adult Leydig Cell Development. Adult Leydig cells develop through 
stem, progenitor and immature stages before becoming mature, fully functional adult Leydig 
cells. Each developmental stage is characterised by alterations in cell morphology, gene 
expression and steroidogenic activity. With age, adult Leydig cells become dysfunctional. N.B. 
the ages given in this schematic are based on development of Leydig cells in the rat testis. This 
image has been modified from Chen et al. (2009b). 
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 Progenitor to Mature Leydig Cells 
In the rat testis, stem Leydig cells begin to express LHCGR and commit to the adult 
Leydig cell lineage by d14, giving rise to progenitor Leydig cells which express 
LHCGR as well as the steroidogenic enzymes P450 cholesterol side-chain cleavage 
enzyme (CYP11A1), HSD3B and 17α-hydroxylase, 17,20-lyase (CYP17A1) (Shan 
and Hardy, 1992, Shan et al., 1993, Ge et al., 2006, Teerds et al., 2007a). As such, 
progenitor Leydig cells have the capacity for steroidogenesis, with androsterone being 
the primary product (Ge and Hardy, 1998). The transition of progenitor Leydig cells 
into immature Leydig cells, at approximately d35 in both rats and mice (Wu et al., 
2010), is characterised by a transformation from spindle-shaped to a more rounded 
morphology, expansion of the smooth endoplasmic reticulum (SER) acquisition of 
numerous large cytoplasmic lipid droplets and increased steroid metabolising activities 
(Shan et al., 1993, Haider et al., 2007, Chen et al., 2009b). Immature Leydig cells 
produce more testosterone than do progenitor Leydig cells however; they primarily 
produce androstanediol (Ge and Hardy, 1998). The final transition into mature adult 
Leydig cells is characterised by further expansion of the SER, a decrease in lipid 
droplets, altered expression of androgen metabolising enzymes and subsequent 
increase in testosterone production (Zirkin and Ewing, 1987, Shan et al., 1993, Ge and 
Hardy, 1998, Baker et al., 1999, Wu et al., 2010). 
 Regulation of Leydig Cells 
As mentioned in section 1.2.1.1, studies in mice lacking circulating LH or LHCGR 
highlight a requirement for LH signalling in the development and maturation of adult 
Leydig cells. For example; in the Hpg mouse, which does not produce gonadotrophin 
releasing hormone (GnRH) and subsequently LH, adult Leydig cell number is reduced 
by approximately 90% (Baker and O'Shaughnessy, 2001). The Hpg mouse is also 
devoid of follicle stimulating hormone (FSH) and treatment of Hpg mice with FSH 
results in an increase in Leydig cell number (O'Shaughnessy et al., 2010a). 
Additionally, Leydig cell number is reduced in mice lacking FSH receptors (FSHR) 
suggesting a role for FSH in adult Leydig cell development (O’Shaughnessy et al., 
2012). However, in FSH-deficient mice no such difference is observed (Baker et al., 
2003). In this model, circulating LH levels are normal, whereas FSHR-deficient mice 
have supraphysiological levels, which may account for this discrepancy and suggests 
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that FSH per se is not required for Leydig cell development in the presence of normal 
LH. Interestingly, Baker et al. (2003) demonstrated constitutive activation of the 
FSHR under baseline conditions in MLTC-1 cells transfected with murine FSHR. 
Thus, basal FSHR activation in Sertoli cells may stimulate the production of trophic 
factors required for proper attainment of the adult Leydig cell population. 
Indeed, Sertoli cells provide paracrine support required for the development and 
maintenance of adult Leydig cells (Rebourcet et al., 2014a, Rebourcet et al., 2014b). 
Whilst the full complement of Sertoli cell-derived factors mediating Sertoli-Leydig 
cell crosstalk remains to be established, DHH and PDGF have been implicated as 
important players. Adult Leydig cells fail to develop in both DHH and PDGF-A 
deficient mice (Clark et al., 2000, Gnessi et al., 2000) and both molecules have been 
shown to influence stem Leydig cell proliferation and differentiation in vitro (Odeh et 
al., 2014, Li et al., 2016). Furthermore, altered expression of Dhh and Pdgfa during 
EDS-mediated adult Leydig cell ablation and regeneration has been reported 
(O'Shaughnessy et al., 2008). Additionally, platelet derived growth factor-beta 
(PDGF-B) has been shown to promote stem Leydig cell proliferation in vitro, while 
inhibiting their differentiation (Odeh et al., 2014, Li et al., 2016).  
In addition to DHH and PDGF-A, O'Shaughnessy et al. (2008) also suggested that 
leukemia inhibitory factor (LIF) may play a role in adult Leydig cell development. LIF 
is a pleiotropic cytokine belonging to the IL-6 family and is produced by multiple cell 
types in the testis, particularly by the peritubular myoid cells (Piquet-Pellorce et al., 
2000). Leukemia inhibitory factor signals through a heterodimeric receptor complex 
composed of the leukemia inhibitory factor receptor (LIFR, also known as gp190), 
which binds LIF, and the signal transducing gp130 subunit common to the IL-6 family 
members (Gearing et al., 1991, Gearing et al., 1992, Ip et al., 1992). As mentioned in 
section 1.2.1.1.1, stem Leydig cells express LIFR and LIF has been shown to stimulate 
proliferation of stem Leydig cells (Ge et al., 2006). In vitro studies have implicated 
the closely related IL-6-type cytokine oncostatin M (OSM) in aspects of adult Leydig 
cell development and function (Teerds et al., 2007b). Additionally, in vitro studies 
have demonstrated LIF can have both inhibitory and stimulatory effects on Leydig cell 
steroidogenesis (Mauduit et al., 2001, Wang et al., 2016b). However, the role of LIF 
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signalling in the testis remains to be determined. No testicular phenotype is reported 
in Lif-deficient mice (Stewart et al., 1992), which may be attributed to redundancy 
between IL-6 family cytokines. In contrast, Lifr disruption results in perinatal death 
(Ware et al., 1995). Thus, LIFR-deficient mice cannot be used for in vivo studies into 
the role of LIF/LIFR signalling in the development and function of the adult Leydig 
cell population. 
Androgens are also thought to be necessary for adult Leydig cell development as 
Leydig cell number and function is significantly impaired both in androgen receptor 
knock-out (ARKO) and Tfm mice (Murphy et al., 1994, O'Shaughnessy et al., 2002a, 
De Gendt et al., 2005, O’Shaughnessy et al., 2012). However, the testes of ARKO and 
Tfm animals are cryptorchid, complicating the interpretation of androgen actions in 
adult Leydig cell development in these models. Furthermore, global androgen action 
is abolished in both ARKO and Tfm mice thus, assigning cell-specific effects of 
androgens on adult Leydig cell development is challenging. Conditional ablation of 
androgen receptors in Sertoli cells (De Gendt et al., 2005), peritubular myoid cells 
(Welsh et al., 2012) and Leydig cells (O’Hara et al., 2015) suggest that paracrine and 
autocrine androgen action may impact aspects of Leydig cell development and 
maturation. 
Development of the adult Leydig cell population may also be influenced by thyroid 
hormone. For example, experimentally-induced hypothyroidism via propyl-2-
thiouracyl (PTU) during the neonatal/pre-pubertal period is reported to reduce the 
proportion of Leydig cells during early development (d12-16) whereas treatment with 
bioactive thyroid hormone (T3) significantly increased Leydig cell numbers (Teerds et 
al., 1998). More recently, studies in hypothyroid rats at older ages suggest that dietary-
induced hypothyroidism delays, rather than blocks, adult Leydig cell development 
(Rijntjes et al., 2009). The effect of thyroid hormone on Leydig cell regeneration 
following EDS-mediated ablation has been studied, although conflicting results are 
reported. Ariyaratne et al. (2000) reported that Leydig cell differentiation was 
inhibited in hypothyroid rats and accelerated in hyperthyroid rats. Conversely, Rijntjes 
et al. (2010) reported that the Leydig cell population returns to pre-treatment size in 
hypothyroid rats although regeneration kinetics may be slightly altered (i.e. a delayed 
wave of progenitor Leydig cell proliferation was observed in hypothyroid animals). It 
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is not clear whether the proposed effects of thyroid hormones are a result of direct 
signalling in developing Leydig cells or via paracrine signals from Sertoli cells which 
are also sensitive to thyroid hormones (Wagner et al., 2008, Rijntjes et al., 2017). 
Insulin-like growth factor-1 (IGF-1) which belongs to the insulin family of growth 
factors has been shown to support the development and function of adult Leydig cells. 
Baker et al. (1996) reported an eighty percent reduction in circulating testosterone 
levels in Igf1 null mice, accompanied by ultrastructural abnormalities indicative of 
retarded Leydig cell development. Altered proliferation and differentiation of adult 
Leydig cells, from the progenitor stage onwards, results in a reduction in adult Leydig 
cell number in IGF-1 deficient testes which is rescued upon administration of 
recombinant IGF-1 (Wang and Hardy, 2004, Hu et al., 2010a). During the transition 
from immature to adult Leydig cell, a reduction in the androgen metabolising enzymes 
3α-hydroxysteroid dehydrogenase (HSD3A) and 5α-reductase type-1 (SRD5A1) 
occurs, resulting in increased testosterone production characteristic of mature adult 
Leydig cells. In IGF-1 deficient mice, Srd5a1 expression remains high suggesting that 
Leydig cell development is arrested at the immature stage (Wang et al., 2003, Hu et 
al., 2010a). 
1.2.2 Sertoli Cells 
Sertoli cells, the somatic component of the seminiferous epithelium (Figure 1.2), were 
first described by Enrico Sertoli in 1865 (Baratelli et al., 2002). As discussed in section 
1.1.1, emergence of the Sertoli cells is crucial for the development of a testis and 
subsequent establishment of a phenotypic male. In the postnatal testis, the primary role 
of the Sertoli cell is to create the optimal environment within the seminiferous tubule 
to maintain the germ cell niche and provide support to the germ cells as they develop 
into spermatids. Experimental/genetic manipulations, which alter the number of 
Sertoli cells in the adult testis, have demonstrated that the size of the Sertoli cell 
population determines germ cell number and daily sperm production (Orth et al., 1988, 
Hess et al., 1993, Simorangkir et al., 1995, Meachem et al., 1996, Auharek et al., 
2011). More recently, it has been suggested that the number of Sertoli cells also 
determines the number and/or function of adult Leydig cells (Rebourcet et al., 2014a, 
Rebourcet et al., 2014b, Rebourcet et al., 2017) as well as influencing the 
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intratesticular vascular volume and subsequently the exchange of fluid between the 
interstitial and vascular compartments (Rebourcet et al., 2016). 
 Sertoli Cell Development 
In mice, immature Sertoli cells proliferate during late embryonic and early postnatal 
life, such that the full Sertoli cell population is established by d20 (Vergouwen et al., 
1991, Baker and O'Shaughnessy, 2001). Initial development of the Sertoli cell 
population occurs independently of gonadotrophins; however, establishment of the full 
Sertoli cell population requires the action of FSH as evidenced by a reduction in adult 
Sertoli cell number in Hpg, FSH- and FSHR-deficient mice (Baker and 
O'Shaughnessy, 2001, Johnston et al., 2004). Furthermore, in rats treated with 
recombinant FSH (Meachem et al., 1996) and in Hpg mice with transgenic expression 
of either FSH or a mutation activated FSHR (Allan et al., 2004), Sertoli cell number 
is increased. Thyroid hormone signalling, through Sertoli cell thyroid hormone 
receptor alpha-1 (THRa1), has also been implicated in Sertoli cell development. 
Transient neonatal hypothyroidism or THRa1 knockout increases Sertoli cell 
proliferation resulting in increased Sertoli cell numbers (Simorangkir et al., 1995, 
Holsberger et al., 2005, Auharek et al., 2011, Fumel et al., 2012), whereas 
hyperthyroidism has been shown to reduce Sertoli cell proliferation and thus reduce 
final Sertoli cell numbers (van Haaster et al., 1993, Auharek et al., 2011). Interestingly, 
Pitetti et al. (2013) noted a reduction in Sertoli cells due to decreased proliferation 
when insulin/IGF signalling is disrupted in Sertoli cells. Phenotypic similarities 
between this model and the models of FSH/FSHR deficiency and hyperthyroidism 
described above prompted the authors to investigate whether there is an interaction 
between these signalling pathways. The response of Sertoli cell insulin receptor/IGF 
receptor deficient mice to transient neonatal hypothyroidism (i.e. increased testis 
weight) was similar to control mice whilst the response to neonatal hemi castration or 
recombinant FSH administration was blocked. This suggests that the effects of FSH, 
but not thyroid hormone, on immature Sertoli cells is supported by active Sertoli cell 
insulin/IGF signalling. Adequate action of androgen is also required for the attainment 
of normal Sertoli cell number. In Tfm and androgen receptor knockout mice, final 
Sertoli cell number is reduced (Johnston et al., 2004, Tan et al., 2005). This effect is 
thought to be due to alterations in androgen-dependent paracrine factors as Sertoli cell 
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number is unaltered in Sertoli cell-specific androgen receptor knockout mice (De 
Gendt et al., 2005). Which cell types mediate androgen actions on Sertoli cell 
proliferation is not entirely clear. Disruption of androgen receptors in peritubular 
myoid cells or Leydig cells does not result in altered Sertoli cell numbers however, 
androgen receptor ablation is not completely lost from these respective cell 
populations (Welsh et al., 2009a, O’Hara et al., 2015). 
 The Blood-Testis-Barrier 
Following the phase of pubertal proliferation, Sertoli cells transform from their 
immature state into their mature form, taking on a number of specialised functions 
necessary for spermatogenesis to take place (Sharpe et al., 2003, O’Shaughnessy et 
al., 2007, Franca et al., 2016). Mature Sertoli cells secrete fluid under the control of 
FSH which is required to nourish developing germ cells and aid their transport out of 
the testis (Jegou et al., 1982, Richburg et al., 1994, Rato et al., 2010). Sertoli cell 
maturation is also associated with the development of the blood-testis barrier (BTB). 
Tight junctions, which consist of a number of junctional proteins including occludin 
and claudins (Saitou et al., 2000, Mazaud-Guittot et al., 2010), are formed between 
neighbouring Sertoli cells, which separates the basal, and adluminal regions of the 
seminiferous tubule (Dym and Fawcett, 1970). Together with immunosuppressive 
factors produced by Sertoli cells, the BTB restricts access to immune cells and other 
molecules to the adluminal compartment, thus creating an immunologically privileged 
site conducive to the development of auto-antigen expressing germ cells (Cesaris et 
al., 1992, Mital et al., 2010, Haverfield et al., 2014, Terayama et al., 2016). A number 
of factors regulate BTB function. Both FSH and androgen have been reported to 
modulate BTB permeability (Janecki et al., 1991, Meng et al., 2005). Additionally, 
cytokines also exert profound effects on BTB dynamics. For example, toxicant-
induced disruption of the BTB is associated with a surge in TGFB3 (Lui et al., 2003) 
and local administration of TGFB3 into the rat testis causes a transient increase in BTB 
permeability (Xia et al., 2009). Similarly, injection of recombinant IL1 into the rat 
testis interstitium has been shown to impact BTB permeability (Sarkar et al., 2008). 
Additionally, intratesticular injection of IL6 results in altered expression of occludin 
and claudin-11 and subsequent disruption to the seminiferous epithelium (Perez et al., 
2012). Interestingly, the IL6 signal transducing subunit glycoprotein 130 (gp130), as 
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well as other pleiotropic IL6-family members including LIF are expressed in the testis 
(Piquet-Pellorce et al., 2000, Molyneaux et al., 2003, Dorval-Coiffec et al., 2005). 
Whilst IL6 and LIF signalling has been shown to be active in Sertoli cells in vitro, 
(Jenab and Morris, 1996, 1998, 2000), their precise role in vivo remains to be 
established. 
1.2.3 Peritubular Myoid Cells 
Peritubular myoid cells surround the seminiferous tubules (Figure 1.2) and, together 
with Sertoli cells, produce extracellular matrix (ECM) components including 
collagens, fibronectin and laminin which contribute to the basement membrane of the 
tubular wall (Skinner et al., 1985, Richardson et al., 1995, Flenkenthaler et al., 2014). 
Peritubular myoid cells express the smooth muscle marker alpha actin (SMA) and are 
contractile to facilitate the movement of sperm toward the rete testis (Tung and Fritz, 
1990, Palombi et al., 1992, Tripiciano et al., 1996, Tripiciano et al., 1998, Rossi et al., 
2002). Additionally, the peritubular cells may also play a role in blood-testis barrier 
function. Early studies reported that junctions between peritubular cells could exclude 
a lanthanum tracer from the majority of the seminiferous tubules (Dym and Fawcett, 
1970). It has since been shown that this function is likely supported by the Sertoli cell 
population; although peritubular myoid cells alone are able to prevent immune cells 
infiltrating the seminiferous tubules (Rebourcet et al., 2014b). 
Given their anatomical location, the peritubular myoid cells are well positioned to 
influence both interstitial and intratubular compartments. With regards to the former, 
disruption of androgen receptors in peritubular myoid cells results in compensated 
Leydig cell failure (increased LH to maintain testosterone production) suggesting 
androgen-dependent factors produced by peritubular cells promote Leydig cell 
function (Welsh et al., 2009a). Peritubular myoid cells have also been suggested to 
play a role in the maintenance of the spermatogonial stem cell niche through androgen-
stimulated production of glial-derived neurotrophic factor (GDNF) which mediates 
stem cell renewal (Chen et al., 2014, Chen et al., 2016). Leukemia inhibitory factor, 
first noted for its ability to inhibit the differentiation of M1 leukemic myeloid cell line 
(Ichikawa, 1969), is required to maintain the pluripotent state of embryonic stem cells 
in vitro (Smith et al., 1988). LIF has also been shown to promote the proliferation and 
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survival of gonocytes in culture (De Miguel et al., 1996). Using a bioassay based on 
the proliferative response of DA-1 cells to LIF, Piquet-Pellorce et al. (2000) 
demonstrated that peritubular myoid cells are the primary source of LIF within the rat 
testis. Additionally, Dorval-Coiffec et al. (2005) assayed the expression of Lifr in 
purified testicular cell populations and found that Leydig cells, Sertoli cells, 
peritubular myoid cells, spermatogonia and macrophages all express Lifr, whilst no 
expression was detected in spermatocytes and spermatids. The authors further 
characterised these cell populations using a flow cytometry approach to detect binding 
of biotinylated LIF. This revealed that, whilst all Lifr-expressing populations were able 
to bind LIF, spermatogonia displayed the highest level of LIFR expression. Finally, 
using an in vitro seminiferous tubule culture system, the authors also reported that LIF 
increased the number of [3H]-thymidine labelled cells after 72-hours of culture 
suggesting that LIF may stimulate spermatogonial proliferation and/or survival. 
 
Figure 1.4 Leukemia Inhibitory Factor in the Testis. Peritubular myoid (PTM) cells are the 
predominant source of leukemia inhibitory factor (LIF) in the testis. The leukemia inhibitory 
factor receptor (LIFR) is widely expressed in the testis including in somatic Sertoli cells (SC) and 
Leydig cells (LC). Spermatogonia are considered a major target of LIF/LIFR signalling. 
As mentioned in section 1.2.1.2, LIF may also play a role in Leydig cell development. 
Peritubular myoid cell-derived LIF may therefore be an important regulator of the 
peritubular stem Leydig cell niche. Further to its potential role in the development of 
the adult Leydig cell population, LIF may also regulate Leydig cell steroidogenic 
function. Mauduit et al. (2001) reported an inhibition of human chorionic 
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gonadotrophin (hCG)-stimulated testosterone production when LIF was added to 
primary porcine Leydig cell cultures. The authors further demonstrated that this was 
due to impaired cholesterol transport into the inner mitochondrial membrane, as LIF 
dose-dependently reduced hCG-stimulated steroidogenic acute regulatory (Star) 
expression. Furthermore, the inhibitory effect of LIF on maximal testosterone 
production was absent in cultures treated with 22R-hydroxycholesterol which can 
readily diffuse the mitochondrial membrane and serve as a substrate for 
steroidogenesis. Interestingly, in the above studies, LIF had no effect on basal 
testosterone production which is consistent with studies of mature rat Leydig cells 
(Wang et al., 2016b). In contrast, Wang et al. (2016b) reported that LIF can stimulate 
basal testosterone production in immature rat Leydig cells through up-regulation of 
Star and Hsd17b3 and down regulation Akr1c14 and Srd5a1 which are involved in 
testosterone metabolism. Together, these studies suggest that peritubular myoid cell-
derived LIF may be an important paracrine regulator of testicular function. However, 
a role for LIF/LIFR signalling in the testis in vivo is yet to be described. 
1.2.4 Germ Cells and Spermatogenesis 
 Spermatogonia & Mitosis 
In the mature mammalian testis, haploid sperm are continually produced from diploid 
spermatogonial stem cells within the seminiferous tubules (Figure 1.2 and Figure 1.5) 
via the process of spermatogenesis. The sequence of spermatogenesis can be divided 
into mitotic, meiotic and post-meiotic phases. Spermatogonia, which comprise both 
stem and differentiating cell types, are located in the basal compartment between the 
basement membrane of the seminiferous tubule and the tight junctions of the blood-
testis-barrier. During the mitotic phase, spermatogonia proliferate under the influence 
of various molecules including glial derived neurotrophic factor (GDNF) signalling 
via GDNF family receptor-alpha (GFRA)(Meng et al., 2000); kit ligand (KITL) 
signalling via c-KIT receptor (Blume-Jensen et al., 2000, Yoshinaga et al., 1991) and 
Wnt/β-catenin signalling (Kumar et al., 2016, Takase and Nusse, 2016, Chassot et al., 
2017). As mentioned in section 1.2.3, spermatogonial proliferation may also be 
influenced by LIF/LIFR signalling but in vivo evidence is lacking. 
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Incomplete cytokinesis during mitosis results in the formation of syncytial daughter 
spermatogonia (Dym and Fawcett, 1971, Moens and Hugenholtz, 1975), the 
significance of which is not entirely understood, but may promote synchronisation of 
subsequent cell divisions. Spermatogonia can thus be sub-divided into Asingle (As), 
Apaired (Apr) or Aaligned (Aal) which are often referred to as undifferentiated 
spermatogonia (Figure 1.5). It was initially thought that stem cell activity is restricted 
to the As spermatogonia population (Huckins, 1971, Oakberg, 1971). However, it has 
since been proposed that whilst only a subset of As cells are spermatogonial stem cells, 
spermatogonia within cysts can recover stem cell potential via fragmentation 
(Nakagawa et al., 2010, Hara et al., 2014). Differentiating spermatogonia proceed 
through further mitotic divisions to produce A1, A2, A3 and A4, intermediate (In) and 
type B spermatogonia (Figure 1.5). Transition of B spermatogonia into primary 
spermatocytes is the last step of the mitotic phase of the spermatogenic cycle (Leblond 
and Clermont, 1952a). 
 
Figure 1.5 Overview of Spermatogenesis. On the left is an H&E stained mouse testis section 
showing the arrangement of germ cells within the seminiferous tubules. The schematic 
representation shown on the right highlights the location of the blood-testis-barrier. The 
mitotic phase of spermatogenesis takes place in the basal compartment whereas the meiotic 
and post-meiotic phases occur in the adluminal compartment. Modified from (Yoshida, 2010). 
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 Spermatocytes & Meiosis 
As discussed in section 1.2.2, junctional complexes between adjacent Sertoli cells 
within the seminiferous epithelium form the blood-testis barrier, which separates the 
basal and adluminal compartments (Figure 1.5). Primary spermatocytes must migrate 
across the BTB to the adluminal compartment where meiotic and post meiotic stages 
of spermatogenesis occurs. This is facilitated by a complex series of junctional 
degradation and restructuring (Mruk and Cheng, 2015). 
A round of DNA replication occurs in primary spermatocytes prior to the initiation of 
meiosis, which proceeds in two rounds (meiosis I and meiosis II). Meiosis occurs in 
four phases (prophase, metaphase, anaphase and telophase). During prophase, DNA 
condenses, homologous chromosomes pair and recombination occurs, inducing 
genetic variation between developing germ cells. During metaphase and anaphase, 
chromosomes are separated and, in telophase they move to opposite poles of the cell 
prior to cell division. These processes are repeated during meiosis II, giving rise to 4 
haploid round spermatids from each spermatocyte. Retinoic acid (RA), the active 
metabolite of vitamin A, stimulates the expression of Stra8 (stimulated by retinoic 
acid) in pre-meiotic germ cells which is required for meiotic initiation as evidenced by 
the lack of meiotic spermatocytes in Stra8-deficient testes (Anderson et al., 2008). The 
action of retinoic acid is balanced by its degradation via the activity of Cytochrome 
P450 Family 26 Subfamily B1 (CYP26B1) which functions to prevent meiosis in the 
fetal testis until the initiation of spermatogenesis (Bowles et al., 2006, MacLean et al., 
2007). 
 Spermatids & Spermiogenesis 
Following the meiotic phase of spermatogenesis, round spermatids undergo dramatic 
morphological changes, developing a distinctive head, mid-piece and tail as they 
transform into elongate spermatids during the process of spermiogenesis. The 
transition from round spermatids into elongate spermatids involves acrosome 
development, chromatin remodelling, a significant reduction in cytoplasmic volume 
and development of the characteristic sperm tail (Leblond and Clermont, 1952b, 
Oakberg, 1956). Acrosome development begins after the completion of meiosis II 
when pro-acrosomic granules accumulate and fuse (Ventela et al., 2000, Kang-Decker 
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et al., 2001). As elongating spermatids develop, extensive chromatin remodelling 
takes place as histones are replaced by protamines which results in compaction of 
DNA (Kistler et al., 1996, Braun, 2001, Cho et al., 2001). Shaping of the sperm head 
is facilitated by a transient structure termed the manchette - a ‘skirt-like’ arrangement 
of microtubules originating just below the acrosome and projecting into the spermatid 
cytoplasm (Russell et al., 1991, O’Donnell and O’Bryan, 2014). A second microtubule 
based structure called the axoneme develops during the post-meiotic phase of 
spermatogenesis and forms the core structure of the spermatid tail required for sperm 
motility. A mitochondria-rich sheath termed the mid-piece surrounds the axoneme and 
provides energy (Inaba, 2003). Cytoplasm is gradually displaced from the developing 
spermatid tail, forming a cytoplasmic lobule next to the spermatid head which is 
eventually expelled as a residual body and subsequently phagocytosed by Sertoli cells 
(Beardsley and O'Donnell, 2003, Russell, 1979). The final stage of spermiogenesis is 
the release of elongate spermatids into the seminiferous tubule lumen during the 
process of spermiation (O'Donnell et al., 2011). 
1.3 The Hypothalamic-Pituitary-Gonadal Axis 
The hypothalamic-pituitary-gonadal (HPG) axis (Figure 1.6) is a master endocrine 
regulator of testicular function. Gonadotrophin releasing hormone (GnRH) is 
produced by the hypothalamus and is released under stimulation by kisspeptins 
signalling through the kisspeptin receptor (GPR54) (d'Anglemont de Tassigny et al., 
2007, d'Anglemont de Tassigny et al., 2008, Kirilov et al., 2013). GnRH in turn 
stimulates gonadotrophs in the anterior pituitary to produce the gonadotrophins 
luteinising hormone (LH) and follicle-stimulating hormone (FSH). The Hpg mouse 
illustrates the importance of GnRH in the control of reproduction. In these mice, a 
mutation in the Gnrh gene results in the absence of GnRH, and subsequently 
gonadotrophins, leading to defective testicular development and function (Cattanach 
et al., 1977, Mason et al., 1986). 
As discussed in section 1.4.1, LH binds to its receptor on Leydig cells to stimulate 
testosterone production. Circulating testosterone, either directly or via peripheral 
aromatisation to estradiol, feeds back to the hypothalamic-pituitary unit to decrease 
LH production (Matsumoto and Bremner, 1984, Sheckter et al., 1989, Matsumoto, 
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1990, Hayes et al., 2000, Pitteloud et al., 2008). Follicle stimulating hormone binds to 
the follicle stimulating hormone receptor on Sertoli cells to promote spermatogenesis 
and testis function (discussed in sections 1.2.1.2 and 1.2.2). Inhibins, first isolated from 
ovarian follicular fluid (Ling et al., 1985), are produced by Sertoli cells in response to 
FSH stimulation (Le Gac and de Kretser, 1982, Morris et al., 1988, Pineau et al., 1990, 
Sharpe et al., 1988). Inhibins feedback to the pituitary to inhibit FSH production 
(Tilbrook et al., 1993, Kishi et al., 2000, Hayes et al., 2001). 
 
Figure 1.6 The Hypothalamic-Pituitary-Gonadal (HPG) Axis. Testicular function is under 
endocrine control by the HPG axis. Gonadotrophin releasing hormone (GnRH) is released from 
the hypothalamus and stimulates the production of luteinising hormone (LH) and follicle 
stimulating hormone (FSH) by pituitary gonadotrophs. LH and FSH bind to their receptors on 
Leydig (LH) and Sertoli (FSH) cells to stimulate steroidogenesis and spermatogenesis. 
Gonadotrophin-stimulated production of testosterone and inhibin feeds back to the 
hypothalamic-pituitary unit to negatively regulate gonadotrophin secretion. Green and red 
lines represent a stimulatory or inhibitory role respectively. 
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1.4 Androgen Production 
Androgens (e.g. testosterone) are produced within testicular Leydig cells via the 
process of steroidogenesis. During steroidogenesis, a cascade of enzymatic reactions 
convert cholesterol, the common steroid hormone precursor, into sex steroid 
hormones. 
1.4.1 Luteinising Hormone Receptor Signalling 
Leydig cell androgen biosynthesis is regulated by pituitary-derived luteinising 
hormone (see section 1.3). Disruption of either the luteinising hormone-beta subunit 
(Lhb) or the luteinising hormone receptor (Lhcgr) results in dramatically reduced 
testosterone levels and defective testicular development (Lei et al., 2001, Zhang et al., 
2001, Ma et al., 2004, Zhang et al., 2004). Luteinising hormone binds to its cognate 
G-protein coupled receptor (LHCGR) on the cell surface (McFarland et al., 1989, Xie 
et al., 1990). Binding of luteinising hormone to LHCGR stimulates the cyclic 
adenosine 3′,5′-monophosphate (cAMP) pathway which induces a rise in intracellular 
cAMP levels via the action of adenylyl cyclase. Increased cAMP in turn activates 
downstream effector molecules including protein kinase A (PKA) and protein kinase 
C (PKC) (Dufau et al., 1977, McFarland et al., 1989, Hansson et al., 2000, Stocco et 
al., 2005, Manna et al., 2007). The cAMP pathway stimulates steroidogenesis through 
the activation of transcription factors including CREB (cAMP response elements 
binding protein) and GATA4 (GATA binding protein 4) which activate downstream 
target genes including Scarb1, Star, Cyp11a1, Hsd3b1, Hsd3b6 and Cyp17a1 (Manna 
et al., 2002, Tremblay and Viger, 2003, Bergeron et al., 2015). Phosphodiesterase 
(PDE) enzymes balance the activity of adenylyl cyclase by catalysing the breakdown 
of cAMP to regulate intracellular levels. Pharmacological and genetic manipulation of 
PDEs has been shown to increase the sensitivity of Leydig cells to LH/hCG-stimulated 
testosterone production (Dufau et al., 1974, Shimizu-Albergine et al., 2012). 
1.4.2 Cholesterol Trafficking  
A readily available pool of cholesterol is a prerequisite for steroid biosynthesis. To 
meet the demand of steroidogenic cells cholesterol can be synthesised de novo, 
mobilised from intracellular lipid droplets or obtained from circulating lipoproteins 
either by bulk-uptake or selectively via scavenger receptor B1 (SRB1) (Andersen and 
Chapter 1 Literature Review 
23 
 
Dietschy, 1978, Hu et al., 2010b). The cascade of reactions that convert cholesterol 
into steroid hormones take place in the mitochondria and smooth endoplasmic 
reticulum. For steroidogenesis to occur, cholesterol must first be transferred across the 
mitochondrial membrane. This is dependent on the action of steroidogenic acute 
regulatory protein (StAR), deficiency of which impairs steroidogenesis (Clark et al., 
1994, Lin et al., 1995, Caron et al., 1997). The translocator protein (TSPO); previously 
called peripheral benzodiazepine receptor (PBR), may act in concert with StAR to 
facilitate cholesterol trafficking although experimental findings are conflicting. Initial 
in vitro studies suggested TSPO played a role in the movement of cholesterol between 
the outer to inner mitochondrial membranes (Krueger and Papadopoulos, 1990) and 
that its genetic disruption inhibited steroidogenesis due to defective cholesterol 
transfer (Papadopoulos et al., 1997). However, it has recently been demonstrated that 
steroidogenesis is unaffected upon global or cell-specific Tspo ablation (Morohaku et 
al., 2014, Tu et al., 2014). 
1.4.3 The Steroidogenic Cascade 
Cholesterol is converted to pregnenolone within the mitochondria by the action of 
P450 cholesterol side-chain cleavage enzyme (CYP11A1) (Burstein and Gut, 1976, 
Simpson, 1979, Pelletier et al., 2001). This step is common to, and essential for, the 
biosynthesis of all steroids. Severe steroid deficiency and 44,XY sex-reversal is 
observed in humans with CYP11A1 mutations (Hiort et al., 2005, al Kandari et al., 
2006) and, in Cyp11a1-deficient mice, lipids accumulate in steroidogenic tissues (Hu 
et al., 2002). 
Conversion of pregnenolone to testosterone occurs in the smooth endoplasmic 
reticulum through four reactions catalysed by hydroxysteroid dehydrogenase 3-beta 
(HSD3B), 17α-hydroxylase, 17,20-lyase (CYP17A1) and hydroxysteroid 
dehydrogenase 17-beta (HSD17B). Interestingly, an ultrastructural localisation study 
of steroidogenic enzymes in rat adrenal and testis suggested that, in contrast to 
steroidogenic cells of the adrenal cortex, conversion of pregnenolone to progesterone 
by HSD3B in Leydig cells may take place in the mitochondria rather than the smooth 
endoplasmic reticulum (Pelletier et al., 2001). In the mouse, there are six HSD3B 
isoforms, with HSD3B1 and HSD3B6 predominant in the testis (Baker et al., 1999). 
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In humans, deficiency of HSD3B results in impaired steroidogenesis and in males can 
disturb sexual development due to the absence of androgen (Burckhardt et al., 2015). 
Steroidogenic enzymes can act on and compete for multiple substrates. As such, 
pregnenolone can be converted into androgen by either the Δ4 or the Δ5 pathway 
which diverge at the point of pregnenolone metabolism (Conley and Bird, 1997). In 
the Δ4 pathway, pregnenolone is initially metabolised to progesterone by the action of 
HSD3B. Progesterone is then converted to 17α-hydroxyprogesterone and then 
androstenedione through the action of CYP17A1 (Nakajin and Hall, 1981, Zuber et 
al., 1986). Conversely, in the Δ5 pathway, CYP17A1 acts first to convert pregnenolone 
to 17α-hydroxypregnenolone and then dehydroepiandrosterone (DHEA), which is 
then converted to androstenedione by HSD3B. It has been suggested that preferential 
utility of the Δ4 or the Δ5 pathway varies between species with the Δ4 being 
predominant in rodents and the Δ5 in humans (Brock and Waterman, 1999, Fluck et 
al., 2003). However, the studies of Brock and Waterman (1999) used partially purified 
recombinant human and rat CYP17A1 and those of Fluck et al. (2003) utilised 
microsomal isolates of the human fetal testis. As such, spatiotemporal context, which 
may influence which pathway predominates, is lacking. For example, Sheffield and 
O'Shaughnessy (1988) reported variation in the pathways of pregnenolone metabolism 
across development in the mouse testis. The importance of CYP17A1 in androgen 
biosynthesis is highlighted by defective sexual development/46,XY sex-reversal in 
individuals with CYP17A1 mutations (Geller et al., 1997, Di Cerbo et al., 2002, 
Camats et al., 2015). 
The final step in testosterone biosynthesis is the conversion of androstenedione to 
testosterone by HSD17B3. In humans, the loss of HSD17B3 results in defective sexual 
development/46,XY sex-reversal (Geissler et al., 1994, Werner et al., 2012). 
Interestingly, in rat testes devoid of Leydig cells, some HSD17B enzyme activity is 
retained which suggests expression may not be restricted to the Leydig cell population 
(O'Shaughnessy and Murphy, 1991). In contrast to steroidogenesis in adult mouse 
testis, testosterone production in the embryonic testis is a combined effort from the 
fetal Leydig and Sertoli cells (SC). Fetal Leydig cells do not express HSD17B3 that is 
required for the final conversion of androstenedione to testosterone. Instead, 
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androstenedione is the principal androgen produced by fetal Leydig cells and is 
converted to testosterone by the fetal Sertoli cells (O'Shaughnessy et al., 2000, Shima 
et al., 2013). Testosterone can be further metabolised to the more potent androgen 
dihydrotestosterone (DHT) or to estradiol via the action of 5α-reductase (SRD5A) or 
aromatase (CYP19A1) respectively. 
1.4.4 Androgens Support Male General Health 
Further to their established role in masculinisation and development of the male 
reproductive tract in utero (Welsh et al., 2008, MacLeod et al., 2010), and the 
maintenance of reproductive function/fertility in adulthood (Dohle et al., 2003), 
androgens have also been implicated in aspects of bone, muscle and lipid metabolism. 
For example, a role for androgens in bone turnover has been suggested whereby 
androgens function to negatively regulate bone resorption (Kawano et al., 2003). 
Furthermore, androgen deprivation therapy (i.e. chemical or surgical castration for the 
treatment of prostate cancer) is associated with a decrease in bone mineral density, 
decreased muscle strength and increased fat mass (Daniell et al., 2000, Basaria et al., 
2002). Additionally, in studies of chemical castration and testosterone replacement in 
healthy young men, testosterone levels are positively correlated with muscle strength 
and volume and negatively correlated with fat mass and high-density lipoprotein 
(HDL) cholesterol (Bhasin et al., 2001, Finkelstein et al., 2013). As such, the overall 
general health, as well as reproductive health, of adult males is thought to be supported 
by testosterone and its metabolites. 
Indeed, both cross-sectional and prospective large cohort studies of adult males report 
an inverse relationship between testosterone levels and the risk of age-related cardio-
metabolic diseases (Muller et al., 2005, Kupelian et al., 2006, Yeap et al., 2014, Pye 
et al., 2014, Antonio et al., 2015). However, there is also a suggestion of reverse 
causality (i.e. that underlying ill health causes a reduction in testosterone levels) 
(Eriksson et al., 2017). For example, Laaksonen et al. (2005) suggested that presence 
of the metabolic syndrome predisposes middle-aged men to the development of 
hypogonadism. However, serum gonadotrophins were not measured so the existence 
of subclinical hypogonadism at baseline could not be ruled out. 
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The causal relationship between ageing, testosterone and disease is clearly complex 
and requires further clarification. Nevertheless, androgen replacement therapy is 
becoming increasingly common with the number of testosterone prescriptions 
increasing by 90% between 2001 and 2010 in the United Kingdom, costing the 
National Health Service an estimated 11.7 million pounds per year (Gan et al., 2013). 
Similar increasing trends in testosterone prescribing are also reported in the United 
States (Baillargeon et al., 2013) and Australia (Handelsman, 2012) despite conflicting 
evidence regarding the risks and benefits of androgen replacement therapy. Some 
studies have reported beneficial effects of androgen replacement therapy on muscle, 
lipid and glucose metabolism in hypogonadal men (Kovacheva et al., 2010, 
Frederiksen et al., 2012, Yassin et al., 2016, Sharma et al., 2017). Conversely, Basaria 
et al. (2015) reported no beneficial effect of testosterone replacement on the 
progression of subclinical atherosclerosis in ageing men; but reported an increase in 
haematocrit and levels of prostate-specific antigen which may be indicative of an 
increased risk of adverse cardiovascular events and prostate cancer respectively 
(Osterberg et al., 2014). Indeed, a clinical trial of testosterone replacement in elderly 
men was prematurely halted due to an increased frequency of adverse cardiovascular 
events in the testosterone treated group (Basaria et al., 2010). 
1.5 Testicular Ageing 
1.5.1 Age-related Testicular Atrophy 
In contrast to the female menopause, ageing in males is not accompanied by a cessation 
of reproductive capacity. However, as with many tissues, testicular atrophy is 
associated with advancing age although the age of onset and severity is highly variable 
between individuals. Handelsman and Staraj (1985) reported that testis size is reduced 
in aged males, independently of underlying ill health. More recently, scrotal ultrasound 
examination of 150 males up to 96 years of age revealed that maximum testis volume 
is seen in 25 year-old men and a slight but significant reduction is observed in ageing 
men (Well et al., 2007). Similar findings were also reported by Yang et al. (2011). In 
addition, Mahmoud et al. (2003) related testicular volume to circulating hormone 
levels and demonstrated an indirect correlation between testicular volume and both 
luteinising hormone and follicle-stimulating hormone in ageing men. This suggests 
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that age-related testicular atrophy is not likely due to hypothalamic-pituitary failure 
and subsequent diminished testicular gonadotrophin stimulation. In contrast, 
Pasqualotto et al. (2005) did not detect an association between age and testicular 
volume. However, this study only included males up to 67 years of age. The authors 
did however report an increase in circulating FSH and decrease in semen sperm 
concentration in older men, consistent with age-related Sertoli cell dysfunction 
(Neaves et al., 1984, Tenover et al., 1988, Johnson et al., 1990, Mahmoud et al., 2000). 
Several studies have suggested that the number of Sertoli cells declines as men age 
(Johnson et al., 1984b, Jiang et al., 2013, Petersen et al., 2015), and that sperm output 
of the ageing testis is compromised (Chen et al., 2003, Eskenazi et al., 2003, Ng et al., 
2004, Johnson et al., 2015). Ultrastructural studies have revealed progressive 
degeneration and involution of the seminiferous tubules associated with 
multinucleated germ cells, germ cell exfoliation and subsequent vacuolation of the 
Sertoli cells in the ageing testis (Paniagua et al., 1987, Paniagua et al., 1991, Jiang et 
al., 2013). Additionally, the basement membrane of tubules with spermatogenic arrest 
is reported to be thickened (Paniagua et al., 1987, Dakouane et al., 2005, Sasano and 
Ichijo, 1969). Paniagua et al. (1987) suggested that these changes were similar to those 
induced by experimental testicular ischaemia which would be consistent with a 
reduction in capillary network in regions of tubule degeneration in aged testes 
(Suoranta, 1971). In addition, testicular atrophy and a reduction in sperm production 
is observed in the atherosclerotic ApoE−/−;LDL receptor−/− double knockout mouse 
model in which testicular vascular volume is reduced (Langheinrich et al., 2012). 
Interestingly, Sertoli cell function has been suggested to modulate the vascular 
network in the mouse testis (Rebourcet et al., 2016) and, the testicular vasculature has 
been reported to contribute to the spermatogonial stem cell niche (Yoshida et al., 
2007). As such, the interdependence between ageing, the testicular microvasculature 
and seminiferous tubule function is complex and the sequence of events leading to 
testicular atrophy/seminiferous tubule degeneration is not fully understood. In general, 
the testes of aged men contain a mosaic of seminiferous tubules with apparently 
normal spermatogenesis as well as completely atrophic tubules and variation between 
individuals is high, probably explaining the individual variation in testis volume. 
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There are conflicting reports on the fate of the Leydig cell population during the ageing 
process. Kothari and Gupta (1974) initially reported that Leydig cell number was in 
fact increased in the ageing testis. However, their analysis was based only on total 
Leydig cell volume per testis. Thus, the observed increase may be due to Leydig cell 
hypertrophy rather than hyperplasia. In a later study, Kaler and Neaves (1978) reported 
that individual Leydig cell volume did not change significantly with advancing age but 
total Leydig cell volume and thus absolute Leydig cell number decreased with age. In 
another study, a forty-four percent reduction in Leydig cell number was observed 
between men aged 20-48 and 50-70 years old (Neaves et al., 1984). Interestingly, the 
authors reported that this was not associated with a reduction in circulating 
testosterone, instead a two-fold elevation in luteinising hormone was observed in the 
older men (Neaves et al., 1984). Contrary to these early reports, more recent evidence 
suggests that Leydig cell numbers do not decrease with age in men. Initially reporting 
the results of a pilot study, Petersen and Pakkenberg (2000) suggested that, whilst 
Sertoli cell number may decline with age, no such change is observed in the Leydig 
cell population. Using a larger sample size of men ranging from 16 to 80 years old, the 
authors later reported that an inverse relationship exists between cell number and 
advancing age for Sertoli cells but not for Leydig cells (Petersen et al., 2015). It must 
be considered however, that each of the aforementioned studies quantifying Sertoli 
cell and Leydig cell numbers is cross-sectional. As such, it is not entirely possible to 
conclude whether cell number decreases due to ageing per se or due to a secular effect. 
Nevertheless, hormonal parameters (i.e. increased gonadotrophins) suggest that even 
if Sertoli and Leydig cell numbers do not decline with age, cell function may be 
reduced. 
1.5.2 Testicular Endocrine Function Declines with Age 
In humans, circulating testosterone is either specifically bound to sex hormone binding 
globulin (SHBG), weakly bound to albumin, or is not associated with binding proteins 
(i.e. is ‘free’) (Vermeulen and Verdonck, 1968, Kaufman and Vermeulen, 2005). Sex 
hormone binding globulin is produced by the liver whereas in rodents, the equivalent 
(androgen binding protein; ABP) is produced by testicular Sertoli cells (Joseph et al., 
1997). The ‘free’ and albumin-bound fractions are generally considered to represent 
bioavailable testosterone that is readily available to target tissues (Manni et al., 1985). 
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However, the relative contribution of albumin-bound testosterone to the bioavailable 
pool is likely influenced by multiple factors in different tissue contexts (Vermeulen et 
al., 1999). A consensus regarding the ‘normal’ reference range for testosterone has 
been lacking (Giannetta et al., 2012). In a recent study, Travison et al. (2017) obtained 
serum samples from four large cohort studies previously conducted in the United 
States and Europe. Testosterone was re-measured in a subset of samples from each 
cohort to allow cross-calibration of the different assays previously used to measure 
testosterone in each of the cohorts. The authors then compared the newly measured 
values to those previously obtained to develop a normalisation strategy that they then 
applied to the entire cohorts. Using this strategy, normal reference range for 
testosterone in healthy men aged 19 to 30 years old is reported to be 264-916 ng/dL 
(Travison et al., 2017). 
As discussed in section 1.4.4, androgens are thought to support general health in men. 
Several longitudinal studies from Europe (Wu et al., 2008), the United States (Harman 
et al., 2001, Feldman et al., 2002, Mohr et al., 2005, Fabbri et al., 2016) and Australia 
(Liu et al., 2007) have demonstrated a decrease in testosterone and increase in SHBG 
(ultimately indicating decreased bioavailable testosterone) as males age, although the 
rate of decline varies between studies. Generally, testosterone decreases by 1-2% per 
year from the age of 40 years onwards. However, the presence of a clinical syndrome 
in which low testosterone is associated with adverse sexual, physical and 
psychological symptoms only manifests in a small number of aged males (Huhtaniemi, 
2014). Intriguingly, it has been suggested that a greater age-related decline in 
testosterone is associated with later year of birth (Andersson et al., 2007, Travison et 
al., 2007, Perheentupa et al., 2013, Mazur et al., 2013). Although the mechanism(s) 
underlying the age-associated decline in testosterone and its clinical significance are 
not fully understood, the suggestion of a secular decline may indicate 
environmental/lifestyle factors are be of etiological importance. 
Reduced levels of circulating testosterone (hypogonadism) can be due to either a defect 
in Leydig cell androgen biosynthesis (termed primary hypogonadism), or due to 
reduced stimulation of Leydig cells due to defects in the hypothalamic-pituitary unit 
(see section 1.3) resulting in decreased luteinising hormone secretion (termed 
secondary hypogonadism). Secondary hypogonadism is commonly associated with 
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obesity due to decreased luteinising hormone production (Vermeulen et al., 1993) and 
its prevalence is not reported to increase with age Tajar et al. (2010). Conversely, the 
proportion of men with primary hypogonadism is increased with advancing age thus, 
age-related reduction in testosterone level is thought to be predominantly caused by 
primary testicular dysfunction (Tajar et al., 2010, Tajar et al., 2012). 
Androgen levels may remain within the normal range in the face of Leydig cell 
dysfunction. In this scenario, increased pituitary-derived luteinising hormone is 
required to drive Leydig cell steroidogenesis (Rubens et al., 1974, Andersson et al., 
2004, Tajar et al., 2010). Given this plasticity in the hypothalamic-pituitary-gonadal 
axis, inferences of Leydig cell function can only be made from the luteinising 
hormone/testosterone ratio, with a high ratio indicative of Leydig cell dysfunction 
(compensated Leydig cell failure). It has been reported that the proportion of men with 
compensated Leydig cell failure also increases with age and is associated with an 
increased likelihood of physical symptoms considered to be related to low testosterone 
(including inability to carry out vigorous activity, walk more than one kilometre, or 
reduced flexibility)(Tajar et al., 2010). Thus, it is suggested that compensated Leydig 
cell failure is a distinct clinical state associated with ageing and that men with 
compensated hypogonadism may be poised to develop primary hypogonadism as they 
age. As such, understating the mechanism(s) underlying age-related Leydig cell 
dysfunction is important to aid the development of novel therapeutic interventions 
aimed at reversing age-related primary hypogonadism. 
1.5.3 Mechanisms of Reduced androgen Production 
It has been suggested that aged Leydig cells may be less sensitive to gonadotrophin 
stimulation resulting in reduced testosterone production (Longcope, 1973, Rubens et 
al., 1974, Harman and Tsitouras, 1980, Veldhuis et al., 2012). Interestingly, the studies 
of Longcope (1973) and Rubens et al. (1974) reported that the relative increase in 
gonadotrophin-stimulated testosterone production over baseline was similar between 
young and old men. This raises the possibility that a deficit in Leydig cell number, 
rather than function, may underlie the reduced ability of the aged testis to produce 
testosterone in this setting (i.e. when gonadotrophin level is limiting). Consistent with 
this theory, Neaves et al. (1984) suggested that increased luteinising hormone 
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production by the pituitary is able to maintain testosterone production in the testes of 
aged men which were reported to contain fewer Leydig cells. However, in light of the 
suggestion that Leydig cell number does not decline with age (Petersen et al., 2015); 
decreased steroidogenic efficiency of aged Leydig cells may indeed be responsible for 
age-related primary hypogonadism. This is further supported by studies using the aged 
Brown Norway rat as a model of human reproductive ageing (in which Leydig cell 
numbers are not reported to decrease with age) that demonstrate a blunted response 
(i.e. reduced androgen biosynthesis) of aged Leydig cells to gonadotrophin stimulation 
(Chen et al., 1994, Chen et al., 2002). 
 Impaired Luteinising Hormone Receptor Signalling 
Impaired luteinising hormone receptor (LHCGR) signalling (see section 1.4.1) has 
been described in aged Leydig cells. A reduction in LHCGR number on the surface of 
aged Leydig cells results in decreased intracellular cAMP accumulation following 
stimulation with luteinising hormone (Chen et al., 2002). Stimulation of Leydig cells 
with forskolin (which raises cAMP independently of LHCGR signalling) causes 
equivocal increases in cAMP in young and aged cells; suggesting that adenylyl cyclase 
activity is maintained in aged cells (Chen et al., 2002). Furthermore, incubation of 
aged Leydig cells with saturating concentrations of dibutyryl cAMP (a membrane-
permeable cAMP agonist that bypasses the LHCGR/adenylyl cyclase cascade) restores 
testosterone production by aged cells to levels produced by young cells (Chen et al., 
2004). Together, these studies suggest that LHCGR signal transduction is less efficient 
in aged Leydig cells. 
 Defects in the Steroidogenic Cascade 
A number of defects in the steroidogenic pathway have been identified in aged rat 
Leydig cells. Firstly, Culty et al. (2002) reported that cholesterol transport across the 
mitochondrial membrane is reduced, consistent with a reduction in mRNA and protein 
expression of StAR and TSPO in aged Leydig cells (Luo et al., 2001, Culty et al., 
2002, Luo et al., 2005). The contribution of the latter to the age-related reduction in 
androgen biosynthesis may be insignificant as recent evidence suggests that TSPO 
may be redundant for normal steroidogenesis (Morohaku et al., 2014, Tu et al., 2014). 
However, Chung et al. (2013) reported that pharmacological activation of TSPO both 
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in vitro and in vivo resulted in increased testosterone production by aged rat Leydig 
cells to levels equivalent of young controls. In addition to impaired cholesterol 
trafficking, mRNA and protein expression of CYP11A1, HSD3B and CYP17A1 is 
decreased in aged Leydig cells (Luo et al., 1996, 2001, Culty et al., 2002, Luo et al., 
2005). Furthermore, incubation of Leydig cells with either 25-hyroxycholesterol, 
pregnenolone, progesterone, 17-hydroxyprogesterone, or androstenedione, as 
substrates for androgen production, allowed individual reactions in the steroidogenic 
cascade to be monitored. This demonstrated that the enzymatic activity of CYP11A1, 
HSD3B, CYP17A1 and HSD17B are all reduced in aged Leydig cells (Luo et al., 
1996). 
 Pro/Antioxidant Balance & Cumulative Damage  
Leydig cell turnover in the adult testis is thought to be minimal (Teerds et al., 1989, 
Mendis-Handagama, 1991) thus, the terminally differentiated Leydig cell population, 
which is established during pubertal development, is probably not replenished to any 
significant extent. As such, the reduced capacity for androgen production by aged 
Leydig cells likely reflects a degenerative response to a myriad of insults received over 
the lifetime of individual cells. Initially proposed by Harman (1956), the ‘free-radical 
theory of ageing’ suggests that cumulative damage by reactive oxygen species (ROS) 
results in impaired cellular function which in turn leads to age-related tissue 
degeneration (Finkel and Holbrook, 2000). Reactive oxygen species are generated as 
a by-product of mitochondrial respiration (Turrens, 2003). As highly reactive 
molecules, they can induce damage to lipid membranes, proteins and DNA and 
interfere with intracellular signalling cascades. Gonadotrophin stimulation of primary 
rat Leydig cells and the MA-10 mouse Leydig cell tumour line has been shown to 
increase intracellular ROS concentrations and induce DNA damage, an effect which 
is more profound in aged Leydig cells (Beattie et al., 2013). 
In steroidogenic cells such as Leydig cells, ROS are also generated by cytochrome 
P450 enzymes which function in the steroidogenic cascade (Hanukoglu, 2006). As 
such, Leydig cells are equipped with enzymatic and non-enzymatic antioxidant 
defence systems to prevent ROS-induced damage (Aitken and Roman, 2008). During 
the ageing process, the oxidant/antioxidant balance is thought to become 
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compromised, leading to establishment of an oxidative environment that impairs 
cellular functions. Indeed using the redox-sensitive probe lucigenin, Chen et al. (2001) 
detected increased levels of superoxide in aged rat Leydig cells and it has been reported 
that the expression and activity of key antioxidant enzymes including superoxide 
dismutase-1 and -2, glutathione peroxidase as well as the antioxidant glutathione, is 
reduced in aged Leydig cells and testis tissue (Cao et al., 2004, Luo et al., 2006, Huang 
et al., 2017). Furthermore, glutathione depletion both in vitro and in vivo reduces 
Leydig cell testosterone production in normal Leydig cells (Chen et al., 2008). 
Further evidence that steroidogenesis itself may cause cumulative damage to Leydig 
cells is provided by an experiment conducted by Chen and Zirkin (1999), in which 
long-term suppression of Leydig cell steroidogenesis via silastic testosterone implants 
to supress endogenous testosterone production, protects cells against age-related 
reductions in testosterone biosynthesis. Additionally, when hypo-functional aged 
Leydig cells are ablated from the rat testis using ethane dimethanesulphonate (EDS), 
the ‘new’ Leydig cells which repopulate the aged testis are able to restore testosterone 
to levels observed in young controls (Chen et al., 1996). However, in a more recent 
study, Chen et al. (2015) assessed the fate of newly re-generated Leydig cells 10 and 
30 weeks post EDS ablation and found that the ‘new’ Leydig cells in the aged testis 
failed to maintain their ability to produce testosterone compared to those of young 
animals. As such, factors extrinsic to Leydig cells in aged animals (i.e. within the 
testicular microenvironment or systemic factors) may also contribute to age-related 
Leydig cell dysfunction. 
Despite the accumulation of knowledge regarding the age-related changes which occur 
in Leydig cells, the precise mechanism(s) which lead to such changes remain to be 
elucidated. Deeper mechanistic insights into the age-related dysfunction of Leydig 
cells could identify novel therapeutic strategies to promote androgen production in 
ageing males thus improving quality of life in older males as well as reducing the 
healthcare burden of an increasing aged population. 
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1.6 Animal Models for the Study of Testicular Ageing 
1.6.1 Naturally Aged Animals 
Naturally aged animals have been widely used to characterise the impact of ageing on 
the reproductive system. The naturally aged Brown Norway rat is perhaps the best 
studied; much of what is known about the age-related changes in the testis, particularly 
with reference to Leydig cell testosterone production (discussed in section 1.5.3), has 
arisen through studies conducted using this model. Importantly, compared to other 
strains of rat including Fisher F344 (Turek and Desjardins, 1979), Sprague-Dawley 
(Kaler and Neaves, 1981), and Wistar (Teerds et al., 1991), in which circulating 
gonadotrophins are maintained or even decreased; the hormonal profile of aged Brown 
Norway rats is considered to best resemble the age-related primary hypogonadism 
observed in ageing men (i.e. increased LH and decreased testosterone)(Chen et al., 
1994). Studies of naturally ageing mice report conflicting findings regarding the 
impact of ageing on circulating testosterone. It has been suggested that LH production 
decreases with age leading to reduced circulating testosterone (Bronson and 
Desjardins, 1977, Coquelin and Desjardins, 1982). In contrast, Finch et al. (1977) 
reported no difference in LH and testosterone levels between young and old mice. As 
such, naturally aged mice may be of limited utility for the study of age-related Leydig 
cell dysfunction.  
Intriguingly, Poutahidis et al. (2014) reported that consumption of probiotic microbes 
could promote spermatogenesis and steroidogenesis during ageing. Specifically, in 
outbred CD-1 mice, consumption of Lactobacillus reuteri resulted in increases in testis 
weight, seminiferous tubule cross-sectional area, germ cell volume, Leydig cell 
number and circulating testosterone (Poutahidis et al., 2014). This suggests that the 
composition and/or health of the intestinal microflora may be an important mediator 
testicular function during the ageing process. The authors further suggested that anti-
inflammatory properties of Lactobacillus reuteri may be responsible for the observed 
‘anti-ageing’ effects on the testis as systemic administration of blocking antibodies 
against the pro-inflammatory cytokine interleukin-17 produced similar effects on the 
above reproductive parameters in 12-month old mice (Poutahidis et al., 2014). 
Unfortunately, circulating gonadotrophins were not measured in these studies, so 
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whether the ‘anti-aging’ effects of both Lactobacillus reuteri and interleukin-17 
blockade act at the hypothalamic/pituitary level or directly on the testis remains to be 
established.  
1.6.2 Premature Ageing Models 
Studying naturally aged animals is time consuming, expensive and is accompanied by 
protracted welfare issues. As such, models of premature ageing may be attractive 
alternatives for the expedited study of age-related testicular dysfunction. However, 
whilst prematurely ageing models may display general degenerative phenotypes 
resembling ageing, they may not fully recapitulate normal ageing processes. As such, 
the characteristics of individual models must be carefully considered in order to select 
the most appropriate model for use in tissue/organ-specific ageing research projects. 
For example, administration of D-galactose to mice and rats results in accelerated 
ageing and is reported to model aspects of age-related primary hypogonadism. D-
galactose treatment induces oxidative stress in the testis and is associated with 
decreased testis weight, reduced sperm production, decreased circulating testosterone 
and an increase in both LH and FSH (Ahangarpour et al., 2014, Liao et al., 2016, Yang 
et al., 2015a). Additionally, in the senescence accelerated SAMP8 mouse line, 
premature ageing is also thought to be partly mediated by oxidative stress. SAMP8 
mice have increased levels of DNA damage in sperm as well as decreased circulating 
testosterone in the presence of increased gonadotrophins - indicative of primary 
testicular dysfunction (Flood et al., 1995, Smith et al., 2013, Wang et al., 2016a). 
Conversely, Trifunovic et al. (2004) described an accelerated ageing phenotype 
characterised by weight loss, hair loss, osteoporosis and premature death in 
mitochondrial DNA (mtDNA) mutator mice that lack the proofreading activity of 
mitochondrial DNA polymerase. A significant reduction in testis weight and reduced 
fertility, associated with degeneration of the seminiferous epithelium concomitant with 
increased FSH is observed in mtDNA mutator mice (Trifunovic et al., 2004, Shabalina 
et al., 2015). However, whilst Leydig cells of mtDNA mutator mice contain 
dysfunctional mitochondria and show signs of oxidative stress, circulating testosterone 
and LH are normal (Shabalina et al., 2015). 
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 The CISD2-Deficient Prematurely Ageing Model 
In 2009, a premature ageing phenotype characterised by nerve and muscle 
degeneration, osteopenia, reduced body weight and premature death, was reported in 
mice deficient for Cisd2 (CDGSH iron sulphur domain 2), (Chen et al., 2009c). 
Conversely, transgenic Cisd2 over expression in mice has been reported to extend 
healthy lifespan and delay ageing; protecting against age-associated mitochondrial 
dysfunction (Wu et al., 2012). Interestingly, human CISD2 is located on chromosome 
4q, in a region that has been associated with longevity (Puca et al., 2001). 
Cisd2 encodes the second member of small family of transmembrane proteins that 
contain a CDGSH iron sulphur domain. There is little known regarding the regulation 
and function of CISD2, even the subcellular localisation is disputed with conflicting 
reports suggesting it is localised to the mitochondrion (Chen et al., 2009c) and/or the 
endoplasmic reticulum (Chang et al., 2010, Wiley et al., 2013). Chang et al. (2010) 
suggested that CISD2 may be involved in facilitating the interaction of BCL-2 and 
beclin-1, an interaction that antagonises the autophagy pathway. It has also been 
suggested that CISD2 may be involved in the cellular response to oxidative stress 
(Tamir et al., 2013, Tamir et al., 2015). Indeed, using a redox-sensitive fluorescent 
probe, Wiley et al. (2013) demonstrated that CISD2-loss results in a pro-oxidative 
intracellular environment. Furthermore, CISD2-loss causes endoplasmic reticulum 
stress and mitochondrial dysfunction associated with dysregulation of intracellular 
calcium homeostasis (Chang et al., 2010, Chang et al., 2012, Wiley et al., 2013, Wang 
et al., 2014). 
The reproductive phenotype of CISD2-deficient mice has not been characterised. As 
such, whether this prematurely ageing model has utility for the studies of age-related 
testicular dysfunction remains to be established. In humans, CISD2 mutation is 
associated with Wolfram syndrome, which is characterised by early onset of age-
associated phenotypes including juvenile-onset diabetes, progressive neurologic 
degeneration, and endocrine dysfunction (Amr et al., 2007, Rohayem et al., 2011). 
Testicular atrophy and infertility have also been described in patients with Wolfram 
syndrome. More specifically, reduced testosterone accompanied by elevated 
gonadotrophins (indicative of primary testicular dysfunction) has been reported (Peden 
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et al., 1986, Homan and MacKay, 1987, Barrett et al., 1995, Medlej et al., 2004, 
Rohayem et al., 2011, Haghighi et al., 2013). This indirect evidence suggests that 
Cisd2-deficient mice may be expected to model age-related primary hypogonadism as 
observed in ageing men. 
1.7 Therapeutic Potential of Stem Cells to treat Primary Hypogonadism 
As discussed in section 1.4.4, hypogonadism (i.e. in the ageing male) is associated 
with an increased risk of chronic, age-related cardiometabolic disorders. Age related 
hypogonadism is thought to be partly due to primary testicular dysfunction (see section 
1.5.2). Indeed, a number of defects, which may contribute to reduced testosterone 
production, have been described in aged Leydig cells (discussed in section 1.5.3). 
Exogenous testosterone replacement is widely used to treat hypogonadism although 
the risks and benefits associated with the administration of exogenous testosterone are 
not entirely clear (Bassil et al., 2009, Handelsman, 2017). As an alternative to 
exogenous androgen replacement, recent efforts have been made to develop stem cell-
based therapies to treat testicular dysfunction. 
In general, there have been two approaches towards a stem cell therapy for the 
treatment of primary hypogonadism. Firstly, significant attention has been focussed 
on the isolation and in vitro characterisation of endogenous stem Leydig cells and their 
subsequent transplantation into the testis. An initial study suggested that a ‘side 
population’ of cells isolated from the mouse testis contained stem/progenitor cells that 
could form Leydig cells and increase testosterone levels when transplanted into 
hypogonadal luteinising hormone receptor-deficient mice (Lo et al., 2004). However, 
the precise identity of the responsible stem cell population was unknown. As 
mentioned in section 1.2.1.1.1, Ge et al. (2006) isolated a population of stem cells from 
the neonatal rat testis based on expression of platelet-derived growth factor receptor-
alpha. The authors suggested these cells could differentiate into testosterone producing 
Leydig-like cells in vitro when cultured in the presence of a differentiation inducing 
medium containing luteinising hormone, insulin-like growth factor 1, platelet-derived 
growth factor-beta and thyroid hormone. This cocktail differentiation inducing factors 
was also reported to induce Leydig cell differentiation of nestin-positive (Jiang et al., 
2014) and CD51-positive (Zang et al., 2017) testicular stem cells isolated from the 
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mouse testis. Whilst these studies provide promising evidence that endogenous stem 
cells may have therapeutic potential for the treatment of primary hypogonadism, 
isolation of stem cells from a patient’s testis would be impractical, as the testis is 
digested to isolate the cells. Theoretically, activation of endogenous stem Leydig cells 
would circumvent the need for cell isolation and transplantation procedures however, 
the factors controlling stem Leydig cell fate are yet to be fully elucidated. 
The second approach involves the use of extra-gonadal stem cells, including 
pluripotent stem cells (i.e. embryonic or induced pluripotent stem cells) and 
multipotent mesenchymal stem cells (MSCs). For example, Yang et al. (2015b) 
reported that murine embryonic stem cells could be transformed into Leydig-like cells 
via steroidogenic factor-1 (SF-1 ) overexpression and, when transplanted into Leydig 
cell ablated rat testes, could transform into mature Leydig cells. More recently, to 
overcome ethical and safety concerns concomitant with the use of pluripotent 
embryonic stem cells, a protocol to transform mouse fibroblasts into Leydig cells via 
viral transduction of SF-1, DMRT-1 and GATA-4 was described (Yang et al., 2017b). 
The authors demonstrated that forced expression of these transcription factors resulted 
in the reprogramming of fibroblasts into Leydig cells, without the induction of a 
pluripotent state. However, this procedure was more efficient in embryonic fibroblasts 
compared to fibroblasts isolated from adult tissue. 
In the case of mesenchymal stem cells, bone marrow MSCs have been reported to 
differentiate into Leydig cells when transplanted into the mouse testis (Yazawa et al., 
2006, Lue et al., 2007). However, further in vitro characterisation of steroidogenic 
cells derived from bone marrow MSCs suggested they might favour glucocorticoid 
over androgen production (Yazawa et al., 2006). Transfection of adipose-derived 
MSCs with SF-1 is reported to induce their differentiation into steroidogenic cells in 
vitro. However, similar to the aforementioned reports of bone marrow MSCs, the 
resulting cells appear to predominantly produce glucocorticoids (Gondo et al., 2008). 
Adipose-derived mesenchymal stem cells have been reported to improve Leydig cell 
function in an experimentally induced ageing model although the positive effects may 
be indirect via suppression of reactive oxygen species rather than differentiation into 
Leydig cells (Yang et al., 2015a). Similarly, Zhang et al. (2017) suggested that 
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umbilical cord MSCs could promote Leydig cell regeneration following EDS-
mediated ablation, but very few of the transplanted cells appeared to form Leydig cells. 
1.8 Hypothesis, Aims & Approach 
As outlined in the preceding sections, the mammalian testis is a complex organ divided 
into two distinct compartments that carry out its principal functions of spermatogenesis 
and steroidogenesis. Both these processes are reported to become impaired as males 
age. Perhaps of most significance is the reported age-related decrease in androgen 
production as androgens are thought to support lifelong general health in men. It is 
well established that testicular function is critically dependent on the somatic Sertoli 
and Leydig cells and age-related degenerative changes have been described in each of 
these cell populations. However, the interrelationship between testicular function, 
ageing and disease is not fully understood. Specifically, the paracrine interactions 
between testicular cell populations that support testicular function and the extent to 
which intrinsic age-related Sertoli and Leydig dysfunction contributes to alterations in 
the testicular microenvironment remain to be established. 
1.8.1 Hypothesis 
The main hypothesis underpinning the experiments described herein is that 
manipulation of the paracrine network in the testis in vivo would provide significant 
novel insights into the regulation of testicular function, uncovering potential 
therapeutic targets to treat age-related testicular dysfunction. 
1.8.2 Aims 
1. To determine the utility of novel premature ageing mouse models for the 
expedited study of testicular ageing and to define the contribution of Leydig 
and Sertoli cells to age-related primary hypogonadism. 
2. To establish the role(s) of leukemia inhibitory factor as a putative paracrine 
regulator of testicular development and function in vivo. 
3. To determine the regenerative potential of human perivascular stem cells to 
promote endogenous testosterone production as a potential therapeutic strategy 
to treat hypogonadism. 




To address the first aim, a novel Cisd2 premature ageing allele was utilised. In the first 
instance, the testicular phenotype of constitutive Cisd2-deficient mice was 
characterised and compared to that of naturally aged mice. Next, the conditional 
potential of the novel Cisd2 allele was exploited to limit premature ageing to Leydig 
cells or Sertoli cells separately such that the impact of ageing in these cell populations 
on testicular function could be determined. 
To dissect out and characterise the role of leukemia inhibitory factor signalling in the 
testis, novel models of testis cell-specific LIFR ablation were generated and 
characterised to determine the influence of paracrine LIF/LIFR signalling in the 
regulation of testicular development and function. 
To address the third aim, the ability of human adipose-derived perivascular stem cells 
to differentiate into Leydig cells under defined conditions in vitro was determined. In 
addition, a model of Leydig cell ablation and regeneration was used to establish the 
impact of human adipose-derived perivascular stem cells on Leydig cell regeneration 
in vivo. 
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 Materials & Methods 
2.1 Animals 
2.1.1 Husbandry, Welfare and Ethics 
All animal experiments were carried out in the Biomedical Research Facility Little 
France (LF2) in strict compliance with the Animals (Scientific Procedures) Act, 1986. 
All procedures were conducted in accordance with UK Home Office regulations under 
project licences 60/4200 and 70/8804 held by Professor Lee B. Smith. Animals were 
maintained on a 12hr light cycle (07:00 – 19:00) with controlled temperature (20-25oC) 
and humidity (~55%). Soya-free chow and drinking water were available ad libitum. 
Daily husbandry and technical assistance with experimental procedures were carried 
out by Mr Michael Dodds (mice) and Mr William Mungall (rats) – Senior Technical 
Officers within Central Bioresearch Services. 
2.1.2 Transgenic Mouse Lines 
Both constitutive and conditional knockout alleles used in the studies herein were 
obtained from the International Mouse Phenotyping Consortium (IMPC; 
http://www.mousephenotype.org/). The majority of embryonic stem cell and/or mouse 
lines produced by the IMPC harbour the ‘knockout-first’ allele (Figure 2.1). These 
alleles are designed around a critical exon, shared between all transcript variants 
which, upon removal, results in a frame-shift mutation (theoretically) abolishing 
protein expression. While knockout-first alleles are targeted, they essentially function 
as gene-trap knockouts in the first instance as the large targeting cassette disrupts gene 
expression. Owing to the elegant design of the targeting cassette, (Testa et al., 2004, 
Skarnes et al., 2011), targeted mutation-1a alleles (Tm1a; Figure 2.1) are highly 
versatile and, upon exposure to site-specific recombinases, can give rise to reporter-
tagged knockout (Tm1b), conditional (Tm1c), and null (Tm1d) alleles (Figure 2.1).  




Figure 2.1 Schematic of the Knockout-First Allele. To generate the targeted mutation 1a 
(Tm1a) allele, the wild-type allele is targeted in C57BL/6N embryonic stem cells, through 
homologous recombination mediated by 5’ and 3’ homology arms of the targeting vector. The 
Tm1a allele can be converted to a reporter-tagged knockout allele (Tm1b) or a conditional 
allele (Tm1c) by exposure to Cre or Flp recombinase respectively. The Tm1c allele can be 
further converted to a null allele (Tm1d) upon exposure to Cre recombinase.  
 Constitutive Knockout Alleles 
 Constitutive Cisd2-knockout 
Mice carrying a knockout-first Cisd2 allele (Cisd2tm1a(EUCOMM)Wtsi) were obtained from 
the IMPC project. Constitutive Cisd2-knockout mice were generated by crossing male 
and female Cisd2wt/tm1a mice to generate Cisd2wt/wt, Cisd2wt/tm1a and Cisd2tm1a/tm1a 
offspring. Animals were genotyped as described in section 2.1.2.6, using the 
appropriate primers listed in Table 2-1. The genotyping strategy is outlined in Figure 
2.2. 
 Constitutive Lifr-knockout 
Mice carrying a reporter-tagged Lifr knockout allele (Lifrtm1b(EUCOMM)Hmgu) were 
obtained from the IMPC project. Constitutive Lifr-knockout mice were generated by 
crossing male and female Lifrwt/tm1b mice to generate Lifrwt/wt, Lifrwt/tm1b and Lifrtm1b/tm1b 
offspring. Animals were genotyped as described in section 2.1.2.6, using the 
appropriate primers listed in Table 2-1. The genotyping strategy is outlined in Figure 
2.2. 




Figure 2.2 Constitutive and Conditional Alleles. Schematic representation of constitutive 
(tm1a) and conditional (tm1c) Cisd2 (A and B) and Lifr (D and E) alleles. The location of 
genotyping primers are highlighted. Primer sequences and further details are listed in Table 
2-1. Conversion of conditional Cisd2 and Lifr alleles to null (tm1d) alleles following Cre 
exposure is illustrated in (C) and (F) respectively. 
 Conditional Knockout Alleles 
While constitutive knockout alleles (e.g. Tm1a and Tm1b) are powerful tools for 
interrogating gene function, determining specific tissue/cell contributions to any 
observed phenotype becomes challenging. Furthermore, constitutive gene deletion 
may result in lethal developmental phenotypes, making it difficult, if not impossible, 
to study tissue/cell specific gene function during postnatal life. The Cre/LoxP system 
of conditional gene deletion permits spatio-temporal control of gene deletion (Nagy, 
2000). Briefly, the Cre/LoxP system relies on the cyclisation recombination (Cre) 
enzyme from bacteriophage P1 which recognises and induces recombination between 
two LoxP sites engineered around a critical portion of the target gene sequence (Figure 
2.1). The use of a cell/tissue-specific promoter to drive Cre expression limits 
recombination to the cell/tissue type of interest.  
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 Conditional Cisd2-knockout 
Mice carrying a conditional Cisd2 allele (Cisd2tm1c(EUCOMM)Wtsi) were obtained from the 
IMPC project. Cell-specific Cisd2-knockout mice were generated by mating Cisd2tm1c 
mice to Cre recombinase-expressing mice (see section 2.1.2.3). Animals were 
genotyped as described in section 2.1.2.6, using the appropriate primers listed in Table 
2-1. The genotyping strategy is outlined in Figure 2.2. 
 Conditional Lifr-knockout 
Mice carrying a conditional Lifr allele (Lifrtm1c(EUCOMM)Hmgu) were obtained from the 
IMPC project. Cell-specific Lifr-knockout mice were generated by mating Lifrtm1c mice 
to Cre recombinase-expressing mice (see section 2.1.2.3). Animals were genotyped as 
described in section 2.1.2.6, using the appropriate primers listed in Table 2-1. The 
genotyping strategy is outlined in Figure 2.2. 
 Cre Recombinase Alleles 
As outlined above, conditional gene deletion relies on tissue/cell-specific Cre 
expression. Several Cre-expressing mouse lines were used in these studies to convert 
conditional (Tm1c) alleles to null (Tm1d) alleles in specific testicular cell populations. 
 Leydig Cell Conditional Knockouts 
Conversion of conditional (Tm1c) to null (Tm1d) alleles within testicular Leydig cells 
was achieved using a mouse line expressing Cre-recombinase under control of the 
Platelet-Derived Growth Factor Receptor-beta (Pdgfrb) promoter. Tg(Pdgfrb-cre)9Rha 
mice (Foo et al., 2006) were gratefully received from Professor Neil Henderson (MRC 
Centre for Inflammation Research, University of Edinburgh). Animals were genotyped 
as described in section 2.1.2.6, using the appropriate primers listed in Table 2-1. 
 Sertoli Cell Conditional Knockouts 
Conversion of conditional (Tm1c) to null (Tm1d) alleles within testicular Sertoli cells 
was achieved using a mouse line expressing Cre-recombinase under the control of the 
Anti-Müllerian Hormone (Amh) promoter. Tg(AMH-cre)1Flor mice (Lecureuil et al., 
2002) were obtained from a colony maintained on site by Professor Lee Smith (MRC 
Centre for Reproductive Health, University of Edinburgh). Animals were genotyped 
as described in section 2.1.2.6, using the appropriate primers listed in Table 2-1. 
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 Germ Cell Conditional Knockouts 
Conversion of conditional (Tm1c) to null (Tm1d) alleles within testicular germ cells 
was achieved using a mouse line expressing Cre recombinase under the control of the 
Stimulated by Retinoic Acid-8 (Stra8) promoter. Tg(Stra8-icre)1Reb mice (Sadate-
Ngatchou et al., 2008) were obtained from a colony maintained on site by Professor 
Lee Smith (MRC Centre for Reproductive Health, University of Edinburgh). Animals 
were genotyped as described in section 2.1.2.6, using the appropriate primers listed in 
Table 2-1. 
 Cre Recombinase Reporter Alleles 
In order to determine the utility of Cre-expressing lines for the targeting of specific 
cell populations within the testis, mice carrying Cre-inducible reporter alleles were 
used. Briefly, these alleles consist of transgenes, expressed from the ubiquitous Rosa26 
locus in Gt(ROSA)26Sor mice, encoding fluorescent proteins downstream of a LoxP-
flanked STOP codon. Following Cre exposure, the STOP codon is removed resulting 
in expression of the fluorescent protein. 
 Red Fluorescent Protein Cre-reporter Mice 
Mice carrying the red fluorescent protein (RFP) reporter allele Gt(ROSA)26Sortm14(CAG-
tdTomato)Hze (Madisen et al., 2010) were gratefully received from Professor Neil 
Henderson (MRC Centre for Inflammation Research, University of Edinburgh). 
Animals were genotyped as described in section 2.1.2.6, using the appropriate primers 
listed in Table 2-1. 
 Timed Matings 
To obtain embryos at specific gestational time points, timed matings were conducted. 
Male and female breeding animals were paired in the afternoon and females were 
monitored for copulatory plugs the following morning. The day of plug discovery was 
designated embryonic (e) day 0.5. 
 Genotyping 
Inheritance of transgenes in offspring derived from transgenic matings was determined 
by transgene-specific polymerase chain reaction (PCR) assays. Routine genotyping 
was performed by the technical support team in the laboratory of Professor Lee Smith. 
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I am particularly grateful to Laura Milne, Sarah Smith, Nathan Jeffery and Lyndsey 
Wilson (née Cruickshanks) for assistance with genotyping. 
 Genomic DNA Extraction 
Genomic DNA (gDNA) was extracted from ear biopsies taken at weaning. Briefly, ear 
biopsies were digested in 25uL TE-Tween (section 2.9.1.3) supplemented with 20µg 
of proteinase K (Sigma-Aldrich, Dorset, UK) for 1 hour at 55oC. Samples were then 
incubated at 95oC for 7mins to denature remaining proteinase K before being cooled 
to 25oC. Incubations were carried out on a Tprofessional thermocycler (Biometra 
GmbH, Göttingen, Germany). Following digestion, samples were briefly centrifuged 
at 2500rpm to pellet undigested tissue. The supernatant was diluted 1:10 in sterile 
water for use in downstream PCR assays. Samples were stored at 4oC short term, or -
20oC long term. 
 Genomic PCR 
PCR was performed on crude gDNA extracts (section 2.1.2.6.1) using either BioMix™ 
PCR reaction buffer (Bioline Reagents Ltd, London, UK) or Type-it Mutation Detect 
PCR Kit (QIAGEN Ltd., Crawley, UK) according to the manufacturer’s instructions. 
Details of individual assays including primer sequences, annealing temperatures and 
PCR buffer are listed in Table 2-1. PCR products were analysed using the QIAxcel 
capillary electrophoresis system (QIAGEN Ltd., Crawley, UK). A reaction containing 






Table 2-1. Details of Primers used for Genotyping Assays 
Assay Forward Primer(s) Reverse Primer(s) Annealing Temp. (oC) Master Mix 
Product Size 
(bp) 
Cisd2tm1a Cisd2 wt-fwd    GAATATTCAATGTGTAAAGGTTTCAA Cisd2 wt-rev    GAAAACATTTTCACTCCTTTCTTTTT 
Cisd2 mut-rev    GAACTTCGGAATAGGAACTTCG 56 
Biomix 
Cisd2wt - 257 
Cisd2tm1a - 178 
Cisd2tm1c Cisd2 wt/flox-fwd    GAGTAAGTTGACTGATCAGG Cisd2 wt/flox-rev    CCTATCTCATTAGATCTGCT 56 Type-it Cisd2
wt - 285 
Cisd2tm1c - 389 
Cisd2tm1d 5'cas-fwd    AAGGCGCATAACGATACCAC Cisd2 wt-rev    GAAAACATTTTCACTCCTTTCTTTTT 
3' loxP-rev    ACTGATGGCGAGCTCAGACC 61 
Type-it 
Cisd2tm1c - 268 
Cisd2tm1d - 174 
Lifrtm1b Lifr wt-fwd    GGAAACCCTGGTATTGTGGA 
LacZ-fwd    CCAGTTGGTCTGGTGTCA Lifr wt-rev    CATGCCACAGTGCGACAG 59 
Type-it 
Lifrwt - 1150 
Lifrtm1b - 406 
Lifrtm1c Lifr wt-fwd    GGAAACCCTGGTATTGTGGA Lifr wt-rev2    GGCTGTCCTGGAACTCACTC 59 Type-it Lifr
wt- 244 
Lifrtm1c - 418 
Lifrtm1d 5'cas-fwd    AAGGCGCATAACGATACCAC 3' loxP-rev    ACTGATGGCGAGCTCAGACC 
Lifr wt-rev2    GGCTGTCCTGGAACTCACTC 62 
Type-it 
Lifrtm1c - 389 
Lifrtm1d - 172 
Pdgfrb-Cre Pdgfrb-cre fwd    TGCCACGACCAAGTGACAGCA 
Il2-fwd    CTAGGCCACAGAATTGAAAGATCT 
Pdgfrb-cre rev    AGAGACGGAAATCCATCGCTC 
Il2-rev    GTAGGTGGAAATTCTAGCATCATCC 57 
Biomix 
Pdgfrb-cre - 374 
Il2 - 330 
Amh-Cre Amh-cre fwd    CACATCAGGCCCAGCTCTAT 
Il2-fwd    CTAGGCCACAGAATTGAAAGATCT 
Amh-cre    rev GTGTACAGGATCGGCTCTGC 
Il2-rev    GTAGGTGGAAATTCTAGCATCATCC 59 
Biomix 
Amh-cre - 180 
Il2 - 330 
Stra8-Cre Str8-cre fwd    GTGCAAGCTGAACAACAGGA 
Il2-fwd    CTAGGCCACAGAATTGAAAGATCT 
Stra8-cre rev    AGGGACACAGCATTGGAGTC 
Il2-rev    GTAGGTGGAAATTCTAGCATCATCC 59 
Biomix 
Stra8-cre - 260 
Il2 - 330 
Td-tomato td-Tomato-fwd    CTGTTCCTGTACGGCATGG 
Il2-fwd    CTAGGCCACAGAATTGAAAGATCT 
tdTomato-rev    CTGTTCCTGTACGGCATGG 
Il2-fwd    CTAGGCCACAGAATTGAAAGATCT 61 
Biomix 
td-Tomato - 196 
Il2 - 330 




Male Wistar Kyoto rats (Wky/NCrl) at 70-90 days of age were obtained from Charles 
River (Charles River Laboratories, Margate, UK). The animals were housed in groups 
of four and maintained in the Biomedical Research Facility Little France (LF2) as 
described in section 2.1.1. Animals were acclimatised for at least one week prior to 
entry into experiments.  
2.1.4 Treatments 
 Human Chorionic Gonadotrophin  
To assess the maximal capacity of Leydig cell testosterone production, animals were 
treated with human chorionic gonadotrophin (hCG; Chorulon®; Henry Schein, 
Dumfries, UK). hCG is an agonist for the luteinising hormone/chorionic 
gonadotrophin receptor (LHGCR), thus stimulates Leydig cell androgen biosynthesis. 
Animals were given a single 20IU dose of hCG 16hrs prior to sacrifice (see 2.1.5.1). 
Plasma was harvested as outlined in section 2.1.5.3. Aliquots of stock hCG solution 
(200IU/mL in saline) were obtained from Central Bioresearch Services within 
Biomedical Research Facility at Little France and stored at -80oC until use. Aliquots 
were thawed immediately prior to use and 100µL per animal was injected 
intraperitoneally. 
 Ethane Dimethanesulphonate 
Ethane dimethanesulphonate (EDS) is an alkylating agent and has been widely used to 
induce Leydig cell-specific ablation and regeneration in the rat testis (Morris et al., 
1986). To ablate Leydig cells in preparation for cell transplantation studies, rats were 
treated with a single dose of EDS (85mg/kg). EDS is not commercially available; the 
EDS used in experiments herein was a kind gift from Professor Peter O’Shaughnessy 
(Institute of Biodiversity, Animal Health and Comparative Medicine, University of 
Glasgow). On the day of injection, EDS was dissolved in sterile dimethyl sulfoxide 
DMSO (Hybri-Max™; Sigma-Aldrich, Dorset, UK) to give a 200mg/mL stock. 
Immediately prior to injection a 50mg/mL working solution was prepared by diluting 
the 200mg/mL stock with DMSO:Water (1:3). Animals were weighed and injected 
intraperitoneally with 85mg/kg EDS. Animals were monitored closely over the next 
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48hrs to ensure no adverse reaction to the injection occurred. Control animals were 
injected with an equivalent volume of vehicle (DMSO:Water). 
 Intratesticular Cell Transplantation 
Human adipose-derived perivascular stem cells (hAd-PSC) (see section 2.7.1), were 
injected into the interstitium of rat testes 4 days after EDS-mediated Leydig cell 
ablation (see section 2.1.4.2). hAd-PSCs were cultured in Corning® 75cm2 tissue 
culture flasks (Sigma-Aldrich, Dorset, UK) for 1 week with or without differentiation-
inducing media (see section 2.7.1.1). Cells were harvested from 5 flasks per treatment, 
pooled, and re-suspended in 250uL Opti-MEM™ reduced serum media (Gibco® 
Thermo Scientific, Runcorn, UK). Surgeries were performed by Mr William Mungall 
(Senior Technical Officer - Central Bioresearch Services). In brief, rats were 
anaesthetized by inhalation of isoflurane. The testes were exposed through a scrotal 
incision and 50µL cell suspension was injected into each testis, under the tunica 
albuginea, using a Micro-Fine™+ 0.3mL (30G) syringe (BD Bioscience, Oxford, UK). 
Testes were returned to the scrotum and the incision closed with Coated VICRYL® (5-
0, polyglactin 910) Sutures (Ethicon, Johnson & Johnson Health Care Systems Inc., 
New Jersey, USA). A single sub-cutaneous injection of analgesic (Buprenorphine; 
0.05mg/kg) was administered prior to the animals regaining consciousness. Following 
surgery, live cell number was quantified in the excess suspension in order to estimate 
the number of cells transplanted. On average, approximately 1.8 (±0.62) million cells 
were injected into each testis.  
Following sacrifice and tissue collection (see section 2.1.5), genomic DNA (gDNA) 
was isolated from testes and interrogated for the presence/absence of human-specific 
genomic DNA by PCR as described by (Caspi et al., 2007). Briefly, gDNA from four 
separate samples per testis was isolated using the GeneJET Genomic DNA Purification 
Kit (Thermo Scientific, Runcorn, UK) following the manufacturer’s instructions. 
Multiplex PCR amplification of α-satellite region of human chromosome 17 
(HUMSAT17A) and rat beta actin (Actb) was performed using the Type-it Mutation 
Detect PCR Kit (QIAGEN Ltd., Crawley, UK) according to the manufacturer’s 
instructions. The primer sequences were HUMSAT17A-FWD 
GGGATAATTTCAGCTGACTAAACAG, HUMSAT17A-REV GTGTTTCATAGCTGCTCTTTCCA 
and Actb-FWD TGTGTTCTTGCCCTCTTTGC, Actb-REV CAGGAAGGAAGGCTGGAAGA. 
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PCR products were analysed using the QIAxcel capillary electrophoresis system 
(QIAGEN Ltd., Crawley, UK). A reaction containing no template (NTC) was included 
to ensure reagents were free from contaminating nucleic acids. Genomic DNA 
extracted from pre-grafted cells was also included as a positive control.  
2.1.5 Tissue Collection 
 Sacrifice 
Animals were sacrificed by methods conforming to Schedule 1 of the Animals 
(Scientific Procedures) Act, 1986. For adult animals, this was achieved by exposure to 
an increasing concentration of carbon dioxide, followed by confirmation of permanent 
cessation of the circulation by palpitation. For embryonic ages, pregnant dams were 
dispatched as described above, and the fetuses rapidly removed and decapitated.  
 Dissection  
Animals were weighed prior to blood collection (detailed in 2.1.5.3) using a digital 
balance (Mettler Toledo, London, UK). Testes, epidiymides and seminal vesicles 
(including coagulating glands) were removed and trimmed of surrounding adipose 
tissue. The weights of the testes and seminal vesicle (intact including seminal fluid) 
were recorded. Ovaries and uteri were collected from female animals as well as a panel 
of extra gonadal tissues (from both sexes) including pituitary, adrenal, pancreas, liver, 
kidney and spleen. 
 Tissue Processing and Storage 
Blood was collected immediately after sacrifice via cardiac puncture using a 23G 
needle fitted to a 1 mL syringe (BD Bioscience, Oxford, UK) pre coated with heparin 
(LEO Laboratories Ltd., Hurley, UK). Plasma was harvested by centrifugation at 
17136g for 10mins and stored at either -20oC (short-term) or -80oC (long term). Organs 
were either snap frozen on dry ice and stored at -80oC for molecular analyses, or fixed 
in Modified Bouin’s Solution (Clin-Tech Ltd, Guildford, UK) for subsequent 
histological analyses. In the case of the testes; the left testis was cut in half along the 
axial plane, roughly through the vascular plexus overlying the rete testis, and both 
halves were snap frozen immediately. The right testis was submerged in Bouin’s 
solution for 6hrs at room temperature. After an initial 4hrs, the testis was cut in half 
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along the axial plane to ensure fixative penetration to the centre of the organ during 
the final 2hrs of fixation. Fixed samples were then stored in 70% ethanol (EtOH; 
VWR, Lutterworth, UK) until processing and embedding. Frozen tissues and Bouin’s-
fixed samples from naturally aged mice (18 months old) were obtained from the MRC 
Harwell Ageing Screen, through collaboration with Dr. Paul Potter (MRC Harwell, 
Oxfordshire, UK). 
For tissues expressing fluorescent proteins, organs were dissected into cold phosphate 
buffered saline (PBS, see section 2.9.5; Sigma-Aldrich, Dorset, UK) and imaged using 
a Leica M2FIII fluorescence stereomicroscope (Leica Microsystems, Milton Keynes, 
UK) prior to fixation as described above. 
Where integrity of the blood testis barrier was to be assessed, a biotin tracer (EZ-link 
sulfo-NHS-LC-biotin; Thermo Scientific, Runcorn, UK) was injected into the testis. 
Briefly, 10-15µL of freshly prepared biotin solution (10mg/mL in 0.01M MgCl2 in 
PBS) was injected under the tunica albuginea of freshly collected testes. Contralateral 
testes were injected with vehicle only (0.01M MgCl2 in PBS). Testes were incubated 
on ice for 30mins and then fixed and processed as described above. Localisation of the 
biotin tracer was visualised in testis sections by incubation with Streptavidin Alexa 
Fluor™ 546 conjugate (S11225, Thermo Scientific, Runcorn, UK), diluted 1:200 in 
PBS, for 1hr at room temperature. Tissue sections were imaged using an LSM 780 
confocal microscope (Carl Zeiss, UK). 
2.2 Histological Analyses 
2.2.1 Tissue Sectioning 
Fixed tissues were subject to an automated tissue processing procedure using the Leica 
P1050 processing system (Leica Biosystems, Milton Keynes, UK). During this 
process, samples were dehydrated through an ascending series of ethanol, cleared 
through xylene (VWR, Lutterworth, UK) and impregnated with Shandon™ Paraffin 
(Thermo Scientific, Runcorn, UK). Processed tissues were then embedded in molten 
paraffin. Processing and embedding was carried out by Mr Garry Menzies – Technical 
Officer within the Shared University Research Facilities core (SuRF), Edinburgh. 
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Once cooled, the paraffin blocks were stored at room temperature in a tissue archive 
maintained by the SuRF histology facility at Little France. 
Paraffin embedded tissue sections were cut at a thickness of 5μm using a Leica 
RM2125RTS rotary microtome (Leica Biosystems, Milton Keynes, UK). Sections 
were mounted onto positively charged X-tra® microscope slides (Leica Biosystems, 
Milton Keynes, UK) and dehydrated in an oven at 50oC overnight (~16hrs). Slides 
were then allowed to cool before being stored at room temperature for use in 
downstream staining applications detailed in sections 2.2.2 and 2.2.3. 
2.2.2 Haematoxylin and Eosin Staining  
Gross histological architecture was examined in prepared tissue slides using the 
nuclear and cytoplasmic stains haematoxylin and eosin (H&E) respectively. The 
staining procedure is detailed in Figure 2.3.  
 Dewaxing and Rehydration  
In preparation for use in histological and immunohistochemical staining experiments, 
tissue sections were dewaxed and rehydrated using standard procedures outlined in 
Figure 2.3. Briefly, slides were immersed in xylene to remove paraffin wax, passed 
through a decreasing series of ethanol to displace the xylene and washed in tap water 
to fully rehydrate the tissue. 
 Staining 
Following dewaxing and rehydration (detailed in 2.2.2.1), slides were immersed in 
Harris haematoxylin (Leica Biosystems, Milton Keynes, UK) to stain nuclei. Slides 
were then immersed in 1% acid-alcohol (Leica Biosystems, Milton Keynes) to remove 
background cytoplasmic staining. To increase contrast, the nuclear staining was then 
developed from purple to blue by immersing the slides in Scott’s tap water substitute 
(Cell Path, Powys, UK). Slides were then immersed in Eosin Y solution (Leica 
Biosystems, Milton Keynes, UK) to stain basophilic structures, such as cell cytoplasm, 
with various pink/orange hues. Following staining, slides were dehydrated and cleared 
as outlined in Figure 2.3. Briefly, the tissue sections were passed through an ascending 
series of ethanol and then cleared of alcohol by immersion in xylene. Finally, slides 
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were mounted with glass cover slips (Leica Biosystems, Milton Keynes) using the non-
aqueous mounting medium, Pertex (Cell Path, Powys, UK). 
 
Figure 2.3 Haematoxylin & Eosin Staining Procedure. (A) Sections are dewaxed in xylene 
and rehydrated through a series of graded ethanol to water. (B) Haematoxylin and Eosin stain 
nuclei and cytoplasm respectively. (C) Sections are dehydrated through a series of graded 
ethanol, and cleared in xylene prior to mounting. 
2.2.3 Immunohistochemistry 
In order to visualise the localisation of specific proteins on tissue sections, 
immunohistochemistry (IHC) experiments were performed. For simplex detections, 
chromogenic IHC was generally performed, whereas fluorescent IHC was used for 
multiplex detections. Details of the antibodies used are shown in Table 2-2. In the first 
instance, an initial optimisation step was performed in order to determine the 
appropriate conditions for each antibody (i.e. antibody dilution, antigen retrieval 
method and secondary detection reagent). 
 Antigen Retrieval 
One way in which tissue fixation preserves tissue structure is by cross-linking proteins. 
However, this can lead to masking of specific epitopes recognised by primary 
antibodies. As such, an antigen retrieval step may be required for optimal antigen 
detection (Pileri et al., 1997, Shi et al., 2001). For IHC experiments described in this 
thesis, a heat-induced epitope retrieval (HIER) was used. Following dewaxing and 
rehydration (detailed in 2.2.2.1), slides were boiled in a pressure cooker (Instant Pot, 
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Burnaby, CA) in either pH 6.0 citrate buffer (section 2.9.2.2) or pH 9.0 Tris-EDTA 
buffer (see section 2.9.3) for 5mins. Retrieval methods for the antibodies used herein 





Table 2-2. Details of the Antibodies used for Immunohistochemistry 
Target Antigen 
Retrieval 
Primary Antibody Secondary Reagent Detection 
Method Source Catalogue No. Dilution Source Catalogue No. Dilution 
HSD3b Citrate pH 6 
Santa Cruz Biotechnology 
Heidelberg, Germany 
sc30820 1:2000 Vector Laboratories 
Burlingame, CA, USA 
MP-7405 n/a ImmPRESS™ HRP 
DAB 
HSD3b Citrate pH 6 
Santa Cruz Biotechnology 
Heidelberg, Germany 
sc30820 1:2000 Santa Cruz Biotechnology 
Heidelberg, Germany 
sc-2961  1:200 ChαG HRP 
Tyramide 
SOX9 Tris-EDTA pH 9 
Merk Millipore 
Billerica, MA, USA 
AB5535 1:4000 Vector Laboratories 
Burlingame, CA, USA 
MP-7451 n/a ImmPRESS™ HRP 
DAB 
SOX9 Tris-EDTA pH 9 
Merk Millipore 
Billerica, MA, USA 
AB5535 1:4000 Vector Laboratories 
Burlingame, CA, USA 
PI-1000 1:200 GαR HRP 
Tyramide 
RFP n/a Evrogen 
Moscow, Russia 
AB233  1:800 Vector Laboratories 
Burlingame, CA, USA 
BA-1000 1:500 Streptavidin HRP 
DAB 
RFP Citrate pH 6 
Clontech Laboratories Inc. 
Montain View, CA, USA 
632496 1:2000 Vector Laboratories 
Burlingame, CA, USA 
PI-1000 1:200 GαR HRP 
Tyramide 
YFP Citrate pH 6 Abcam 
Cambridge, UK 
ab6556 1:4000 Vector Laboratories 
Burlingame, CA, USA 
PI-1000 1:200 GαR HRP 
Tyramide 
CASP3 n/a 
Cell Signalling Technology 
Leiden, Netherlands 
9661S 1:300 Anti-rabbit Poly-HRP-IgG 
Leica Biosystems, UK 
DS 9800 n/a Poly-HRP 
DAB 
COUP-TFII Citrate pH 6 
Persus Proteomics Inc. 
Tokyo, Japan 
PP-H7147-00 1:1000 Agilent Technologies (DAKO) 
Cheadle, UK 
P0447 1:500 GαM HRP 
Tyramide 
DDX4 Citrate pH 6 Abcam 
Cambridge, UK 
ab13840 1:1000 Vector Laboratories 
Burlingame, CA, USA 
PI-1000 1:200 GαR HRP 
Tyramide 
PDGFRb Citrate pH 6 
Abcam 
Cambridge, UK 
ab32570 1:1500 Vector Laboratories 
Burlingame, CA, USA 
PI-1000 1:200 GαR HRP 
Tyramide 
HLA n/a Abcam 
Cambridge, UK 
ab70328 1:80 Thermo Scientific 
Runcorn, UK 
A-11030 1:200 GαM  
Alexa Flour 546 
HuNu n/a Merk Millipore 
Billerica, MA, USA 
MAB1281  1:320 Thermo Scientific 
Runcorn, UK 
A-11030 1:200 GαM  
Alexa Flour 546 
ChαG = Chicken anti-Goat; GαR = Goat anti-Rabbit; GαM = Goat anti-Mouse; HRP = Horseradish Peroxidase; DAB =  3, 3’-diaminobenzidine.
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 Chromogenic Detection 
Prior to the addition of primary antibodies, endogenous peroxidase activity was 
quenched by immersing slides in 0.3% (w/vol) hydrogen peroxide (Fisher Scientific, 
Loughborough, UK) in TBS (see section 2.9.4.2) for 30mins at room temperature. All 
subsequent incubations were carried out in a humidity chamber. Unless otherwise 
stated, slides were subjected to 3x5min washes in TBS between each incubation step. 
Binding of antibodies to non-specific epitopes was reduced by incubating sections with 
a normal serum blocking solution (see section 2.9.6.1), of the same species in which 
the secondary antibody was raised, for 30mins at room temperature. Tissue sections 
were then incubated with primary antibody, diluted in blocking solution, overnight 
(~16hrs) at 4oC. Next, sections were incubated with either a biotin-conjugated 
secondary antibody specific to the species of the primary antibody (see Table 2-2), 
diluted 1:500 in blocking solution, followed by a streptavidin-horseradish peroxidase 
conjugate (SA-5004; Vector Labs, Burlingame, CA, USA) diluted 1:1000 in TBS; or 
with the appropriate ImmPRESS™ peroxidase polymer detection reagent (Vector 
Labs, Burlingame, CA, USA). Localisation of primary antibody was visualised by the 
addition of the chromogenic peroxidase substrate 3, 3’-diaminobenzidine (DAB; SK-
4105, Vector Labs, Peterborough, UK) according to the manufacturer’s instructions. 
Colour development was timed on control slides and the remaining slides were 
developed concurrently based on this time. Chromogenic reactions were stopped by 
immersing slides in tap water. Tissue sections were then counterstained with Harris 
haematoxylin, dehydrated and mounted with glass coverslips as described in section 
2.2.2. Control sections from which the primary antibody had been omitted were 
included in each experiment. Depending on availability, further controls were also run 
in each experiment which included pre-incubation of the primary antibody with the 
peptide it was raised against and/or a tissue section known to be negative for the 
antigen of interest. 
 Automated Chromogenic Detection 
In certain instances (i.e. for the detection of CASP3), chromogenic 
immunohistochemistry was performed using the Bond™ Polymer Refine Detection 
system (Leica Biosystems, Milton Keynes, UK) in conjunction with the BOND-MAX 
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automated staining robot (Leica Biosystems, Milton Keynes, UK) according to the 
manufacturer’s instructions. 
 Fluorescent Detection 
For Fluorescent IHC, tissue sections were treated as described for chromogenic IHC 
(see section 2.2.3.2) until the addition of the secondary antibody. Following overnight 
incubation at 4oC with the primary antibody, sections were incubated with the 
appropriate peroxidase-conjugated secondary antibody (Table 2-2), diluted 1:200 in 
blocking solution, for 30mins at room temperature. Sections were then incubated for 
10mins at room temperature with the fluorogenic Tyramide Signal Amplification 
System (TSA; PerkinElmer, UK), diluted 1:50 in the kit substrate as per the 
manufacturer’s instructions. All subsequent steps were carried out with limited light 
exposure to prevent degradation of fluorescent dyes. Sections were next incubated with 
SYTOX® Green nucleic acid stain (Molecular Probes, Life Technologies, Paisley UK), 
diluted 1:10,000 in TBS, for 10mins. Slides were then mounted with glass cover slips 
(Leica Biosystems, Milton Keynes) using Lab Vision™ PermaFluor™ aqueous 
mounting medium (Thermo Scientific, Runcorn, UK). Controls as described in section 
2.2.3.2 were included. Stained slides were stored in the dark at 4oC until imaging 
(section 2.2.5) 
 Multiplex Antigen Detection 
In order to visualise the localisation of multiple proteins on the same tissue section, 
multiplex fluorescent IHC experiments were performed. Following detection of the 
primary antibody as described in section 2.2.3.3, sections were subjected to further 
HEIR, peroxidase quenching and non-specific epitope blocking steps, as described in 
sections 2.2.3.1 and 2.2.3.2, before overnight incubation at 4oC with a second primary 
antibody. Primary antibody detection and nuclear counterstaining were carried out as 
described in section 2.2.3.3. Controls as described in section 2.2.3.2, were included. 
Stained slides were stored in the dark at 4oC until imaging (see section 2.2.5). 
2.2.4 Fluorescent Immunocytochemistry 
In order to assess the expression of specific proteins in cultured cells, fluorescent 
immunocytochemistry experiments were performed. Cells were grown and stained 
using the Nunc™ Lab-Tek™ II Chamber Slide™ System (Thermo Scientific, Runcorn, 
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UK). Culture media was removed and the cells were washed twice with PBS. Cells 
were fixed by incubation with 4% paraformaldehyde (PFA; Thermo Scientific, 
Runcorn, UK) for 10mins at 4oC. After washing twice with PBS, cells were 
permeablised by incubation with PBS containing 0.1% (vol/vol) Triton™ X-100 
(Sigma-Aldrich, Dorset, UK) for 10mins at 4oC. Binding of antibodies to non-specific 
epitopes was reduced by incubating sections with a normal serum blocking solution 
(see section 2.9.6.1), of the same species in which the secondary antibody was raised. 
Cells were then incubated with primary antibody, diluted in blocking solution, 
overnight (~16hrs) at 4oC. After washing twice with PBS, cells were incubated with 
the appropriate fluorophore-conjugated secondary antibody (see Table 2-2) for 1hr at 
room temperature. Cells were then washed twice with PBS and incubated with DAPI 
nucleic acid stain (Sigma-Aldrich, Dorset, UK). Slides were then mounted with glass 
cover slips (Leica Biosystems, Milton Keynes) using Lab Vision™ PermaFluor™ 
aqueous mounting medium (Thermo Scientific, Runcorn, UK). Controls as described 
in section 2.2.3.2 were included. Stained slides were stored in the dark at 4oC until 
imaging (see section 2.2.5). 
2.2.5 Microscopy and Image Capture 
Images were captured using either an Axio Scan Z.1 slide scanner (Carl Zeiss Ltd, 
Welwyn Garden City, UK) or an LSM 780 confocal microscope (Carl Zeiss Ltd, 
Welwyn Garden City, UK) with Zen imaging software (Carl Zeiss Ltd, Welwyn 
Garden City, UK). 
2.2.6 Stereological Analysis 
Leydig and Sertoli cells were identified in tissue sections by chromogenic 
immunostaining (see section 2.2.3.2) for HSD3b and SOX9 respectively. 
Quantification of cells was conducted using the stereology plug-in for Image-Pro plus 
7.0 software (Media Cybernetics, UK) and a Zeiss Axio Imager A1 microscope (Carl 
Zeiss, UK) fitted with a Qimaging QICAM Fast 1394 digital camera (Qimaging, 
Canada) and a Prior ProScan automated stage (Prior Scientific Instrument Ltd, UK). 
For each sample, a tiled image encompassing the entire testis cross-section was 
generated and highlighted as the area of interest (AOI). 200-300 random fields were 
generated within the AOI for interrogation at 630X magnification. The software then 
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drove the stage between random fields, a counting grid (18 x 24) was overlaid onto the 
tissue and the ‘count’ function was used to score points falling over nuclei of immuno-
positive cells. Only fields containing ≥50% tissue area were scored. Typically, 100 or 
30 fields per section were analysed for Leydig and Sertoli cells respectively. This 
ensured the standard error (SE) for counting remained <10%. The SE was calculated 
using the formula: 
SE = √(Ppi(100-Ppi)/Pt) 
SE (%) = (SE/Ppi) x 100 
(Where Ppi = the number of points falling over nuclei as a percentage of the total 
number of points counted and Pt = the total number of points counted). 
These data, which reflect the relative volume occupied by the object of interest (e.g. 
Leydig or Sertoli cell nuclei), were then converted into absolute volume using testis 
weight: 
Absolute volume = (Ppi x Testis Weight [mg])/100 
The ‘nucleator’ function in the stereology plugin, was then utilised to obtain the mean 
nuclear volume (MNV) of each cell type in the same sections used for point counting. 
Briefly, random fields within the AOI were generated as described above. At 630X 
magnification, the centre of the nucleus was selected and three random lines 
intersecting the nuclear membrane and the centre of the nucleus were generated. The 
point(s) at which each line intersected the nuclear boundary were selected, generating 
6 random radii measurements which were averaged and used to extrapolate the nuclear 
volume. Typically, measurements were obtained from approximately 150 nuclei per 
sample. The absolute volume and MNV were then used to calculate the number of 
each cell type per testis using the following formula: 
Number of Cells per Testis = (Absolute Volume [mg]/MNV [µm3]) x 1000 
Seminiferous tubule and lumen diameters were also measured using the stereology 
‘nucleator’ function as described for the MNV. However, these measurements were 
performed at 100X magnification, across two sections from the same sample. Only 
circular tubules were scored and care was taken to avoid scoring tubules in sections 
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with obvious fixation-induced shrinkage artefact. Typically, 100 tubules per sample 
were scored. 
I am very grateful to Professor Nina Atanassova (Institute of Experimental 
Morphology, Pathology and Anthropology with Museum, Sofia, Bulgaria) who carried 
out the quantification of Sertoli and germ cell absolute nuclear volume in Sertoli cell 
LIFR-KO testes (Chapter 4). 
2.3 Evaluation of the Epididymal Sperm Reserve 
Epididymal sperm reserves were quantified from frozen epididymides. Epididymides 
were thawed on ice and the cauda epididymis was separated, taking care to ensure 
consistency in sampling through the corpus epididymis and vas deferens. The cauda 
epididymis was then homogenised on ice in 500µL of homogenisation buffer (0.9% 
NaCl, 0.5% Triton X-100) using an Eppendorf® micro-pestle (Sigma-Aldrich, Dorset, 
UK). If necessary, the sample was further diluted in homogenisation buffer to ensure 
accurate counting. Homogenisation-resistant elongate spermatids were quantified 
using a Neubauer haemocytometer (Marienfeld Superior, Lauda-Königshofen, 
Germany). Briefly, 15-25µL of homogenate was loaded into the two counting 
chambers of the haemocytometer and allowed to settle for 2-3mins before counting. 
To reduce error, at least 5 quadrants from the counting grid in each chamber were 
counted and the number averaged to give the number of elongate spermatids in 
0.004µL. This value was then multiplied by 2.5x104 to arrive at the number of 
spermatids per mL. Finally, the dilution factor applied to the original homogenate was 
corrected for. I gratefully acknowledge the assistance of Mr Nathan Jeffery who 
carried out the sperm counts. 
2.4 Hormone Analysis 
2.4.1 Mouse samples 
The quantification of luteinising hormone in mouse plasma was carried out using the 
Milliplex MAP Pituitary Magnetic Bead Panel Kit (PPTMAG-86K; Merk Millipore, 
Billerica, MA, USA) according to the manufacturer’s instructions. Samples were read 
on a Bio-Plex® 200 suspension array system with Bio-Plex ManagerTM software (Bio-
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Rad Laboratories Ltd., Watford, UK). I gratefully acknowledge the assistance of Dr 
Laura Milne who carried out the assays. 
The quantification of testosterone in mouse plasma was carried out using an isotope-
dilution liquid chromatography-mass spectrometry (LC-MS/MS) method as described 
by Søeborg et al. (2017). LC-MS/MS was performed by collaborators in the 
Department of Growth and Reproduction, Rigshospitalet, Copenhagen University 
Hospital. I am particularly grateful to Dr Hanne Frederiksen and Dr Anne Jørgensen 
for their assistance.  
2.4.2 Rat samples 
The quantification of luteinising hormone in rat plasma was carried out using an in-
house ELISA as previously described (Tyndall et al., 2012). Testosterone was 
quantified in rat plasma using an in house competitive ELISA. Briefly, 96-well plates 
(Greiner Bio-One GmbH, Frickenhausen, Germany) were coated with 100µL of 
donkey anti rabbit IgG (Jackson ImmunoResearch Inc, West Grove, USA) per well at 
a dilution of 1:500 in ELISA coating buffer (100mM NaHCO3, pH 9.6). After 
overnight incubation at 4oC, plates were washed twice with wash buffer (0.05M Tris-
HCl, 0.05% Tween 20, pH 7.4) and incubated with 250μL of blocking buffer (PBS pH 
7.4 containing 0.5 % BSA) for 1hr at room temperature. Plates were then washed twice 
with wash buffer prior to the addition of standards, samples and controls (20µL per 
well), followed by 80µL of testosterone-HRP conjugate (Astra Biotech GmbH, Berlin, 
Germany) at 1:20,000 in assay buffer (PBS pH 7.4 containing 0.1 % BSA and 250 
ng/mL Cortisol), followed by 50μL of rabbit anti-testosterone-19 antibody (AMS 
Biotechnology, USA) at 1:200,000 in assay buffer. Plates were incubated at room 
temperature for 2 hr on an IKA®, Schuttler MTS4 plate shaker (IKA Labortechnik, 
Staufen, Germany), then washed 5 times with assay wash buffer. Next, 120µL of 
substrate solution (3,3,5,5-Tetramethylbenzidine, Millipore Corporation, Temecula, 
CA, USA) was added to each well and plates were incubated at room temperature, 
without shaking, in the dark, for 20mins. The reaction was stopped by the addition of 
80µL stop solution (2N H2SO4; Sigma-Aldrich, Dorset, UK). Finally, plates were read 
on a plate reader at 450nm. Assays were carried out by Dr Forbes Howie and Miss 
Kirsten Wilson in the SuRF assay lab. 
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2.5 mRNA Expression Analysis 
2.5.1 RNA Extraction 
Total RNA was extracted from frozen tissues or from cell cultures using the RNeasy® 
Mini kit (QIAGEN Ltd., Crawley, UK) as per the manufacturer’s instructions 
including an on column DNase (QIAGEN Ltd., Crawley, UK) treatment step. In the 
case of the testis, an external control Luciferase RNA (5ng/testis; Promega, 
Southampton, UK) was added to each sample prior to extraction. RNA purity and 
concentration were determined using a NanoDrop 1000 v3.8.1 spectrophotometer 
(Thermo Scientific, Runcorn, UK) with a 260:280 absorbance ratio of ~2.0 indicative 
suitably pure RNA. Resulting RNA was stored in RNase free tubes at -80oC. 
2.5.2 cDNA Synthesis 
Random hexamer-primed cDNA was reverse transcribed from up to 2µg total RNA 
(see section 2.5.1) using the SuperScript® VILO™ cDNA Synthesis Kit (Life 
Technologies, Paisley, UK) as per the manufacturer’s instructions. Incubations were 
carried out using a Tprofessional thermocycler (Biometra GmbH, Göttingen, 
Germany). A reverse transcriptase negative (-RT) control was included to ensure 
reagents were free of nucleic acid contamination. The resulting cDNA was stored at -
20oC. 
2.5.3 Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
For non-quantitative analysis of mRNA expression, RT-PCR was performed. cDNA 
(see section 2.5.2) was amplified using BioMix™ PCR reaction buffer (Bioline 
Reagents Ltd, London, UK) according to the manufacturer’s instructions. Target 
specific primers were designed using Primer 3 online tool (http://primer3.ut.ee/), and 
ordered from Eurofins MWG Operon (Eurofins Genomics, Ebersberg, Germany). 
Optimal primer annealing temperature was determined using the gradient function on 
the thermocycler. PCR products were analysed using the QIAxcel capillary 
electrophoresis system (QIAGEN Ltd., Crawley, UK). A reaction containing no 
template (NTC) was included to ensure reagents were free from contaminating nucleic 
acids.  
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2.5.4 Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) 
For quantitative analysis of mRNA expression, qRT-PCR was performed on cDNA 
(see section 2.5.2) using the Universal ProbeLibrary (UPL; Roche Diagnostics Ltd., 
Burgess Hill, UK). Briefly, UPL probes are short (8-9 nucleotide) hydrolysis probes 
harbouring a 5’ fluorescent reporter and a 3’ quencher which acts to prevent reporter 
emission. During PCR cycling, the UPL probe binds the target amplicon and the 5’-3’ 
nuclease activity of DNA polymerase liberates the reporter from the quencher; 
resulting in fluorescent emission which is recorded by a suitable detector. During PCR 
cycling, the fluorescent signal increases proportionally with the amount of amplified 
product. As PCR cycling proceeds, the fluorescence is recorded and plotted against the 
cycle number (Figure 2.4). During the exponential amplification phase of the PCR 
reaction, as the amplicon accumulates, the fluorescent signal becomes readily 
detectable above background levels. It is in this phase, when reagents are not limiting, 
that the threshold cycle (Ct) is set (Figure 2.4). The Ct value is inversely related to the 
amount of template at the start of the reaction thus reflects the mRNA expression level 
in the original sample. 
The online Universal ProbeLibrary Assay Design Centre was used to select target-
specific primers and corresponding UPL probes. Where possible, assays were 
designed across an intron to avoid the amplification of potential genomic DNA 
contaminants. qRT-PCR assays were carried out in 384-well format on the ABI Prism 
7900HT Real-Time PCR System with SDS 2.4 software (Applied Biosystems, Life 
Technologies, Paisley, UK), using the Applied Biosystems™ TaqMan™ Universal 
PCR Master Mix (Applied Biosystems, Life Technologies, Paisley, UK) according to 
the manufacturer’s instructions. Samples were assayed in triplicate. Reverse 
transcriptase negative (section 2.5.2) and no template controls were included to ensure 
reagents were free of contamination. Details of the assays used in these studies, 
including primer sequences, UPL probe number and amplification efficiency, are 
listed in Table 2-3. The external Luciferase control was assayed using 
gcacatatcgaggtgaacatcac and gccaaccgaacggacattt forward and reverse primers 
respectively and, a 5’NED labelled probe (tacgcggaatacttc). 




Figure 2.4 qRT-PCR Assay Validation. Top panel shows representative amplification plot of 
a 5-fold dilution series of template cDNA. Bottom panel shows the threshold cycle (Ct) plotted 
against log-template concentration. The slope of the line is used to calculate assay efficiency.
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Table 2-3. Details of Primers and Probes used for qRT-PCR Assays 
Gene Forward Primer Reverse Primer UPL Probe 
Efficiency 
(%) 
Lhcgr gatgcacagtggcaccttc cctgcaatttggtggaagag 107 96 
Star aaactcacttggctgctcagta tgcgataggacctggttgat 83 99 
Cyp11a1 aagtatggccccatttacagg tggggtccacgatgtaaact 104 98 
Hsd3b1 gaactgcaggaggtcagagc gcactgggcatccagaat 12 98 
Hsd3b6 accatccttccacagttctagc acagtgaccctggagatggt 95 101 
Cyp17a1 catcccacacaaggctaaca cagtgcccagagattgatga 67 94 
Hsd17b3 aatatgtcacgatcggagctg gaagggatccggttcagaat 5 95 
Ocdn gcggaaagagttgacagtcc atctcctgggccacttcag 25 99 
Cldn3 tgggagctgggttgtacg caggagcaacacagcaagg 26 99 
Cldn11 tggagtggccaagtacagg gacaatggcgcagagagc 20 93 
Stra8 ttgacgtggcaagtttcct agttgcaggtggcaaacata 107 102 
Spo11 ggctcctggacgacaactt cagatctggaacgcccttt 18 99 
Tpn1 agccgcaagctaaagactca cggtaattgcgacttgcat 91 96 
Gdnf gctcaaaattgtgacaacctca cagagggtctggaacgacat 107 104 
Cyp26b1 aacatggcaaggagatgacc ttgcatgatcaaggatgtgc 17 99 
Kitl gctgctggtgcaatatgct gataaatgcaagtgataatccaagttt 50 97 
STAR ggcatccttagcaaccaaga tctgggaccactttactcatca 18 104 
CYP11A1 gatgacctgttccgctttg cctcggggttcactacttcc 89 102 
CYP17A1 ctatgctcatcccccacaag ccttgtccacagcaaactca 67 108* 
HSD17B3 aacttgcaggcttagaaattgg ggtgcgttcaggaaatgg 7 108* 
* These assays were not used for quantitative analyses
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 Assay Validation 
As described in section 2.5.4, quantification of mRNA expression by qRT-PCR relies 
on the relationship between initial target abundance and the Ct value obtained during 
exponential amplification. As such, it is absolutely necessary that the PCR reaction is 
suitably efficient in order to obtain reliable results. Assays with an efficiency between 
90 and 105% were considered fit for purpose. In order to establish the efficiency of 
each assay, a serial dilution of cDNA was prepared and amplified with appropriate 
primers and probe. Following amplification, the Ct value was plotted against the log 
dilution factor (Figure 2.4). The equation of the linear regression line was then used to 
calculate the efficiency of the reaction using the following formulas: 
Exponential amplification (E) = 10-1/slope 
Reaction Efficiency (%) = (E-1) x 100 
In an ideal situation, there would be perfect doubling of the amplicon during each cycle 
(i.e. a reaction efficiency of 100%). In the example shown in Figure 2.4, the efficiency 
was calculated to be 98.7%: 
E = 10-1/3.3529 = 1.987235 
Reaction Efficiency = (1.987235-1) x 100 = 98.7% 
 Analysis 
Relative quantification of mRNA expression was carried out using the 2-ΔΔCt method 
(Livak and Schmittgen, 2001, Schmittgen and Livak, 2008). Briefly, the Ct of the 
external control (Luciferase) was subtracted from the Ct of the target to give the ΔCt. 
The triplicates for each sample were then averaged, and corrected to a reference 
(control ΔCt) to give the ΔΔCt. This was achieved by subtracting the reference ΔCt 
from the ΔCt of each sample. The fold-change between control and experimental 
groups was then calculated using the formula 2-ΔΔCt. 
2.6 Western Blotting 
2.6.1 Protein Extraction 
Protein was extracted from frozen tissues collected and stored as described in section 
2.1.5. A piece of tissue, approximately 30mg, was used for extractions. Samples were 
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homogenised in 500µL RIPA buffer (15mM HEPES-NaOH [pH 7.5], 0.5mM NaCl, 
1mM sodium orthovanadate, 10mM EDTA; 1% Triton X-100, 1% sodium 
deoxycholate and 0.1% sodium dodecyl sulphate) supplemented with cOmplete™ 
MINI protease inhibitors and PhosSTOP™ protease inhibitors (Roche Diagnostic Ltd., 
Burgess Hill,UK) using a Retsch tissue lyser (Qiagen QIAGEN Ltd., Crawley, UK). 
The homogenate was incubated on ice for 1hr before centrifugation at 2500rpm for 
10mins at 4oC. The resulting supernatant was stored in aliquots at -80oC. Protein 
concentration was determined using the Bio-Rad DC protein assay kit (Bio-Rad 
Laboratories Ltd., Watford, UK) following the manufacturer’s instructions. 
2.6.2 Protein Electrophoresis and Transfer 
Protein samples in NuPage LDS sample buffer (Life Technologies, Paisley UK) 
containing NuPage reducing agent (Life Technologies, Paisley UK) were heated to 
70oC for 5mins and loaded onto Novex® Tris-Glycine or Tris-Acetate polyacrylamide 
gels (Life Technologies, Paisley UK). Samples were electrophoresed under denaturing 
conditions in NuPAGE MOPS SDS or NuPage Tris-Acetate SDS running buffer (Life 
Technologies, Paisley UK) at 200V for approximately 45mins using the XCell 
SureLock™ Mini-Cell Electrophoresis System (Thermo Scientific, Runcorn, UK). 
Proteins were then transferred in NuPage transfer buffer (Life Technologies, Paisley 
UK) onto Immobilon-FL PVDF membranes (Merk Millipore, Billerica, MA, USA) at 
400V for 90mins. Appropriate care was taken to ensure buffers remained as cool as 
possible during electrophoresis and transfer steps. 
2.6.3 Protein Detection 
Membranes were washed in PBS. Non-specific epitopes were blocked by incubating 
membranes with PBS containing 5% (w/v) semi-skimmed milk powder (Premier 
Foods Ltd., St. Albans, UK) for 1hr at room temp. Membranes were then incubated 
with primary antibodies diluted in blocking buffer at 4oC overnight.  
Membranes were then subjected to 3x5min washes with PBS containing 0.1% (v/v) 
Tween® 20 (PBST; Sigma-Aldrich Co. Ltd., Dorset, UK) before incubation with the 
appropriate IRDye® secondary antibodies (LI-COR Biotechnology Ltd, Cambridge, 
UK), diluted in blocking buffer, for 1hr at room temp. Finally, membranes were 
washed in PBST and stored in PBS in the dark at 4oC until being read on a LI-COR 
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Odessey Infra-red scanner (LI-COR Biotechnology Ltd, Cambridge, UK). Details of 





Table 2-4. Details of the Antibodies used for Western Blotting 
Target 
Primary Antibody Secondary Antibody 
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2.7 Primary Cell Culture 
2.7.1 Human Adipose-derived Perivascular Stem Cells 
Human adipose-derived perivascular stem cells (hAd-PSC; CD146pos, CD34neg, 
CD31neg, CD45neg), isolated from the stromal vascular fraction of human lipoaspirates 
(Crisan et al., 2008), were gratefully received from Professor Bruno Pèault (MRC 
Centre for Regenerative Medicine, University of Edinburgh). Technical advice with 
the handling of these cells was kindly provided by Dr Zaniah Gonzalez Galofre (MRC 
Centre for Regenerative Medicine, University of Edinburgh). 
hAd-PSCs were maintained in expansion media (EM) consisting of DMEM 
GlutaMAX™-I (Gibco® Thermo Scientific, Runcorn, UK ) supplemented with 20% 
(vol/vol) fetal bovine serum (FBS; Gibco®, Thermo Scientific, Runcorn, UK) and 1% 
(vol/vol) penicillin-streptomycin (Gibco® Thermo Scientific, Runcorn, UK). Cells 
were maintained at 37oC with 5% CO2 using a Heracell™ 150i incubator (Thermo 
Scientific, Runcorn, UK). Cells were sub-cultivated at a ratio of 1:4. Briefly, cells were 
washed with sterile PBS and incubated with TrypLE Express dissociation reagent 
(Gibco® Thermo Scientific, Runcorn, UK) for 2mins at room temperature. Enzyme 
activity was quenched by the addition of culture media and cells were seeded into fresh 
EM. Cells were not sub-cultivated beyond passage 10. In the first instance, cells were 
expanded and frozen at early passage in FBS containing 10% (vol/vol) DMSO (Hybri-
Max™; Sigma-Aldrich, Dorset, UK) using a Mr. Frosty™ Freezing Container (Thermo 
Scientific, Runcorn, UK) containing fresh isopropyl alcohol. Cells were stored in the 
vapour phase of liquid nitrogen. Frozen cells were rapidly defrosted in a water bath at 
37oC and seeded directly into expansion media. After ~16hrs, when the cells had 
adhered, the media was replaced with fresh media to remove DMSO. 
 In Vitro Differentiation 
To determine whether hAd-PSCs could differentiate into Leydig-like cells in vitro, 
cells were treated with a cocktail of hormones/growth factors initially described by Ge 
et al. (2006). Briefly, cells were grown to sub-confluence (~70%) in EM (see section 
2.7.1) and then switched to a differentiation-inducing medium (DIM) for seven days. 
DIM consisted of phenol red-free DMEM/F-12 (Gibco® Thermo Scientific, Runcorn, 
UK) supplemented with 2% FBS (Gibco®, Thermo Scientific, Runcorn, UK), 1% 
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penicillin-streptomycin (Gibco® Thermo Scientific, Runcorn, UK), 10ng/mL 
recombinant human platelet-derived growth factor beta (rhPDGFb; Sigma-Aldrich, 
Dorset, UK), 1ng/mL human luteinising hormone (hLH; Sigma-Aldrich, Dorset, UK), 
70ng/mL recombinant human insulin-like growth factor-1 (rhIGF-1 Sigma-Aldrich, 
Dorset, UK), 1nM 3,3′,5-Triiodo-L-thyronine sodium salt (thyroid hormone, T3; 
Sigma-Aldrich, Dorset, UK) and 1X human ITS supplement (Sigma-Aldrich, Dorset, 
UK). 
2.8 Statistical Analyses 
All statistical analyses were carried out using GraphPad Prism 7.02 software 
(GraphPad software Inc, San Diego, CA, USA). The distribution of datasets was first 
assessed using the D’Agostino & Pearson or Shapiro-Wilk normality test, where a p-
value ≥0.05 represents conformation to a Gaussian distribution (parametric data), and 
a p-value ≤0.05 indicates deviation from the Gaussian distribution (non-parametric 
data). 
Comparisons were made between two groups using either an unpaired, two tailed, t-
test or a Mann-Whitney U-test for parametric and non-parametric data respectively. In 
each case, a p-value ≤0.05 was considered statistically significant.  
Differences between more than two groups were identified using either a one-way 
analysis of variance (ANOVA) or a Kruskal –Wallis test for parametric and non-
parametric data respectively. For one-way ANOVA, means were compared between 
groups using either Dunnet’s or Tukey’s post hoc analysis. For Kruskal-Wallis, means 
were compared between groups using Dunn’s post hoc analysis. In each case, a p-value 
≤0.05 was considered statistically significant. 
To determine whether inheritance of transgenes conformed to predicted patterns of 
Mendelian inheritance, the observed genotype ratios were compared to the expected 
values using a Chi-square test. Significant discrepancy in the observed ratios was 
indicated by a p-value ≤0.05 
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2.9 Commonly Used Buffers and Solutions 
2.9.1 Lysis Buffer –Genomic DNA Extraction 
 Tris Stock Solution 
For 1L of Tris stock (1M Tris, pH 8.0), 121.14g Tris base (Sigma-Aldrich, Dorset, 
UK) was dissolved in 800mL deionised water. After adjusting the pH to 8.0 using 
concentrated hydrochloric acid (HCl) or sodium hydroxide (NaOH), added dropwise, 
to decrease or increase pH respectively, the volume was made up to 1L with deionised 
water. The solution was stored at room temperature. 
 Ethylenediaminetetraacetic Acid (EDTA) Stock Solution 
For 1L of EDTA stock (0.5M EDTA, pH 8.0), 146.12g EDTA (Sigma-Aldrich, Dorset, 
UK) was dissolved in 800mL deionised water. After adjusting the pH to 8.0, the 
volume was then made up to 1L with deionised water. The solution was stored at room 
temperature. 
 Tris-EDTA-Tween  
Fresh Tris-EDTA-Tween was prepared before use. This was achieved by adding 
2.5mL 1M Tris (2.9.1.1), 100µL 0.5M EDTA (2.9.1.2) and 250uL TWEEN® 20 
(Sigma-Aldrich, Dorset, UK) to 48mL deionised water. After thorough mixing, the 
solution was sterile filtered through a 0.22µm syringe filter unit (Merk Millipore, 
Billerica, MA, USA). 
2.9.2 Citrate HIER Buffer 
 Citrate Buffer Stock Solution 
For 1L of 10X citrate buffer stock (0.1M citric acid, pH 6.0), 21.01g citric acid 
monohydrate (Sigma-Aldrich, Dorset, UK) was dissolved in 875mL deionised water. 
NaOH was added dropwise to achieve a pH of 5.5. The volume was then made up to 
1L with deionised water, and further adjusted to pH 6.0. The solution was stored at 
4oC. 
 Citrate Buffer Working Solution 
Typically, 250mL 1X citrate buffer working solution (10mM citric acid, pH 6.0) was 
prepared by adding 25mL 0.1M stock (see 2.9.2.1) to 225mL deionised water. 
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2.9.3 Tris-EDTA HIER Buffer 
For 1L of 1X Tris-EDTA buffer (10mM Tris, 1mM EDTA, pH 9.0), 1.21g Tris base 
(Sigma-Aldrich, Dorset, UK) and 0.37g EDTA (Sigma-Aldrich, Dorset, UK) were 
dissolved in 900mL deionised water. 500µL Tween® 20 (Sigma-Aldrich, Dorset, UK) 
was then added before adjusting the final volume to 1L. The solution was stored at 
4oC.  
2.9.4 Tris-Buffered Saline (TBS) 
 TBS Stock Solution 
For 1L of 10X TBS stock (0.2M Tris, 1.5M NaCl, pH 7.6), 24g Tris HCl (Sigma-
Aldrich, Dorset, UK), 5.6g Tris base (Sigma-Aldrich, Dorset, UK) and 88g NaCl 
(Sigma-Aldrich, Dorset, UK) were dissolved in 900mL deionised water and adjusted 
to pH 7.6 using concentrated HCl or NaOH to decrease or increase pH respectively. 
The volume was then made up to 1L and the solution stored at 4oC. 
 TBS Working Solution 
Generally, 10L of 1X TBS working solution (20mM Tris, 150mM NaCL, pH 7.6) was 
prepared for communal laboratory use by adding 1L of 10X stock (2.9.4.1) to 9L 
deionised water. 
2.9.5 Phosphate Buffered Saline (PBS) 
For 1L of 1X PBS working solution (10mM Na2HPO4, 2.7mM KCl, 137mM NaCl, 
pH 7.4) 5 PBS tablets (Sigma-Aldrich, Dorset, UK) were dissolved in 950mL 
deionised water. Once dissolved, the volume was adjusted to 1L.  
2.9.6 Normal Sera and Blocking Solutions 
 Normal Sera 
Normal sera were obtained through the SuRF histology facility from Biosera, Uckfield 
UK. Normal goat (NGS), chicken (NChS) or horse (NHS) sera were used for 
immunohistochemistry experiments (see 2.2.3) in which secondary antibodies were 
raised in the respective species. 
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 Blocking Solutions. 
For 200mL of blocking solution, 2g bovine serum albumin (BSA; Sigma-Aldrich, 
Dorset, UK) was dissolved into 140mL of TBS (see 2.9.4.2), 20mL of normal serum 
was then added and the volume made up to 200mL with TBS. The solution was driven 
through a 0.22µm syringe filter unit (Merk Millipore, Billerica, MA, USA). Aliquots 
were stored at -20oC.
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 Dissecting the Paracrine Network in the Ageing Testis 
3.1 Introduction 
Spermatogenesis and steroidogenesis; the two principal functions of the testis are 
entirely dependent on the two major somatic cell populations – the Sertoli cells and 
Leydig cells, respectively. In human males, testicular function declines during the 
ageing process (Perheentupa and Huhtaniemi, 2009, Gunes et al., 2016). Of particular 
significance is the reported age-related decrease in Leydig cell androgen production 
(Morley et al., 1997, Harman et al., 2001, Feldman et al., 2002, Wu et al., 2008, Fabbri 
et al., 2016) as androgens have been suggested to play a crucial role in supporting 
lifelong general health in men, with low circulating testosterone linked to an increased 
risk of developing chronic age-related cardiometabolic diseases (Kupelian et al., 2006, 
Kupelian et al., 2008, Farrell et al., 2008, Brand et al., 2014, Pye et al., 2014). 
Therefore, elucidating the mechanism(s) governing the maintenance of testicular 
function, in particular Leydig cell steroidogenesis, is pertinent to our understanding of 
male health. 
Androgen production is under negative feedback control by the hypothalamic-
pituitary-gonad (HPG) axis. Gonadotrophin-releasing hormone (GnRH), from the 
hypothalamus, stimulates the pituitary to secrete luteinising hormone (LH), which 
stimulates Leydig cell testosterone production. Increased circulating testosterone then 
negatively regulates the hypothalamic-pituitary unit to control LH secretion. The 
nature of this negative feedback loop gives rise to separate etiologies for low 
testosterone levels observed during ageing/disease. Either a deficit in LH production 
by the hypothalamic pituitary unit (hypogonadotrophic hypogonadism/secondary 
hypogonadism) or defective androgen biosynthesis at the level of the Leydig cell, 
usually accompanied by a compensatory increase in LH and subsequent distortion of 
the LH/testosterone ratio (hypergonadotrophic hypogonadism/primary 
hypogonadism). In ageing males, the latter is generally observed although testosterone 
levels may remain within the normal range due to the compensatory increase in LH 
(Wu et al., 2008). 
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Current rodent models for the study of age-related Leydig cell dysfunction are limited. 
The most widely used model is the naturally-aged brown Norway rat which has 
provided significant insight into changes occurring in Leydig cells during ageing, 
including: increased production of reactive oxygen species (ROS), decreased LH-
stimulated cAMP signalling, and reduction in the expression and activity of enzymes 
involved in the conversion of cholesterol to testosterone (Zirkin and Tenover, 2012). 
However, this model is time consuming and expensive to generate and is accompanied 
by protracted welfare issues as the animals are generally aged up to 24 months. As 
such, new models which provide a platform to study the mechanism(s) by which 
testis/Leydig cell function deteriorates during ageing/disease are required. Ideally, a 
model permitting the separation of individual components of the system (i.e. other 
testicular somatic cell populations which may influence Leydig cell function in a 
paracrine manner) would be valuable in assessing cause and effect. 
Genetic models of premature ageing provide an attractive alternative for the expedited 
study of age-related processes. Indeed, a number of progeroid mouse lines have been 
generated to date, primarily through disruption of genes required for DNA 
repair/genomic stability or lamin processing/maintenance of nuclear architecture 
(Carrero et al., 2016, Kõks et al., 2016). However, the majority have been generated 
to model monogenic human progeroid syndromes and thus, have limited utility in the 
study of age-related HPG axis dysfunction. Furthermore, in such models of global gene 
ablation, it is difficult to separate the contribution of specific tissue/cell types to the 
observed phenotypes. A study by Chen et al. (2009c) reported a premature ageing 
phenotype in mice deficient for Cisd2 (CDGSH iron sulphur domain 2), characterised 
by nerve and muscle degeneration, osteopenia, reduced body weight and premature 
death. Conversely, over expression of Cisd2 in transgenic mice has been reported to 
extend healthy lifespan and delay ageing; protecting against age-associated 
mitochondrial dysfunction (Wu et al., 2012). CISD2 is a redox active protein localised 
to the endoplasmic reticulum (ER) and is thought to be important for the maintenance 
of ER and mitochondrial structure/function (Wiley et al., 2013).  
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3.1.1 Hypothesis & Aims 
It is hypothesised herein that Cisd2-deficient mice will have a testicular phenotype 
resembling that of the ageing testis and thus be useful for the expedited study of age-
related testicular dysfunction. The overall aim of this chapter was to determine the 
utility of novel models of premature ageing to dissect the process of age-related 
testicular degeneration. Firstly, a novel knockout-first conditional allele of a 
previously reported premature-ageing model driven by Cisd2 deficiency 
(Cisd2tm1a(EUCOMM)Wtsi) was validated and the testicular phenotype characterised and 
compared to that of naturally aged mice at 18-months of age. Next, Cre/LoxP 
technology was used to delete Cisd2 from specific testicular cell populations in 
Cisd2tm1c(EUCOMM)Wtsi mice to determine the contribution of individual cell types in the 
control/support of Leydig cell function during the ageing process. 
3.2 Results 
3.2.1 Effect of Constitutive CISD2-Knockout in the Adult Testis 
 Validation of the Cisd2tm1a(EUCOMM)Wtsi Allele 
To establish whether CISD2-deficient mice would provide a suitable platform for the 
study of age-related testicular dysfunction, the absence of CISD2 protein in 
Cisd2tm1a(EUCOMM)Wtsi mice was first confirmed. Wild-type (WT), heterozygous (HET) 
and homozygous (KO) mice were generated as described section 2.1.2.1.1. 
Genotyping primers were designed around the synthetic cassette and used to identify 
WT, HET and KO animals (Figure 3.1A). Chi-squared analysis of offspring derived 
from heterozygous crossings confirmed inheritance of WT and KO alleles conform to 
predicted Mendelian ratios (Figure 3.1B). Western blotting on a panel of tissues 
including liver and testis (Figure 3.1C) confirmed the absence of CISD2 protein in KO 
mice. Furthermore, growth curves from WT, HET and KO mice (Figure 3.1D) 
revealed CISD2-deficient animals were significantly lighter from 8 weeks of age 
compared to WT animals, consistent with previous reports of Cisd2 disruption (Chen 
et al., 2009c). Taken together, these data confirm that the knockout-first 
Cisd2tm1a(EUCOMM)Wtsi allele functions as expected and that CISD2 loss associated with 
this allele is functionally significant. 




Figure 3.1 Validation of the Knockout-first Cisd2 Allele. (A) PCR analysis of genomic DNA 
isolated from ear clips of wild-type (WT; 257bp), heterozygous (HET; 257 and 178bp) and 
homozygous (KO; 178bp) mice. (B) Inheritance of WT and KO alleles in offspring derived from 
heterozygous crossings conformed to predicted Mendelian ratios (X2; p = 0.4224). (C) Western 
blot analysis of liver and testis confirmed CISD2 (CDGSH iron sulphur domain 2) protein is 
absent in KO mice. *The lower band is predicted to be CISD1 (CDGSH iron sulphur domain 1) 
based on size and sequence homology in the region of the protein that the antibody was raised 
against. (D) Growth curves of WT, HET and KO mice revealed CISD2-deficient animals were 
significantly lighter from 8 weeks of age compared to WT animals (WT vs. KO individual t-tests; 
p = 0.006823 at 8wks, p = 0.000419 at 26 weeks. n = ≥5 animals per genotype per time point). 
Values are mean ± S.E.M. 
 Testicular Atrophy in CISD2-deficient Mice  
Having validated ablation of CISD2 in KO animals, the impact of CISD2 deficiency 
on testicular architecture was next assessed. No overt dysmorphology of the 
reproductive tract was noted although testes and seminal vesicles appeared slightly 
smaller in KO animals at 6-months of age (Figure 3.2A). In addition, a striking 
reduction in epididymal fat pad mass was observed in the KO mice, in line with the 
previously reported requirement of CISD2 for normal adipogenesis (Wang et al., 
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2014). Indeed, testis weight was significantly lower in 6-month old KO mice compared 
to age-matched WT contols (Figure 3.2B). Although testicular histology was largely 
normal in KO mice, with abundant interstitial Leydig cells and full spermatogenesis 
occurring within seminiferous tubules, occasional degenerating tubules were noted, 
similar to observations of the 18-month old naturally aged testis (Figure 3.2C). 
 
Figure 3.2 Testis Weight and Architecture is Altered in CISD2-deficient Mice. (A) 
Representative reproductive tracts from 6-month old wild-type (WT) and knockout (KO) mice. 
Open arrowheads = seminal vesicle, closed arrows = testis. Note the striking reduction in 
epididymal fat pad mass (asterisks). Scale = 10mm. (B) A significant reduction in testis weight 
was observed in KO mice at 6-months of age. Testis weights of naturally aged mice were also 
reduced at 18 months of age (1-way ANOVA; p = <0.0001; n = 8-10). Error bars = S.E.M. (C) H 
& E stained testis sections from WT and KO mice at 6-months of age and naturally aged mice 
at 18-months of age. In each case abundant interstitial Leydig cells and seminiferous tubules 
(ST) with full spermatogenesis were present. However, occasional degenerating tubules 
(asterisks) were noted in the KO testis, consistent with observations of the naturally aged 
testis. Scale = 100µm.  
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Given that the structure and function of the seminiferous tubules is entirely dependent 
on the Sertoli cell population (Rebourcet et al., 2014a, Rebourcet et al., 2014b), the 
tubular degeneration in the KO testis may be explained by a deficit in this cell 
population. Immuno-reactivity of the Sertoli cell marker SOX9 (SRY-Box 9) was 
observed, as expected, around the periphery of the seminiferous tubules in WT, KO 
and naturally aged testes (Figure 3.3A). Stereological analysis revealed that there are 
significantly fewer Sertoli cells in the KO testis at 6-months of age (Figure 3.3B). This 
decrease in the Sertoli cell population was associated with a significant reduction in 
the diameter of the seminiferous tubules (Figure 3.3C) and a consequent reduction in 
the epididymal sperm reserve in KO mice (Figure 3.3D). Taken together, these 
observations suggest CISD2 loss results in premature testicular atrophy at 6-months of 
age, consistent with that observed in 18-month old naturally aged mice. 
 
Figure 3.3. Sertoli Cell Number, Seminiferous Tubule Diameter and Epididymal Sperm 
Reserves are Reduced in CISD2-deficient Mice. (A) Representative chromogenic 
immunostaining of the Sertoli cell marker SOX9 (SRY-Box 9) in wild-type (WT), knockout (KO) 
and naturally aged testes. Sertoli cell number (B), seminiferous tubule diameter (C) and 
epididymal sperm reserves were significantly reduced in KO testes at 6-months of age 
consistent with changes occurring in the naturally aged testis (1-way ANOVA; p = 0.0034, 
0.0011 and 0.0062 respectively, n = 5-8). Error bars = S.E.M. 
Chapter 3 Dissecting the Paracrine Network in the Ageing Testis 
81 
 
 Leydig Cells are Dysfunctional in CISD2-deficient Mice 
Ageing is associated with a reduction in Leydig cell steroidogenesis (Chen et al., 
2015). Plasma testosterone levels along with seminal vesicle weight (as a biomarker 
of peripheral androgen action) were reduced in the KO mice compared to WT controls 
at 6-months of age (Figure 3.4A and B), indicating a perturbation in Leydig cell 
testosterone biosynthesis in the absence of CISD2. Conversely, seminal vesicle weight 
was significantly increased in naturally aged mice (Figure 3.4B). Although circulating 
luteinising hormone levels were not significantly elevated in the KO mice (Figure 
3.4C), the LH:T ratio was significantly higher (Figure 3.4D), suggesting that the 
reduction in testosterone production is likely due to primary testicular dysfunction 
rather than secondary to dysfunction of the hypothalamic-pituitary unit.  
 
Figure 3.4 Leydig Cell Dysfunction Resembling Compensated Leydig cell Failure in CISD2-
deficient Mice. (A) Circulating testosterone was reduced in knockout (KO) mice at 6-months 
of age (Kruskal-Wallis; p = 0.0158, n =5-12). (B) Seminal vesicle weight (a biomarker of 
peripheral androgen action) was significantly reduced in KO animals at 6-months of age 
converse to the naturally aged animals (1-way ANOVA; p = <0.0001, n =5-10). (D) A significant 
increase in the luteinising hormone:testosterone ratio (LH/T) was observed in the KO mice 
suggesting observed reduction in testosterone is due to dysfunction of CISD2-deficient Leydig 
cells (Mann-Whitney U-test; p = 0.0393, n= 5-9). Error bars = S.E.M. 
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To further probe the basis for the observed reduction in testosterone in CISD2-
deficient mice (Figure 3.4A), Leydig cell number and the mRNA expression of genes 
involved in steroidogenesis were assessed in KO testes at six-months of age. As 
expected, immuno-reactivity of the Leydig cell marker HSD3B (hydroxysteroid 
dehydrogenase 3-beta) was observed in the interstitial compartment in WT, KO and 
naturally aged testes (Figure 3.5A). However, a significant reduction in Leydig cell 
number was observed in both 6-month old KO and naturally aged testes (Figure 3.5A). 
Furthermore, mRNA expression of key Leydig cell-expressed genes, required for the 
conversion of cholesterol to testosterone, were significantly decreased in KO testes 
(Figure 3.5B). Despite a reduction in Leydig cell number in the aged testis (Figure 
3.5A), mRNA expression of steroidogenic genes remained largely stable suggesting 
that reduced expression in the KO testes reflects impaired function rather than simply 
a decrease in Leydig cell number. 
 
Figure 3.5 Leydig Cell Number and Function is Impacted in CISD2-deficient 
Mice at 6-months of Age. Legend on following page  
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Figure 3.5 Leydig Cell Number and Function are Altered in CISD2-deficient 
Mice at 6-months of Age. Figure on preceding page (A) Representative chromogenic 
immunostaining of the Leydig cell marker hydroxysteroid dehydrogenase 3-beta (HSD3B) in 
wild-type (WT), knockout (KO) and naturally aged testes. Leydig cell number was reduced in 
both KO and naturally aged testes (1-way ANOVA; p = 0.0086; n = 5-8). (B) mRNA expression 
of genes involved in Leydig cell testosterone biosynthesis was reduced in the KO testis at 6-
months of age whereas expression was largely unchanged in the naturally aged testis with the 
exception of Lhcgr and Hsd3b1 (1-way ANOVA). Luteinising hormone/chorionic gonadotropin 
receptor (Lhcgr), p = <0.0001; steroidogenic acute regulatory protein (Star), p = 0.0172; P450 
cholesterol side-chain cleavage enzyme (Cyp11a1), p = <0.0001; hydroxysteroid 
dehydrogenase 3-beta type 1 (Hsd3b1), p = 0.0045; hydroxysteroid dehydrogenase 3-beta 
type 6 (Hsd3b6), p = 0.0004; 17α-hydroxylase, 17,20-lyase (Cyp17a1) p = <0.0001; 
hydroxysteroid dehydrogenase 17-beta type 3 (Hsd17b3), p = 0.0003; n = 8). Error bars = 
S.E.M. 
3.2.2 Effect of Cell-specific Cisd2-KO in the Adult Testis 
To better understand how the testicular microenvironment is affected in CISD2-KO 
mice, a conditional Cisd2 allele (Cisd2tm1c(EUCOMM)Wtsi) was used to disrupt Cisd2 in 
Leydig and Sertoli cells separately. 
 Pdgfrb-Cre Targets Adult Leydig Stem/Progenitor Cells in the 
Fetal Testis 
The utility of Pdgfrb-Cre mice for the targeting of the adult Leydig cell population was 
assessed using a red fluorescent protein (RFP) Cre reporter allele 
(Gt(ROSA)26Sortm14(CAG-tdTomato)Hze). During pubertal development adult Leydig cells 
develop from a pool of peritubular and/or perivascular stem/progenitor cells which is 
established during fetal life (Siril Ariyaratne et al., 2000, Mendis-Handagama and 
Ariyaratne, 2001, O'Shaughnessy et al., 2002b, Davidoff et al., 2004, Ge et al., 2005, 
Ge et al., 2006, Chen et al., 2009b, Kilcoyne et al., 2014). Dual fluorogenic 
immunostaining revealed widespread expression of PDGFRB in the interstitial 
compartment of the mouse testis at e18.5 with Cre-mediated RFP expression noted in 
spindle-shaped interstitial/peritubular cells (Figure 3.6B). Co-localisation of RFP and 
the putative stem/progenitor marker COUP-TFII (Kilcoyne et al., 2014) was observed 
in a proportion of spindle-shaped peritubular cells (Figure 3.6C) suggesting the 
Pdgfrb-Cre line may be useful for conditional gene ablation in the adult Leydig cell 
population. 




Figure 3.6 Pdgfrb-Cre Targets Adult Leydig Cell Stem/Progenitor Cells in the Fetal Testis. 
(A) tdTomato red fluorescent protein (RFP) expression was observed in the testes of td-
Tomato Cre-reporter mice at embryonic day (e)18.5. (B) Dual fluorogenic immunostaining 
revealed widespread expression of platelet-derived growth factor receptor beta (PDGFRB) in 
the interstitial compartment of the fetal testis. Cre-mediated RFP expression was noted in 
spindle-shaped interstitial/peritubular cells (arrows); some RFP expression was also noted in 
a number of Sertoli cells (arrowheads). (C) Co-localisation of RFP and the putative 
stem/progenitor marker chicken ovalbumin upstream promoter transcription factor-II (COUP-
TFII) was observed in a proportion of spindle-shaped peritubular cells (arrows) which are 
hypothesised to give rise to the adult Leydig cell population. ST = seminiferous tubule. 
Arrowhead = Sertoli cell. 
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 Generation of Leydig and Sertoli Cell-specific Cisd2-KO Mice 
Having demonstrated that the Pdgfrb-Cre line targets adult Leydig stem/progenitor 
cells in the fetal testis, targeting of the adult Leydig cells was next confirmed. Dual 
fluorescent immunohistochemistry for RFP and HSD3B revealed co-localisation in 
approximately 55 per cent of Leydig cells in the testis at postnatal day (d) 50 (Figure 
3.7A). RFP expression was also observed in peritubular and perivascular cells as well 
as in a small sub-population of Sertoli cells. Specificity of the Amh-Cre line was also 
confirmed in RFP reporter mice by dual fluorescent immunohistochemistry for RFP 
and SOX9. As expected, Cre expression was confined to testicular Sertoli cells as 
evidenced by the pattern of RFP positive staining, characteristic of Sertoli cell 
cytoplasm, in cells positive for the Sertoli cell nuclear marker SOX9 (Figure 3.7B). 
PCR amplification of genomic DNA isolated from the testes of Prdgfrb-Cre-/-; 
Cisd2tm1c/tm1c (WT), and Prdgfrb-Cre+/-; Cisd2tm1c/tm1c (LC-KO) and Amh-Cre-/-; 
Cisd2tm1c/tm1c (WT) and Amh-Cre+/-; Cisd2tm1c/tm1c (SC-KO) mice demonstrated 
recombination of the conditional Cisd2 allele upon exposure to either Cre-recombinase 
(Figure 3.7C and D). In contrast to the phenotype observed in global-KO animals in 
which body weight was significantly reduced from 8-weeks of age, body weight was 
maintained in LC-KO and SC-KO animals (Figure 3.8A). In fact, a slight increase in 
body weight was noted in LC-KO animals at 6-months of age. 




Figure 3.7 Generation of Leydig and Sertoli Cell-Specific Cisd2-KO Mice. (A) Analysis of 
Pdgfrb-Cre activity in the testis of young adult tdTomato Cre-reporter mice. Co-
immunostaining of red fluorescent protein (RFP) with the Leydig cell (LC) marker 
hydroxysteroid dehydrogenase 3-beta (HSD3B; asterisks) showed that this Cre line is active in 
approximately 55 ± 3.9 % (S.E.M) of adult Leydig cells. Expression was also observed in the 
peritubular cells (arrows) as well as in a small proportion of Sertoli cells (closed arrowheads). 
(B) Confirmation of Sertoli cell-specific targeting using Amh-Cre. Co-immunostaining of RFP 
with the Sertoli cell marker SRY box-9 (SOX9) showed RFP expression was restricted to Sertoli 
cells. PCR analysis of testicular genomic DNA confirmed the conditional Cisd2 allele is 
recombined upon exposure to either (C) Pdgfrb-Cre (Leydig cell knockout; LC-KO) or (D) Amh-
Cre (Sertoli cell knockout; SC-KO). Wild-type (WT) = 268bp, Knockout (KO) = 174bp. 
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 Disruption of Cisd2 either in Leydig or Sertoli Cells does not 
Induce Testicular Degeneration 
As testicular atrophy accompanied by decreased Sertoli cell number, seminiferous 
tubule diameter and epididymal sperm reserves is observed in global-KO testes at six 
months of age (see section 3.2.1.2), it was next asked whether this phenotype is 
recapitulated when Cisd2 is disrupted either in Leydig cells or Sertoli cells alone. 
Testis weight was normal in both LC-KO and SC-KO animals (Figure 3.8B), with no 
histological evidence of tubular degeneration (Figure 3.8C) as noted in constitutive 
Cisd2-KO animals. Additionally, Sertoli cell number, tubule diameter and epididymal 
sperm reserves were similar between LC-KO, SC-KO and their respective controls 
(Figure 3.9A-D). Taken together, these observations suggest that neither Leydig cells 
nor Sertoli cells alone are responsible for the degenerative testicular phenotype 
observed in constitutive Cisd2-KO animals. 
 
Figure 3.8 Testicular Architecture is Unaltered when Cisd2 is Disrupted either in Leydig 
or Sertoli Cells. (A) Body weight was not reduced in Leydig cell knockout (LC-KO; left) or Sertoli 
cell knockout (SC-KO; right) animals. In fact, a slight increase in weight was observed in LC-KO 
animals at 6-months of age (unpaired t-test; p = 0.0096). (B) No difference in testis weight was 
observed between control and LC-KO or SC-KO mice (unpaired t-test). n = 7-8. Error bars = 
S.E.M. (C) Representative H & E stained testis sections of LC-KO (top) and SC-KO (bottom) mice 
and 6-months of age. Testicular architecture remained normal when Cisd2 is disrupted either 
in Leydig or Sertoli cells. 




Figure 3.9 Sertoli Cell Number, Seminiferous Tubule Diameter and Epididymal Sperm 
Reserves are Maintained When Cisd2 is Disrupted in Leydig or Sertoli Cells. (A) 
Representative chromogenic immunostaining of the Sertoli cell marker Sry box-9 (SOX9) in 6-
month old Leydig cell knockout (LC-KO) and Sertoli cell knockout (SC-KO) testes and their 
respective controls. In contrast to global KO and naturally aged animals, no reduction in (B) 
Sertoli cell number, (C) seminiferous tubule diameter or (D) epididymal sperm reserves was 
noted in the LC-KO or SC-KO mice at 6-months of age (unpaired t-tests). n = 7-9. Error bars = 
S.E.M. 
In addition to endocrine regulation by pituitary-derived luteinising hormone, Leydig 
cell steroidogenesis is thought to also be subject to regulation by a paracrine network 
within the testis (Saez, 1994). As such, Leydig cell steroidogenic function was 
assessed in both conditional Cisd2-KO models to determine whether the Leydig cell 
dysfunction observed in constitutive CISD2-KO animals is a direct consequence of 
Cisd2 loss from the Leydig cell population, or due to indirect effects of Sertoli cell 
Cisd2 disruption. Interestingly, circulating testosterone levels were normal both in LC-
KO and in SC-KO animals at 6-months of age (Figure 3.10).To test whether maximal 
Leydig cell testosterone production was altered in either conditional models, hCG-
stimulated testosterone was measured. No difference in maximal testosterone 
production was observed when Cisd2 was disrupted in Leydig cells or in Sertoli cells 
(Figure 3.10). Additionally, in contrast to global-KO animals, Leydig cell number 
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(Figure 3.11A) and steroidogenic mRNA expression (Figure 3.11B) were also normal 
in both models compared to their respective controls. Together, these data suggest that 
Leydig cell steroidogenic function is maintained in LC-KO and SC-KO animals. These 
results demonstrate that the mechanism(s) underlying primary testicular failure 
observed in the prematurely aged global-KO animals cannot be assigned to specific 
dysfunction of the Leydig or Sertoli cell populations upon Cisd2 disruption. 
 
Figure 3.10 Circulating Testosterone is Maintained when Cisd2 is Disrupted either in 
Leydig cells or in Sertoli cells. Converse to the global KO animals, plasma testosterone (A) 
remained normal when Cisd2 was disrupted in Leydig cells (LC-KO; unpaired t-test, n = 6-7) or 
Sertoli cells (SC-KO; Mann Whitney U-test n = 10-11). (B) No difference in circulating luteinising 
hormone (LH) or the LH:T ratio was observed in LC-KO mice at 6-months of age (Mann Whitney 
U-test n = 6-7). (C) No difference in seminal vesicle weight was observed in LC-KO or SC-KO 
mice (unpaired t-tests n = 7-8). Error bars = S.E.M. 




Figure 3.11. Leydig Cell Number and Function are Maintained when Cisd2 is 
Disrupted either in Leydig Cells or Sertoli Cells. Legend on following page. 
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Figure 3.11. Leydig Cell Number and Function are Maintained when Cisd2 is Disrupted 
either in Leydig Cells or Sertoli Cells. Figure on preceding page. (A) Representative 
chromogenic immunostaining of the Leydig cell marker hydroxysteroid dehydrogenase 
(HSD3B) in 6-month old Leydig cell knockout (LC-KO) and Sertoli cell knockout (SC-KO) testes 
and their respective controls. (B) Stereological analysis revealed normal Leydig cell number in 
both LC-KO and SC-KO testes (unpaired t-tests). n = 7-8. Error bars = S.E.M. (C) No difference 
in the expression of steroidogenic mRNAs was observed in the LC-KO testis (unpaired t-tests). 
n = 6-8. Error bars = S.E.M. 
3.3 Discussion 
Ageing in men is accompanied by a decline in testicular function. Of particular 
importance is the reported age-related decrease in the endocrine function of the testis 
(e.g. androgen production) (Morley et al., 1997, Harman et al., 2001, Feldman et al., 
2002, Wu et al., 2008, Fabbri et al., 2016), as an inverse relationship between 
testosterone and cardiometabolic disease risk has been suggested (Brand et al., 2014, 
Pye et al., 2014, Farrell et al., 2008, Kupelian et al., 2006, Kupelian et al., 2008). 
However, the cause-consequence relationship between androgens, ageing and disease 
is not entirely clear. Specifically, the precise mechanism(s) by which Leydig cell 
testosterone production becomes compromised, leading to age-related primary 
hypogonadism, remains to be fully established. The studies presented in this chapter 
utilised a series of novel mouse models of premature ageing to begin to dissect the 
process of age-related testicular degeneration. 
Age-related testicular atrophy is well documented both in humans (Johnson et al., 
1986, Paniagua et al., 1991, Mahmoud et al., 2003, Yang et al., 2011, Jiang et al., 
2013) and in rodents (Gosden et al., 1982, Wang et al., 1993, Wright et al., 1993, Levy 
et al., 1999, Morales et al., 2004, Xia et al., 2011). Histomorphometric analyses of 
CISD2-KO animals reveal a testicular phenotype resembling age-related atrophy, 
occurring 12 months earlier than naturally in aged mice. In men testicular volume 
declines with age (Handelsman and Staraj, 1985, Johnson et al., 1986, Mahmoud et 
al., 2003, Yang et al., 2011) and is linked to a reduction in Sertoli cell number and/or 
function, involution of the seminiferous tubules and diminished spermatogenesis 
(Johnson et al., 1984b, Johnson et al., 1986, Johnson et al., 1990, Paniagua et al., 1991, 
Jiang et al., 2013). This is consistent with the reduction in testis weight, seminiferous 
Chapter 3 Dissecting the Paracrine Network in the Ageing Testis 
92 
 
tubule diameter, Sertoli cell number and epididymal sperm reserves observed in both 
CISD2-KO and naturally aged mice. 
Testicular endocrine function also deteriorates during the ageing process. Decreased 
testosterone production may be attributed to either dysfunction of the hypothalamic-
pituitary unit, resulting in decreased LH secretion or, due to the diminished capacity 
of aged Leydig cells to produce testosterone, often accompanied by increased 
circulating LH (Wu et al., 2008). In fact, both testosterone and LH measurement are 
required to inform on Leydig cell function, as circulating testosterone may remain 
within the normal range owing to compensatory LH. A reduction in circulating 
testosterone was noted in CISD2-KO mice at 6-months of age. Although LH is not 
significantly higher, the LH/testosterone ratio is significantly increased in CISD2-
deficient mice, indicative of primary Leydig cell dysfunction (Tajar et al., 2010). 
Interestingly, there is no difference in testosterone levels between WT mice at 6 and 
18-months. Unfortunately, due to technical and time limitations, circulating LH was 
not measured in naturally aged mice, as such compensation by the hypothalamic 
pituitary unit to maintain circulating testosterone cannot be ruled out. Previous studies 
of HPG-axis function in ageing mice report conflicting findings. For example, 
testosterone is reported to decrease in ageing mice due to reduced frequency and 
amplitude of LH pulses (Bronson and Desjardins, 1977, Coquelin and Desjardins, 
1982). However, these studies were carried out using 30-month old CBF1 mice, 
whereas analyses herein were carried out on plasma from 18-month old C57BL/6 
mice; thus, either the age or the strain difference may explain this discrepancy. In 
support of the latter, plasma testosterone levels are reported to remain stable in 
C57BL/6 up to 31-months of age (Eleftheriou and Lucas, 1974, Finch et al., 1977) 
suggesting that the C57BL/6 strain may be refractory to age-related Leydig cell 
dysfunction. When Nelson et al. (1975) considered healthy and diseased aged 
C57BL/6 mice separately, a reduction in circulating testosterone was observed in 
diseased mice. However, the cross-sectional nature of this study prevents any 
interpretation of causality (i.e. whether low testosterone levels drive disease 
progression or vice versa). Additionally, circulating gonadotrophins were not 
measured, thus the authors are unable to conclude whether the hypogonadism noted in 
the diseased animals is primary or secondary in nature. 
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Testosterone deficiency may be attributed to reduced number and/or function of 
Leydig cells. Early studies reported up to a forty four percent reduction in Leydig cell 
number in the ageing human testis, accompanied by a two-fold increase in LH to 
maintain circulating testosterone levels (Kaler and Neaves, 1978, Neaves et al., 1984, 
Neaves et al., 1985). However, a more recent study reported decreased numbers of 
Sertoli, but not Leydig cells in the ageing human testis (Petersen et al., 2015). In 
addition to the relatively small sample sizes of the above studies, these discrepancies 
may be due to differences in methodologies employed to quantify Leydig cells. 
Consistent with the findings of Petersen et al. (2015), Leydig cell number is reported 
to be maintained in aged Brown Norway rats, whereas steroidogenic function is 
reduced due, in part, to reduced expression of genes required for testosterone 
biosynthesis (Wang et al., 1993, Chen et al., 1994). In the studies presented herein, a 
reduction in the number of Leydig cells accompanied by reduced mRNA expression 
of genes encoding the luteinising hormone receptor and steroidogenic enzymes in 
CISD2-KO animals at six months of age was noted. Interestingly, although a similar 
reduction in Leydig cell number was observed in the naturally aged animals, Leydig 
cell steroidogenic function is maintained. This strongly suggests that the decreased 
testosterone production in CISD2-KO mice is due to impaired Leydig cell function 
rather than simply a deficit in cell number. In line with previous studies by Chen et al. 
(2009c) and Wang et al. (2014), the CISD2-KO mice described herein have a marked 
reduction in adipose tissue which may confound analyses of reproductive function. 
Indeed, resection of the epididymal white adipose tissue depot has been shown to have 
a negative impact on spermatogenesis, however circulating testosterone and LH are 
unaffected (Chu et al., 2010). Thus, CISD2-KO mice represent a novel model of age-
related primary hypogonadism. 
Multiple changes intrinsic to aged Leydig cells including decreased number and 
sensitivity of LH receptors (Chen et al., 2002) as well as decreased expression and 
activity of proteins required for the conversion of cholesterol to testosterone (Culty et 
al., 2002, Luo et al., 1996), have been suggested to play a role in their reduced 
efficiency to produce testosterone. Damage to steroidogenic machinery as a result of 
perturbation in the balance between the generation of reactive oxygen species (ROS), 
and their neutralisation by antioxidants, is hypothesised to underlie the decreased 
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testosterone production by aged Leydig cells (Chen and Zirkin, 1999, Chen et al., 
2001, Diemer et al., 2003, Luo et al., 2006, Beattie et al., 2013). However, these data 
are primarily derived from in vitro experiments and, thus, fail to recapitulate the in 
vivo environment, including paracrine interactions, which may influence Leydig cell 
function. Studies by Wiley et al. (2013) demonstrated that CISD2-loss results in a pro-
oxidative intracellular environment which may explain the reduction in testosterone 
observed in CISD2-KO mice. However, in prematurely ageing mitochondrial DNA 
mutator mice (Trifunovic et al., 2004), despite a seven-fold increase in Leydig cell 
superoxide production, testosterone biosynthesis is unaffected thus, increased ROS 
may not be directly toxic to Leydig cells (Shabalina et al., 2015). This would be 
consistent with maintenance of Leydig cell function in LC-KO mice and, suggests that 
alterations in factors extrinsic to Leydig cells may impair steroidogenesis in aged 
testes. Indeed, while Chen et al. (1996) reported that EDS-mediated elimination of 
hypo-functional Leydig cells and their subsequent regeneration in the ageing rat testis 
restored circulating testosterone to levels to that of young animals, it was later reported 
that this elevation in testosterone is not maintained long term (Chen et al., 2015). This 
suggests that alterations in the microenvironment of the aged testis in which the Leydig 
cells reside may play an important role in age-associated Leydig cell dysfunction. 
Sertoli cell number declines in ageing men (Johnson et al., 1984b, Jiang et al., 2013, 
Petersen et al., 2015). Interestingly, age-related Sertoli cell dysfunction has been 
reported to precede reductions in Leydig cell testosterone production (Haji et al., 
1994), raising the possibility that dysfunction of the Sertoli cell population may alter 
Leydig cell function. For example, treatment of Sertoli-Leydig cell co-cultures with 
FSH has been reported to increase LHCGR expression and testosterone production 
(Benahmed et al., 1985, Perrard-Sapori et al., 1986, Saez et al., 1989). As such, it was 
hypothesised herein, that conditional Cisd2 disruption in Sertoli cells may result in 
testicular atrophy and primary hypogonadism as observed in constitutive CISD2-KO 
mice. However, no such phenotype was observed in SC-KO animals up to 6-months 
of age. Unfortunately, due to technical and time limitations, circulating LH was not 
measured in SC-KO mice which would further inform on Leydig cell function (i.e. an 
increase in LH may maintain testosterone levels). 
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While old animals may be considered the simplest rodent models of ageing; significant 
time, cost and welfare implications, concomitant with the generation of naturally aged 
animals, limits their practicality. Furthermore, ageing represents a multifactorial series 
of complex changes across multiple systems; making it difficult to assign cell/tissue 
specific contributions to age-related dysfunction. Although mouse models of 
accelerated ageing may not fully model the natural ageing process, they have been 
employed as alternatives to shed light on the mechanisms underpinning degenerative 
processes associated with ageing (Kõks et al., 2016). The testicular phenotype in 
constitutive CISD2-KO mice closely resembles that of the ageing testis, rendering this 
line a useful tool for the expedited study of testicular ageing. Furthermore, in contrast 
to naturally aged mice, the hormonal profile of CISD2-KO animals may better reflect 
the status of the HPG-axis in ageing men thus providing a useful resource to test novel 
therapeutic interventions aimed at reversing age-related primary hypogonadism. Based 
on observations of the conditional Cisd2-KO models, it is suggested that disruption to 
the testicular microenvironment in which Leydig cells reside may play a significant 
role in age-associated Leydig cell dysfunction.
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 The Role of Leukemia Inhibitory Factor Receptor Signalling in 
Testicular Development and Function 
4.1 Introduction 
Both spermatogenesis and steroidogenesis are subject to tight regulation at endocrine 
and paracrine levels. In addition to negative feedback control of testicular function by 
the hypothalamic-pituitary-gonadal (HPG) axis, cross-talk between different cell types 
within the testis is also required to maintain spermatogenesis and steroidogenesis 
(Gnessi et al., 1997, Schlatt et al., 1997). For example; Leydig cell-derived androgens, 
signalling via androgen receptors in Sertoli cells and peritubular myoid cells, are 
essential for the maintenance of spermatogenesis (De Gendt et al., 2004, Welsh et al., 
2009a, O'Shaughnessy et al., 2010b, Willems et al., 2015) whilst Sertoli cells, 
peritubular myoid cells and testicular macrophages have been shown to support Leydig 
cell development and steroidogenesis (Cohen et al., 1996, De Gendt et al., 2005, 
Welsh et al., 2012, Rebourcet et al., 2014a, Rebourcet et al., 2014b, DeFalco et al., 
2015). However, the full extent of the paracrine network which supports testicular 
function remains to be established. Identification of paracrine factors and/or 
mechanisms that regulate testicular function will be of benefit to the development of 
novel treatments for infertility and hypogonadism as well as for male contraceptive 
strategies. 
 
Locally produced growth factors and cytokines have been suggested to play a role in 
the regulation of normal testicular development and function (Gnessi et al., 1997, 
Hedger and Meinhardt, 2003). One such example is leukemia inhibitory factor (LIF); 
a pleiotropic cytokine belonging to the interleukin-6 family of cytokines, most often 
noted for its role in maintaining the balance between stem cell proliferation and 
differentiation (Heinrich et al., 1998). LIF signalling is mediated by a heterodimeric 
receptor complex consisting of the leukemia inhibitory factor receptor (LIFR, also 
known as gp190), which binds LIF, and the signal transducing gp130 subunit common 
to the IL-6 family members (Gearing et al., 1991, Gearing et al., 1992, Ip et al., 1992). 
Interestingly, mRNA expression of IL-6 type cytokines, including LIF, is increased in 
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the ageing human and is associated with muscular and thymic atrophy (Sempowski et 
al., 2000, Reardon et al., 2001), possibly implicating LIF/LIFR signalling in age-
related tissue dysfunction. In rodents, expression of both LIF and LIFR, as well as the 
gp130 signal transducer, has been detected in the fetal and adult testis, suggesting 
LIF/LIFR signalling may play a role in normal testicular development and function 
(Jenab and Morris, 1998, Piquet-Pellorce et al., 2000, Molyneaux et al., 2003, Dorval-
Coiffec et al., 2005). Peritubular myoid cells have been identified as the principal 
source of LIF within the rat testis and, given the anatomical location of these cells, LIF 
has been hypothesised to be a paracrine regulator of both the tubular and interstitial 
compartments (Piquet-Pellorce et al., 2000). Interestingly, LIF-deficient males are 
reported to be fertile (Stewart et al., 1992) whereas complete knockout of the LIFR 
results in perinatal death due to pleiotropic defects including neurological and 
metabolic disturbances (Ware et al., 1995). This suggests that, whilst alternative 
cytokines of the IL6-type family may be able to substitute for an absence of LIF, LIFR-
signalling per se, is essential for survival. Whilst LIFR is expressed by somatic Sertoli 
cells, Leydig cells, peritubular myoid cells and macrophages; spermatogonia have 
been speculated to be the main target of LIFR signalling within the rat testis based on 
in vitro binding assays with biotinylated LIF and immunohistochemical detection of 
LIFR in testis sections (Dorval-Coiffec et al., 2005). However, the precise role(s) of 
testicular LIFR signalling remains to be established. 
4.1.1 Hypothesis & Aims 
As outlined above, LIF/LIFR may be an important paracrine regulator of testicular 
function. Therefore, it is hypothesised herein that genetic ablation of Lifr will have 
significant impacts on testis development and function. The overall aim of this chapter 
was thus to definitively identify role(s) for LIFR signalling in the testis in vivo. To this 
end, cell-specific LIFR deficient mice were generated and the testicular phenotype 
analysed in order to dissect out and characterise the role of LIFR signalling in the 
development and function of the testis. Firstly, to determine whether LIFR signalling 
is required for prenatal testis development, a novel Lifr knockout allele 
(Lifrtm1b(EUCOMM)Hmgu) was validated and the impact of complete LIFR-loss on testicular 
structure was assessed in new-born mice at postnatal day 0. A conditional Lifr allele 
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(Lifrtm1c(EUCOMM)Hmgu) was then used to generate testis cell-specific Lifr-knockout mice 
to identify potential role(s) for LIFR signalling in the postnatal/adult testis. 
4.2 Results 
4.2.1 LIFR is Not Required for Prenatal Testicular Development 
 Validation of the Lifrtm1b(EUCOMM)Hmgu Allele 
To determine whether there is a requirement for LIFR signalling in prenatal testis 
development, the absence of LIFR protein in new-born Lifrtm1b(EUCOMM)Hmgu mice was 
first validated. Wild-type (WT), heterozygous (HET) and homozygous (KO) mice 
were generated as described in section 2.1.2.1.2. Primers were designed to detect the 
synthetic targeting cassette (see section 2.1.2 Figure 2.2) and used to amplify genomic 
DNA isolated from tail tip biopsies to identify WT, HET and KO animals (Figure 
4.1A). Western blotting analysis of neonatal whole brain protein extracts revealed that 
LIFR protein expression was completely abolished in homozygous 
Lifrtm1b(EUCOMM)Hmgu mice (Figure 4.1B). At weaning, on postnatal day (d) 21, a 
significant deviation from the expected Mendelian genotype ratios was noted (Figure 
4.1C), consistent with previous reports of Lifr-KO mice (Ware et al., 1995), indicating 
that the Lifrtm1b(EUCOMM)Hmgu allele is a true loss of function allele. 
 
Figure 4.1 Confirmation of LIFR Ablation in Lifrtm1b(EUCOMM)Hmgu Mice. Legend on following 
page. 
 
Chapter 4 The Role of Leukemia Inhibitory Factor Receptor Signalling in Testicular Development and Function 
99 
 
Figure 4.1 Confirmation of LIFR Ablation in Lifrtm1b(EUCOMM)Hmgu Mice. Figure on preceding 
page. (A) Representative PCR analysis of genomic DNA isolated from tail-tip biopsies of 
neonatal mice identified wild-type (WT; 1150bp), heterozygous (HET; 1150 and 406bp) and 
homozygous (KO; 406bp) animals. (B) Western blotting analysis of neonatal brain tissue 
homogenates confirmed leukemia inhibitory factor receptor (LIFR) protein expression was 
abolished in KO animals. Tubulin-alpha (TUBA) was used as a loading control (C) Transgene 
inheritance in offspring derived from heterozygous matings based on genomic PCR of DNA 
isolated from ear-clip biopsies collected at weaning. Chi-squared analysis revealed a significant 
deviation from the expected Mendelian ratios (X2; p = <0.0001). 
 Testicular Histology in Neonatal Constitutive LIFR-KO Mice 
Having confirmed the absence of LIFR protein expression in Lifrtm1b(EUCOMM)Hmgu mice 
(see section 4.2.1.1), the impact of LIFR ablation on the neonatal testis was next 
assessed. Histological analysis revealed that testicular architecture was normal in 
LIFR-deficient animals, with fully formed seminiferous cords containing abundant 
spermatogonia (Figure 4.2A). No differences in the immuno-localisation of Sry box-9 
(SOX9; Sertoli cells), mouse vasa homologue (DDX4; germ cells) and hydroxysteroid 
dehydrogenase 3-beta (HSD3B; Leydig cells) were observed in the testes of WT, HET 
or KO animals (Figure 4.2B). This suggests that establishment of the Sertoli, germ and 
fetal Leydig cell populations, and the structural arrangement of these cells in the testis 
occurs normally in the absence of LIFR. 




Figure 4.2 Testicular Histology is Normal in LIFR-deficient Mice. Legend on 
following page  
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Figure 4.2 Testicular Histology is Normal in LIFR-deficient Mice Figure on preceding page. 
(A) Representative H&E stained testis sections from wild-type (WT), heterozygous (HET) and 
homozygous (KO) mice at post-natal day 0. Testes appeared morphologically normal, with fully 
formed seminiferous cords containing abundant spermatogonia. n = 3-5, scale = 100µm. (B) 
Immunostaining for hydroxysteroid dehydrogenase 3-beta (HSD3B; magenta), Sry box-9 
(SOX9; green) and mouse vasa homologue (DDX4; gold) confirmed the presence of fetal Leydig 
cells, Sertoli cells and spermatogonia respectively. No obvious difference was noted between 
WT, HET and KO testes. Inset = primary antibody negative control. n = 3-5, scale = 50µm. 
 
4.2.2 LIFR is Required in Sertoli Cells but not Germ Cells to Maintain 
Normal Spermatogenic Function 
To circumvent the lethality observed in constitutive LIFR deficient animals, a 
conditional variant of the Lifr allele (Lifrtm1c(EUCOMM)Hmgu; see section 2.1.2.2.2) was 
used to generate cell-specific LIFR knock-outs in order to identify potential role(s) for 
LIFR signalling in the development/function of the adult testis. 
 Generation of Germ Cell and Sertoli Cell specific Lifr-KO Mice 
Lifr was selectively disrupted separately in germ cells (GC) and Sertoli cells (SC) or 
both (SC+GC-KO) using the well-established Stra8-Cre (Sadate-Ngatchou et al., 
2008) and Amh-Cre (Lecureuil et al., 2002) lines (GC-KO and SC-KO respectively). 
PCR amplification of genomic DNA isolated from the testes of Stra8-Cre+/-; Lifrwt/tm1c 
and Amh-Cre+/-; Lifrwt/tm1c mice demonstrated recombination of genomic DNA and 
conversion of the conditional Lifrtm1c to the null Lifrtm1d allele upon exposure to either 
Cre-recombinase (Figure 4.3A and B). Furthermore, PCR analysis of testicular cDNA, 
using primers flanking the critical exon, revealed the presence of a mutant Lifr 
transcript following Cre-mediated recombination of Lifr gDNA. This confirmed 
previous reports that Lifr mRNA is expressed both in germ cells and in Sertoli cells 
(Figure 4.3C and D respectively). Interestingly, Western blot analysis of whole adult 
testis protein extracts revealed a significant reduction of LIFR protein in SC-KO but 
not GC-KO testes (Figure 4.3E and F, respectively). This suggests that, although Lifr 
mRNA is expressed in the germ cell population, the Sertoli cell population may be the 
major target of LIFR signalling within the seminiferous tubule. 




Figure 4.3 Generation of Germ Cell and Sertoli Cell Lifr-KO Mice. Representative PCR 
analysis of testicular genomic DNA from (A) Stra8-Cre-/-; Lifrwt/tm1c and Stra8-Cre+/-; Lifrwt/tm1c and 
(B) Amh-Cre-/-; Lifrwt/tm1c and Amh-Cre+/-; Lifrwt/tm1c mice confirmed recombination of the 
conditional Lifr allele upon Cre exposure (WT = 389bp, KO = 172bp). Representative PCR 
analysis of testicular cDNA from (C) Stra8-Cre-/-; Lifrwt/tm1c and Stra8-Cre+/-; Lifrwt/tm1c and (D) 
Amh-Cre-/-; Lifrwt/tm1c and Amh-Cre+/-; Lifrwt/tm1c mice confirmed Lifr mRNA is expressed in germ 
cells and Sertoli cells, evidenced by the presence of a mutant transcript following Cre-
mediated gDNA recombination (WT = 361bp, KO = 197bp). Western blot analysis of whole 
testis protein extracts from (E) Stra8-Cre-/-; Lifrtm1c/tm1c (WT) and Stra8-Cre+/-; Lifrtm1c/tm1c (GC-
KO) and (F) Amh-Cre-/-; Lifr tm1c/tm1c (WT) and Amh-Cre+/-; Lifr tm1c/tm1c (SC-KO) mice. A significant 
reduction in testicular LIFR protein was observed only when Lifr was disrupted in Sertoli cells 
(unpaired t-test; p = 0.001). Tubulin-alpha (TUBA) was used as a loading control. Values are 
expressed as mean ± S.E.M of n = 7 samples per genotype. 
 
 Testicular Morphology is Normal in Germ Cell Lifr-KO Mice 
Leukemia inhibitory factor receptor has been shown to be expressed in germ cells from 
the spermatogonial stage onwards (Jenab and Morris, 1998, Dorval-Coiffec et al., 
2005) suggesting that germ cell LIF/LIFR signalling may be required for the 
maintenance of normal spermatogenesis. However, testis weight did not differ 
between WT and GC-KO mice up to six months of age (Figure 4.4A) and no difference 
in testicular architecture was observed between WT and GC-KO mice (Figure 4.4B). 
In addition, morphologically mature spermatids were present in the cauda 
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epididymides of both WT and GC-KO mice (Figure 4.4C). These data demonstrate 
that LIFR is not essential in the germ cell population for normal spermatogenesis to 
occur. 
 
Figure 4.4 Normal Testicular Morphology in Germ Cell Lifr-KO Mice. (A) No difference in 
testis weight was observed between WT and GC-KO mice up to d270 (unpaired t-test). Values 
are expressed as mean ± S.E.M of n = ≥10 mice per age/genotype. (B) Representative H&E 
staining of WT and GC-KO testes at 6 months. No difference in testis morphology was noted 
between WT and GC-KO mice. ST = seminiferous tubule, scale = 1mm in top panels and 100µm 
in bottom panels. (C) Representative H&E analysis of the cauda epididymis confirmed the 
presence of morphologically mature spermatids in both WT and GC-KO mice. Scale = 100µm. 
 A Progressive Degenerative Testicular Phenotype is observed in 
Sertoli Cell Lifr-KO Mice 
Having demonstrated that LIFR is dispensable in germ cells for normal 
spermatogenesis, the consequence of Sertoli cell LIFR ablation was next assessed. 
Initially, despite slight differences in testis weights (Figure 4.5), testicular histology 
was similar between WT and SC-KO animals up to d100 (Figure 4.6Ai-iii). However, 
degeneration of the seminiferous epithelium was observed from 6 months of age in 
SC-KO animals (Figure 4.6Aiv-v). This was accompanied first by an increase in testis 
weight at d180, followed by a reduction in testis weight at d270 (Figure 4.5). While 
seminiferous tubule degeneration/atrophy was widespread, there were still tubules 
within SC-KO testes that appeared normal (Figure 4.6Aiv-v). Additionally, 
morphologically mature spermatids were present in both WT and SC-KO cauda 
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epididymides at d180 (Figure 4.6B), suggesting that LIFR-deficient Sertoli cells can 
still support all steps of spermatogenesis. 
 
 
Figure 4.5 Testis Weight is Altered in Sertoli Cell Lifr-KO Mice. Significant differences in 
testis weights were noted between WT and SC-KO mice. At d35, a significant decrease in testis 
weight was observed in SC-KO animals (unpaired t-test; p = 0.0028. n = 7-9). At d50, testis 
weight was similar between WT and SC-KO animals (unpaired t-test; n = 9). At d100, a slight 
but significant increase in testis weight was observed in SC-KO mice (unpaired t-test; p = 
0.0354; n = 13). This increase becomes more exaggerated at d180 (unpaired t-test; p = 0.0028; 
n = 12-16). By d270, a significant decrease in testis weight was observed in SC-KO mice 
(unpaired t-test; p = 0.0195; n = 9-11). Values are expressed mean ± S.E.M. 
From d180, the seminiferous tubules in SC-KO mice appeared dilated with larger 
lumens than WT controls. This prompted a more in depth histological analysis of the 
SC-KO testis. Serial sectioning through entire SC-KO testes revealed regions of 
seminiferous tubule, often in close proximity to the rete testis, with increasing 
concentrations of sloughed germ cells/cellular debris and signs of apparent sperm 
stasis (Figure 4.6C). This is consistent with increased back-pressure into the testis, 
similar to that observed in several other rodent models (Jeffs et al., 2001, O'Hara et 
al., 2011, Heuser et al., 2013, Hess, 2014). To determine whether there is an additional 
effect of LIFR ablation from both germ cells and Sertoli cells together, double 
knockout mice were generated. However, testis histology in double mutants was 
similar to that of the SC-KO animals, further confirming that LIFR is not required in 
germ cells (Figure 4.7). Interestingly, in contrast to the single SC-KO mutants 
described above, there is no difference in testis weight between WT and SC+GC 
double mutants or their GC-KO and SC-KO littermate controls at d180 (Figure 4.7). 




Figure 4.6 Disrupted Testicular Histology in Sertoli Cell Lifr-KO Mice. Representative H&E 
staining of WT and SC-KO testes up to d270. (A) Testis histology was normal in SC-KO mice up 
to d100 (i-iii). At d180, degeneration of the seminiferous epithelium was observed in SC-KO 
testes (iv). While morphologically normal tubules (ST) were observed in the SC-KO testis, a 
large proportion of tubules appear distended and vacuolation of the seminiferous epithelium 
was noted (asterisks). (B) Morphologically mature spermatids were present in cauda 
epidiymides of both WT and SC-KO mice at d180. (C) Serial sectioning through entire SC-KO 
testes revealed sections of tubule with increasing concentrations of sloughed germ 
cells/cellular debris and signs of apparent sperm stasis (arrows). Scale bars = 100µm. 




Figure 4.7 No additional Effect is observed when Lifr is Disrupted Both in Germ Cells and 
Sertoli Cells. (A) No difference in testis weight d180 was observed when Lifr is disrupted both 
in germ cells and in Sertoli cells (SC+GC-KO; 1-way AVOVA, n = 6-13). (B) Representative H&E 
staining of WT, GC-KO, SC-KO and SC+GC-KO testes at d180. Testicular phenotype was similar 
in both SC-KO and GC+SC-KO confirming that Lifr is dispensable in germ cells but not Sertoli 
cells for normal spermatogenic function. Scale = 100µm. 
 Sertoli Cell and Spermatogonia Volume is Reduced in d180 
Sertoli cell Lifr-KO Mice 
To determine whether sloughing of a specific germ cell population was responsible for 
the tubule obstruction observed in SC-KO testes, the expression of germ cell-specific 
‘biomarker’ mRNAs was measured. No difference in the expression of Stra8, Spo11 
or Tpn1 was detected between WT and SC-KO testes at d180 (Figure 4.8A), 
suggesting no major deficit in the spermatogonia, spermatocyte or spermatid 
populations respectively. However, stereological analysis of the seminiferous 
epithelium revealed a reduction in the volume of Sertoli cells and spermatogonia per 
testis (Figure 4.8B). Despite this reduction, no differences in spermatocyte and 
spermatid volume was noted (Figure 4.8B). Next, immunostaining for activated 
caspase 3 (CASP3), a marker of apoptosis, was conducted to inform whether increased 
apoptosis may explain the observed reduction in Sertoli cells and spermatogonia. 
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When quantified, no difference in the proportion of activated CASP3-positive tubules 
per section, or CASP3-positive cells in the basal region of seminiferous tubules were 
noted between WT and SC-KO animals (Figure 4.8C). However, CASP3 
immunoreactivity appeared more widespread throughout the seminiferous epithelium 
in SC-KO testes. In WT testes, apoptotic cells were generally confined to the basal 
regions of the seminiferous epithelium. Finally, to determine whether a perturbation 
in the spermatogonial stem cell (SSC) niche may be responsible for the reduction in 
spermatogonia, mRNA expression of Sertoli-cell derived factors which have been 
shown to be important for proper maintenance of SSCs (Garcia et al., 2014) were 
measured. Expression of Gdnf, Cy26b1 and Kitl was similar in WT and SC-KO testes 
(Figure 4.8D), suggesting that dysregulation of the SSC niche may not explain the 









Figure 4.8 Sertoli cell and Spermatogonia Volume is Reduced in Sertoli Cell Lifr-KO 
Testes. Figure on following page (A) Expression of spermatogonia (Stra8), spermatocyte 
(Spo11) and spermatid (Tpn1) specific transcripts. mRNA expression was similar between WT 
and SC-KO testes at d180 of age (unpaired t-test, n = 9-10). (B) Stereological analysis revealed 
a reduction in Sertoli cell and spermatogonia absolute nuclear volume in the SC-KO testes at 
d180 (unpaired t-test; p = 0.0172 and 0.0325 respectively; n = 7). (C) Representative 
immunostaining for activated CASP3 (brown), as a marker of apoptosis, in WT and SC-KO 
testes at d180. No difference in the number of CASP3-positive tubules, or CASP3-positive cells 
lining the basal region of the tubules (black arrows, higher magnification insets) was noted 
between WT and SC-KO testes (unpaired t-test; n = 5-6). CASP3 immunoreactivity was 
occasionally observed throughout the seminiferous epithelium (open arrowheads) in SC-KO 
animals. Primary antibody negative control and induced Sertoli cell death positive controls are 
included. Scale bars = 100µm. (D) Expression of Gdnf, Cy26b1 and Kitl was similar in WT and 
SC-KO testes. All values are expressed as the mean ± S.E.M. 




Figure 4.8 Sertoli cell and Spermatogonia Volume is Reduced in Sertoli Cell 
Lifr-KO Testes. Legend on preceding page  
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 Blood-Testis-Barrier Integrity is maintained in Sertoli Cell Lifr-KO 
Testes 
The blood-testis-barrier (BTB) plays an important role in maintaining the appropriate 
intratubular environment required for normal spermatogenesis. Previous reports have 
suggested a role for IL-6 family cytokines, of which LIF is a member, in the regulation 
of BTB function (Perez et al., 2012, Zhang et al., 2014). Therefore, the ability of LIFR-
deficient Sertoli cells to maintain the integrity of the BTB was determined. Functional 
assessment of the BTB using a biotin tracer confirmed the BTB remained intact in the 
SC-KO testis (Figure 4.9A). This was consistent with normal mRNA expression of the 
BTB associated genes Ocdn, Cldn3 or Cld11 (Figure 4.9B). 
 
Figure 4.9 Analysis of Blood-Testis-Barrier Integrity in Sertoli Cell Lifr-KO Testes. (A) A 
biotin tracer injected into the testis interstitium was restricted to the interstitial compartment 
between seminiferous tubules (ST) confirming the blood-testis-barrier remained intact in SC-
KO mice at d180. A Sertoli cell-ablated testis was included as a positive control demonstrating 
biotin infiltration into seminiferous tubules. Scale bars = 100µm. (B) Expression of the blood-
testis-barrier associated mRNAs Ocdn, Cldn3 or Cld11 was unaltered in SC-KO testes at 6 
months (unpaired t-test; n = 9-10). Values are expressed as mean ± S.E.M. 




Development and function of the mammalian testis is subject to endocrine regulation 
by the HPG axis, as well as a complex suite of paracrine factors, which ensure the 
adequate production of both sperm and androgens in adult males. The experiments 
conducted within this chapter were designed with the aim of identifying the 
contribution of leukemia inhibitory factor receptor (LIFR) signalling to testis 
development and function. Utilising a series of mutant Lifr mouse models, the data 
presented herein demonstrate that LIFR does not appear to be crucial for prenatal 
testicular development. Conversely, LIFR in Sertoli cells, but not in germ cells, is 
required for the maintenance of normal structure/function of the seminiferous tubules 
in adulthood. At the present time these data are believed to provide the first in vivo 
evidence demonstrating the importance of LIFR signalling in Sertoli cells. 
Both Lif and Lifr, are expressed in the prenatal rodent testis from embryonic day (e) 
12.5 (Piquet-Pellorce et al., 2000, Molyneaux et al., 2003, Dorval-Coiffec et al., 2005) 
suggesting a role in testis organogenesis. In the present studies, normal testicular 
architecture, characterised by fully formed seminiferous cords containing Sertoli and 
germ cells, and abundant interstitial fetal Leydig cells, was observed in LIFR-deficient 
mice on the day of birth, suggesting that LIFR is dispensable for the establishment of 
a morphologically normal testis. However, due to time constraints, analysis of 
constitutive LIFR-KO testis was limited to a morphological assessment of testis 
structure, thus further stereological analyses would be required to determine whether 
loss of LIFR results in altered numbers of germ cells, Sertoli cells and Leydig cells. 
Furthermore, LIFR-KO testes were analysed on post-natal day 0. As such the 
possibility that LIFR-loss affects testicular organogenesis at earlier developmental 
time points, which may not be apparent at d0 cannot be ruled out.  
It has been reported previously that the number and morphology of primordial germ 
cells (PGC) is normal in LIFR-deficient mice when analysed at e10.5-13.5 (Ware et 
al., 1995). Conversely, a slight reduction in PCG number was noted in gp130-deficient 
male fetuses (gp130 is the signal transducer with which LIFR must dimerise with to 
induce signalling) (Molyneaux et al., 2003). Whilst neither study made comment upon 
the developing somatic components of the fetal mouse testis, a recent study which 
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aimed to identify genes involved in congenital abnormalities of the kidney and 
urogenital tract (CAKUT), noted a form of cryptorchidism in a CAKUT patient 
heterozygous for a hypomorphic LIFR mutation (Kosfeld et al., 2017). The authors go 
on to suggest that disruption of murine Lifr also results in a potential form of 
cryptorchidism, characterised by an abnormal ligament attaching the testis to the dorsal 
aorta, present at e18.5. Such a defect was not noted in the present study, possibly owing 
to the genetic background of the Lifr mutants – in the above study animals were 
maintained on an outbred Ztm:NMRI background which may be more susceptible to 
development of urogenital defects. Alternatively, regression of this structure may 
occur between e18.5 and d0 – the time point at which constitutive LIFR-KO animals 
were studied herein. It may also be possible that such a defect went unnoticed during 
the course of the present studies. Nevertheless, it can be concluded from the data 
presented in this chapter that LIFR is not required for the development of normal 
prenatal testicular structure. 
Constitutive Lifr deletion results in a lethal phenotype prior to weaning, thus LIFR 
deficient mice cannot be used for the study of adult testis development/function. 
Therefore a Cre/loxP approach to disrupt Lifr in germ cells and Sertoli cells was used. 
Cre recombinase is reported to be active in spermatogonia from postnatal day 3 in the 
TgStra8-icre1Reb mouse line (Sadate-Ngatchou et al., 2008) which was used to disrupt 
Lifr in germ cells. In the rat testis, spermatogonia have been suggested to be a major 
target of LIFR signalling (Dorval-Coiffec et al., 2005), although this conclusion was 
arrived at through the comparison of d9 spermatogonia to d20 somatic cells, thus may 
not accurately represent expression in the adult testis. Surprisingly, analysis of GC-
KO mice suggested that LIFR is in fact dispensable in germ cells, from the 
spermatogonial stage onward, for normal spermatogenesis in mice. Functional 
redundancy between LIF and other IL6-family members signalling through gp130 
provide a possible explanation, however, a previous report using Tnap-cre to delete 
gp130 from primordial germ cells reported no phenotype in mutant male mice 
(Molyneaux et al., 2003). No mention of the endpoints measured, nor the age of the 
animals was made in that study, thus the development of a spermatogenic defect in 
ageing gp130-deficient animals cannot be ruled out. 
Chapter 4 The Role of Leukemia Inhibitory Factor Receptor Signalling in Testicular Development and Function 
112 
 
A number of studies have documented wide-spread expression of Lif and Lifr in both 
germ and somatic cell populations in the adult rodent testis (Jenab and Morris, 1998, 
Piquet-Pellorce et al., 2000, Molyneaux et al., 2003, Dorval-Coiffec et al., 2005), 
implicating LIF/LIFR signalling as a potential regulator of testicular function. Indeed, 
in vitro experiments have demonstrated that LIF can enhance the survival of gonocytes 
and Sertoli cells in a primary co-culture system (De Miguel et al., 1996) and that LIF 
stimulates spermatogonial proliferation and/or survival when added to primary 
cultures of seminiferous tubule segments (Dorval-Coiffec et al., 2005). However, 
Jenab and Morris (1998) reported that LIF/LIFR signalling is active in rat Sertoli cells, 
but possibly not in germ cells, albeit in vitro, indicating that the proliferative and/or 
anti-apoptotic effects of LIF on gonocytes/spermatogonia are likely mediated by the 
Sertoli cells present in the cultures. Indeed, the studies presented herein demonstrate 
that LIFR is dispensable in germ cells for normal spermatogenesis to occur, but Sertoli 
cell LIFR ablation appears to cause spermatogenic defects. 
When LIFR was deleted from the Sertoli cell population, postnatal testis development 
appeared normal, based on histological examination of WT and SC-KO testes up to 
d100. Initially, SC-KO testes appeared slightly lighter than those of WT controls but 
the basis for this is unclear at the present time. Unfortunately time constraints of the 
current project did not permit a more detailed stereological analysis of Sertoli and/or 
germ cells in the developing pubertal testis which may inform on these subtle weight 
discrepancies. Whilst loss of Sertoli cell LIFR did not appear to have a major impact 
on postnatal testicular development, analysis of SC-KO testes at d180 and d270 
showed that LIFR is required to support normal spermatogenesis. Despite an apparent 
reduction in Sertoli cells and spermatogonia, testis weight is significantly increased in 
6 month old SC-KO mice and a large proportion of tubules appeared dilated, likely 
due to mechanical testicular blockage/sperm stasis. However, the molecular 
mechanism(s) behind disruption to the seminiferous epithelium remains to be 
elucidated. One function of mature Sertoli cells is the production of seminiferous 
tubule fluid (Jegou et al., 1982) which is required for the appropriate development of 
sperm as well as their transport out of the testis. As such, defective fluid production 
by LIFR-deficient Sertoli cells may explain the observed sperm stasis in SC-KO testes. 
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In addition to Sertoli cells, LIFR is also expressed by Leydig cells (Jenab and Morris, 
1998, Dorval-Coiffec et al., 2005), as well as their putative stem/progenitors (Ge et 
al., 2006, Jiang et al., 2014), suggesting LIF/LIFR signalling may play a role in 
regulating Leydig cell development and steroidogenic function. Indeed both LIF and 
the closely related cytokine oncostatin M (OSM), which can also signal via LIFR have 
been implicated in development of the adult Leydig cell population (Teerds et al., 
2007b, O'Shaughnessy et al., 2008). Furthermore, in vitro studies have demonstrated 
LIF can have both inhibitory and stimulatory effects on Leydig cell steroidogenesis 
(Mauduit et al., 2001, Wang et al., 2016b). However, a definitive role for LIFR 
signalling in Leydig cell development and steroidogenic function is yet to be 
established, but will certainly be an interesting avenue of further study.  
To conclude, the studies presented in this chapter provide the first in vivo evidence that 
LIFR signalling is required for normal testicular function in adulthood. Specifically, a 
requirement for Sertoli cell LIFR in the maintenance of normal spermatogenic function 
has been identified, widening our understanding of the paracrine network in the testis. 
Elucidation of the precise mechanism(s) by which LIFR signalling contributes to 
Sertoli cell function will further improve our understanding of this fundamentally 
important cell.
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 The Effect of Human Adipose-Derived Perivascular Stem Cells 
in a Rat Model of Leydig Cell Injury 
5.1 Introduction 
Establishment and maintenance of the male phenotype requires adequate production 
and action of androgens (e.g. testosterone). Further to their well-established role in 
male reproductive function, increasing evidence suggest androgens also support 
overall male general health. Low circulating testosterone levels have been linked to an 
increased risk of developing cardiometabolic disorders, which are also often associated 
with advancing age (Kupelian et al., 2006, Farrell et al., 2008, Kupelian et al., 2008, 
Brand et al., 2014, Pye et al., 2014). Indeed, circulating testosterone levels decline as 
males age (Morley et al., 1997, Harman et al., 2001, Feldman et al., 2002, Wu et al., 
2008, Fabbri et al., 2016), often due to diminished ability of testicular Leydig cells to 
produce androgens, resulting in a state of primary hypogonadism. Androgen 
replacement therapy is widely used to treat hypogonadism although the risks and 
benefits associated with the administration of exogenous testosterone are not entirely 
clear (Bassil et al., 2009). Recent efforts have thus been made to develop novel 
therapies that promote and/or maintain endogenous testicular testosterone production 
within a normal physiological range. 
In recent years, considerable attention has been focussed on the development of stem 
cell-based regenerative therapies to treat a number of diseases (Trounson and 
McDonald, 2015). A wide variety of stem cell types, from pluripotent embryonic stem 
(ES) cells and induced pluripotent stem (iPS) cells, to multipotent mesenchymal stem 
cells (MSC), continue to be investigated for their potential utility in the field of 
regenerative medicine. For example, human ES cells differentiated into retinal 
pigment epithelial cells in vitro, are reported to have a positive impact on vision in 
animal models (Lu et al., 2009) and when transplanted in patients with age-related 
macular degeneration or Stargardt's macular dystrophy (Schwartz et al., 2015, Song et 
al., 2015), although the immune privilege of the eye may be a significant factor in 
these transplantation successes. Additionally, ethical controversies surrounding the 
use of ES cells, as well as safety concerns, including tumorigenicity (Amariglio et al., 
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2009), associated with the use of pluripotent stem cells types may impede their 
translation into clinical practice. As such, multipotent MSCs represent an attractive 
alternative for regenerative therapies. MSCs can be isolated from multiple tissues 
(Crisan et al., 2008) and may act as either progenitor cells, differentiating into various 
cell lineages to effect tissue repair; or play a paracrine role by secreting factors which 
promote endogenous tissue regeneration (Chen et al., 2009a, Chen et al., 2013). 
A number of in vitro and in vivo studies have described the generation of Leydig-like 
cells from stem cell populations isolated from rodent testes (Ge et al., 2006, Zhang et 
al., 2013, Jiang et al., 2014, Odeh et al., 2014, Li et al., 2016, Zang et al., 2017). While 
these studies have increased our understanding of stem Leydig cells and their 
differentiation, extraction of stem cells from a patient’s testis would be impractical as 
a therapeutic approach. Adipose tissue is a potentially promising source of stem cells 
as it is easily accessible with minimally invasive techniques. Murine adipose-derived 
stem cells have been driven down a steroidogenic lineage in vitro after transfection 
with steroidogenic factor-1 (Gondo et al., 2008), although these cells appeared to 
favour the production of glucocorticoids over androgens. Additionally, in an 
experimentally induced ageing model, rat adipose derived stem cells were reported to 
have a beneficial effect on testicular function in vivo (Yang et al., 2015a). However, 
to date, the ability of human adipose-derived perivascular stem cells (hAd-PSC) to 
promote Leydig cell function has not been assessed. 
5.1.1 Hypothesis & Aims 
The hypothesis underlying this chapter is that human adipose-derived perivascular 
stem cells (hAd-PSC) could be used for the treatment of Leydig cell dysfunction. As 
such, the overall aim of the experiments herein was to assess the regenerative capacity 
of hAd-PSCs to promote endogenous testosterone production as a potential therapeutic 
strategy for the treatment of hypogonadism. Firstly, the ability of hAd-PSCs to form 
Leydig-like cells in vitro was determined. A well-established rat model of Leydig cell 
ablation-regeneration was then utilised to assess the effect of hAd-PSCs on Leydig cell 
regeneration in vivo. Following ethane dimethanesulphonate (EDS)-mediated Leydig 
cell ablation, hAd-PSCs were transplanted into the rat testis interstitium and Leydig 
cell regeneration was monitored via serial measurements of circulating luteinising 
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hormone (LH) and testosterone (T). The experimental overview is outlined in Figure 
5.1. 
 
Figure 5.1 Experimental Overview. Leydig cells were ablated using a single dose of ethane 
dimethanesulphonate (EDS). Human adipose-derived perivascular stem cells (hAd-PSCs) were 
transplanted into Leydig cell ablated testes 4 days after EDS administration. Tail-vein blood 
samples were collected weekly for the measurement of circulating testosterone and 
luteinising hormone. Animals were sacrificed after 5 weeks (EDS+35). 
5.2 Results 
5.2.1 Effect of Differentiation Inducing Medium on hAd-PSCs In Vitro  
To test whether hAd-PSCs could form testosterone-producing cells in vitro, hAd-PSCs 
(see section 2.7.1) were exposed to a differentiation inducing medium (DIM; (Ge et 
al., 2006, Jiang et al., 2014)) as described in section 2.7.1.1. After one week, cells 
were harvested and the mRNA expression of genes involved in androgen biosynthesis 
was measured by qRT-PCR and compared to control cells cultured in expansion media 
(EM; see section 2.7.1). Exposure of hAd-PSCs to DIM induced the expression of 
STAR and CYP11A1 mRNA however, neither CYP17A1 nor HSD17B3 were detectable 
(Figure 5.2). To assess the utility of antibodies raised against human nuclear antigen 
(HuNu) and human leukocyte antigen class 1 (HLA1) for the identification of 
transplanted cells in rat testes, fluorescent immunocytochemistry was performed (see 
section 2.2.4). Expression of both markers was observed in EM and DIM cultured 
hAd-PSCs (Figure 5.3). 




Figure 5.2 mRNA Expression of Leydig Cell Steroidogenic Enzymes in DIM-Exposed hAD-
PSCs. Expression of STAR (steroidogenic acute regulatory protein) and CYP11A1 (P450 
cholesterol side-chain cleavage enzyme) was induced in hAd-PSCs after one week culture in 
differentiation inducing media (DIM; t-test; p = <0.0001). Neither CYP17A1 (17α-hydroxylase, 
17,20-lyase) nor HSD17B3 (hydroxysteroid dehydrogenase 17-beta type 3) were detectable. 
Arrows in bottom panels indicate the amplification of adult human testis cDNA as a positive 
control. Values represent the mean ± SEM from n=6 separate wells per group. N.D = Not 
detected. The experiment was repeated on two separate occasions with similar results. 




Figure 5.3 Validation of Antibodies Raised against Human-specific Proteins in Cultured 
hAd-PSCs. Both human nuclear antigen (huNuclei; top panels) and human leukocyte antigen 
class 1 (HLA1; bottom panels) were detected in human adipose-derived perivascular stem cells 
(hAd-PSC) exposed to either expansion media (left) or differentiation inducing media (right) 
media. In each case the cells have a spindle-shaped, fibroblast-like morphology. Insets = 
primary antibody negative controls. Scale = 50µm. 
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5.2.2 Effect of hAd-PSC on Leydig Cell Regeneration In Vivo 
 Recovery of Circulating Testosterone 
In the rat testis, complete ablation of Leydig cells occurs within 3-7 days following 
EDS administration, followed by regeneration of the Leydig cell population and 
restoration of circulating testosterone levels from 3-7 weeks (Morris and McCluckie, 
1979, Kerr et al., 1985, O'Shaughnessy et al., 2008, Kilcoyne et al., 2014). To 
determine the effect of hAd-PSCs on Leydig cell regeneration, cells were cultured in 
EM or DIM, and transplanted into the rat testis interstitium 4 days after EDS treatment 
(see section 2.1.4.3). Control groups included (i) Vehicle+Sham – no EDS was 
administered, animals underwent surgery to expose testes but no cells were 
transplanted. (ii) EDS+Sham – Animals were treated with EDS to ablate Leydig cells 
and underwent surgery to expose testes but no cells were transplanted. Leydig cell 
regeneration was monitored via serial measurements of circulating testosterone and 
luteinising hormone. In line with previous studies (Kerr et al., 1985, O'Shaughnessy 
et al., 2008), testosterone was undetectable 7 days after EDS treatment but returned to 
control levels by 21 days (Figure 5.4Ai and ii), confirming successful Leydig cell 
ablation and regeneration. To identify any effect of the transplanted hAd-PSCs on 
recovery of circulating testosterone between these time points, area under the curve 
(AUC) was calculated for each group. As expected, AUC was significantly decreased 
in all EDS treated groups compared to Vehicle+Sham controls. However, no 
difference was observed when EM or DIM cultured hAd-PSCs were transplanted into 
the testis (Figure 5.4Aiii). In line with the circulating testosterone profile (Figure 
5.4A), an increase in LH, peaking at 14 days, was observed following EDS treatment 
(Figure 5.4Bi and ii). AUC of the LH surge was similar between EDS+Sham and both 
hAd-PSC transplanted groups. However, the AUC was significantly higher in the 
EDS+EM group compared to the EDS+DIM group (Figure 5.4Biii). 




Figure 5.4 Circulating Hormones during Leydig Cell Regeneration. Circulating testosterone 
(A) and luteinising hormone (B) were measured in sera from tail vein blood samples collected 
weekly throughout the experiment (5 weeks). In each case, individual animals are plotted in 
(i) and the mean ±SEM are plotted in (ii). The orange shaded areas highlight the proportion of 
the data used for area under the curve (AUC) analyses shown in (iii), based on the time taken 
for testosterone to return to control levels (EDS+21). 1-way ANOVAs were used to identify 
significant differences between experimental groups (p = <0.0001 for both testosterone and 
LH). Tukey’s post-hoc analysis was used to compare means between groups where a shared 
letter denotes no significant difference. n = 5-6 animals per group. 
 Recovery of Testis and Seminal Vesicle Weight 
When animals were sacrificed 35 days post EDS, no difference in body weight was 
observed between groups, suggesting neither EDS nor hAd-PSCs had major negative 
side-effects (Figure 5.5A). Conversely, significant differences in testis and seminal 
vesicle weights were noted (Figure 5.5B and C respectively). Recovery of testis weight 
to that of Vehicle+Sham controls was observed in the EDS+Sham and EDS+DIM 
groups whereas EDS+EM testes remained significantly smaller at 35 days post EDS. 
In the case of seminal vesicle weight, recovery equivalent to Vehicle+Sham was only 
observed in the EDS+DIM group. To determine whether hAd-PSCs remained within 
the testis 1 month post-transplantation, genomic DNA was isolated from frozen testes 
and interrogated for the presence of human-specific DNA (HUMSAT17A). However, 
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no human DNA was detectable in testes which had been transplanted with either EM 
or DIM hAd-PSCs (Figure 5.5D). 
 
Figure 5.5 Recovery of Testis and Seminal Vesicle Weight. (A) No difference in body weight 
was noted between experimental groups at the end of the experiment (EDS+35; 1-way 
ANOVA). (B) Testis weight recovered in EDS+Sham and EDS+DIM groups but remained 
significantly lower in the EDS+EM group (Kruskal-Wallis; p =0.0264). (C) Seminal vesicle weight 
remained significantly lower in both EDS+Sham and EDS+EM groups whereas recovery is 
observed in the EDS+DIM group (1-way ANOVA; p = 0.0044). Shared letters above columns 
indicate no significant difference. n = 5-6 animals per group. (D) Representative multiplex 
genomic PCR for human and rat specific DNA (HUMSAT17A; 450bp and Actb; 552bp 
respectively) in testis biopsies 1 month after transplantation (EDS+35). No human DNA was 
detected in hAd-PSC transplanted testes. Genomic DNA isolated from EM and DIM cultured 
hAd-PSCs was included as a positive control. 
 Transplanted Cells do not engraft in the Rat Testis  
Testicular histology was largely similar between groups at 35 days post EDS (Figure 
5.6), with complete spermatogenesis taking place within seminiferous tubules, and 
abundant interstitial Leydig cells. However, in EDS+EM and EDS+DIM groups, 
occasional regions containing atrophic seminiferous tubules were observed. Given that 
this is not observed in the sham control groups, it is unlikely that these atrophic foci 
are a consequence of surgery or EDS toxicity. 




Figure 5.6 Testicular Histology following Leydig Cell Ablation and hAd-PSC 
Transplantation. Representative H&E stained testis sections revealed testicular architecture 
was largely normal 5 weeks post Leydig cell ablation. Full spermatogenesis within seminiferous 
tubules (ST) and abundant interstitial Leydig cells (arrows) were observed in all groups. 
However, regions containing atrophic tubules (ST*) and possible inflammatory cell infiltrates 
were noted in both EM and DIM hAd-PSC-transplanted testes. Scale = 100µm. 
5.3 Discussion 
The current strategy for treating hypogonadism is the administration of exogenous 
testosterone. However, this approach can have negative side effects, including 
disruption of normal spermatogenesis, which may not be desirable if maintenance of 
fertility is required (Samplaski et al., 2014, McBride and Coward, 2016). Recent 
efforts have thus been focussed on developing stem cell-based regenerative therapies 
to restore endogenous androgen production as an alternative to exogenous testosterone 
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replacement (Peak et al., 2016). In the experiments described herein, the regenerative 
capacity of human adipose-derived perivascular stem cells (hAd-PSC) to promote 
endogenous testosterone production in a rat model of Leydig cell ablation-regeneration 
was assessed. Following EDS-mediated Leydig cell ablation, hAd-PSCs were 
transplanted into the rat testis and Leydig cell regeneration was monitored via serial 
measurements of circulating luteinising hormone (LH) and testosterone (T). Alone, 
hAd-PSCs had negligible effects on Leydig cell regeneration kinetics. When cultured 
with luteinising hormone, insulin-like growth factor 1, platelet-derived growth factor-
β and thyroid hormone the LH spike (induced by the removal of T negative feedback 
upon Leydig cell ablation) was dampened. This suggests the transplanted cells may 
promote the initial stages of Leydig cell regeneration. Notably, hAd-PSCs were 
undetectable in testis tissue five weeks after transplantation, suggesting they may not 
survive in the context of long-term xenogeneic transplantation but may initially 
provide paracrine support to endogenously regenerating Leydig cells. 
In 2006, Ge et al. (2006) described a cocktail of hormones and growth factors for the 
in vitro generation of testosterone-producing Leydig-like cells from platelet derived 
growth factor alpha-positive stem cells isolated from the neonatal rat testis. More 
recently, Jiang et al. (2014) and Zang et al. (2017) used the differentiation inducing 
media to convert nestin-positive and CD51-positive  testicular stem cells respectively 
into Leydig-like cells. Each study reported the induction of steroidogenic cell lineage 
markers including SF-1, GATA-4, LHCGR, STAR, CYP11A1, HSD3B6 and 
CYP17A1 after 7-11 days of culture in DIM. Whilst none demonstrated the expression 
of HSD17B3 – the enzyme required for the final step of testosterone biosynthesis – all 
reported the production of testosterone by cells cultured in DIM. In the current studies, 
only STAR and CYP11A1 were detected in hAd-PSCs exposed to DIM strongly 
suggesting that they would not be able to produce testosterone with this differentiation 
regime. This may be explained by differences in the source of stem cells used. The 
above studies utilised stem cells isolated from the rodent testis. While both Jiang et al. 
(2014) and Zang et al. (2017) demonstrated multi-lineage potential of their respective 
stem cell populations, testicular stem cells may have an increased propensity to 
develop into Leydig cells. MSCs comprise a heterogeneous population of stromal 
cells, and heterogeneity of donor material as well as isolation and cultivation 
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procedures present another layer of complexity when characterising the regenerative 
potential of specific MSC subsets. Indeed, human stem cells isolated from different 
white adipose tissue depots, or even different sub-populations of stem cells from the 
same depot, are reported to have heterogenic differentiation potentials (Rada et al., 
2011, Lopa et al., 2014, Russo et al., 2014, Hindle et al., 2017, Hardy et al., 2017). 
Leydig cell testosterone production is under negative feedback control by the 
hypothalamic-pituitary-gonadal (HPG) axis whereby pituitary-derived LH stimulates 
Leydig cell steroidogenesis, and increased circulating testosterone feeds back to the 
hypothalamic-pituitary unit to reduce LH secretion. Following Leydig cell ablation, 
this feedback loop is disrupted resulting in increased LH secretion (Morris et al., 
1986). Whilst transplantation of either EM or DIM cultured hAd-PSCs did not appear 
to impact recovery of circulating testosterone levels, the LH response in the EDS+DIM 
group was slightly decreased compared to that of the EDS+EM group. This may 
suggest that less LH may be required to drive testosterone synthesis by the 
regenerating Leydig cells when hAd-PSCs are ‘primed’ by exposure to DIM media 
prior to transplantation. Indeed, seminal vesicle weight - an accepted biomarker of 
peripheral androgen action (Welsh et al., 2008, Mitchell et al., 2015, van den Driesche 
et al., 2015) was recovered in the EDS+DIM group by day 35 post EDS, indicative of 
increased peripheral androgen action compared to the EDS+Sham and EDS+EM 
groups.  
Previous studies utilising stem Leydig cells isolated from rodent testes have reported 
successful engraftment and differentiation following EDS mediated Leydig cell 
ablation in immunocompetent hosts (Ge et al., 2006, Jiang et al., 2014, Zang et al., 
2017). However, these studies analysed testis sections only 10-12 days after 
transplantation, thus whether the cells survive long term engraftment remains to be 
established. Furthermore, the extent to which the transplanted cells contribute to the 
population of regenerated Leydig cells (both functionally and numerically) was not 
reported in any of these studies. In addition, none of the above studies measured 
circulating LH during the regeneration period thus the effect of the transplanted cells 
on the overall hypothalamic-pituitary-gonadal (HPG) axis activity is unknown. Zang 
et al. (2017) suggested that CD51-positive stem cells transplanted into the Leydig cell 
ablated rat testis produce testosterone under the regulation of the HPG-axis based on 
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pharmacological suppression of LH secretion by decapeptyl and subsequent reduction 
in circulating testosterone. However, the absence of a crucial control group treated 
with EDS and decapeptyl, but not transplanted with cells, severely limits the strength 
of this conclusion as the influence of decapeptyl on endogenously regenerating Leydig 
cells is not taken into account. Despite a modest effect of DIM cultured hAd-PSCs on 
circulating LH and seminal vesicle weight, hAd-PSCs were undetectable in the testis 
one month after transplantation, indicating that they do not engraft in the rat testis. As 
such, it is likely that any effect(s) may be due to paracrine support of endogenous 
regenerating Leydig cells, rather than their direct differentiation into Leydig cells. This 
is in line with previous reports of hAd-PSCs in a mouse model of ischaemic heart 
injury in which lineage tracing of GFP labelled hAd-PSCs transplanted into the 
myocardium demonstrated that only a very small number of cells differentiated into 
cardiac cells (Chen et al., 2013). This suggests that the positive effects on cardiac 
recovery observed were, in this context, likely paracrine in nature. Similarly, adipose-
derived stem cells were reported to have positive effects in a rat model of tobacco-
induced erectile dysfunction by reducing oxidative stress (Huang et al., 2016). EdU 
(5-ethynyl-2’-deoxyuridine) labelling of transplanted cells revealed minimal 
engraftment four weeks after injection leading the authors to speculate that paracrine 
release of cytokines/growth factors may be responsible for the therapeutic effect. 
Similarly, whilst Yang et al. (2015a) reported that adipose-derived stem cells could 
promote Leydig cell function in a pharmacologically induced ageing model, very few 
cells transplanted appeared to transform into Leydig cells. The authors suggested that 
the effect of the transplanted cells on testosterone production might be partly mediated 
by a reduction in reactive oxygen species. 
Indeed, perivascular mesenchymal stem cells are reported to secrete a variety of factors 
including PDGF-BB (Chen et al., 2009a) and LIF (Chen et al., 2013), both of which 
have been suggested to play a role in stem Leydig cell proliferation/differentiation 
(Odeh et al., 2014, O'Shaughnessy et al., 2008). Furthermore, pre-incubation of 
primary rat Leydig cells with PDGF-BB has been shown to significantly enhance LH-
stimulated testosterone synthesis (Risbridger, 1993) and, LIF has been suggested to 
influence testosterone production in vitro (Mauduit et al., 2001, Wang et al., 2016b). 
The precise extent to which hAd-PSCs support Leydig cell regeneration kinetics 
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requires further study. Nevertheless, these pilot studies represent the first description 
of the use of human adipose-derived perivascular stem cells in an in vivo model of 
Leydig cell injury, and suggest that these cells may exert a positive effect on Leydig 
cell regeneration by providing paracrine support.
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 General Discussion & Future Perspectives 
In males, the testis is arguably the most important organ in the body - it produces germ 
cells through which genetic information is passed onto the next generation thus 
ensuring survival of the species. Additionally, it produces androgens which are 
required not only for sperm production, but also to support secondary sex 
characteristics and wider general health of the body such that adult males can function 
as suitable vehicles to carry the precious germ cell cargo. As males age, the testes 
atrophy and their spermatogenic and steroidogenic function becomes increasingly 
impaired. While maintenance of fertility may not be of primary concern to men 
approaching their twilight years, maintaining appropriate levels of circulating 
testosterone may be critically important to promote healthy ageing. It has been 
suggested that decreasing androgen levels in ageing men are linked to chronic age-
related disorders including cardiovascular disease, metabolic syndrome, as well as 
decreased muscle mass and increased frailty (Kupelian et al., 2006, Pye et al., 2014, 
Yeap et al., 2014, Antonio et al., 2015). It has also been suggested that androgen levels 
are becoming increasingly lower in men compared with previous generations 
(Travison et al., 2007, Andersson et al., 2007, Perheentupa et al., 2013). With an 
expanding ageing population in developed countries, it is essential the relationship 
between ageing, androgen levels and disease be further explored. Central to this is a 
well-developed understanding of the mechanisms that regulate proper testicular 
development and function, as well as the mechanisms by which testicular function (i.e. 
androgen production) deteriorates with age. As such, the main hypothesis behind the 
experiments carried out in the context of this thesis was that manipulation of the 
paracrine network in the testis in vivo would provide significant novel insights into the 
regulation of testicular function, uncovering potential therapeutic targets to treat age-
related testicular dysfunction. To address this question, three sets of experiments were 
designed and carried out. Firstly, a series of novel mouse models of premature ageing 
were utilised to begin dissecting the process of age-related testicular degeneration, 
with the aim of establishing the cell specific contributions of premature ageing Leydig 
cells and Sertoli cells to the age-related decline in androgen production. Second, with 
the aim of determining the role(s) of leukemia inhibitory factor as a putative paracrine 
regulator of testis function, models of testicular cell-specific leukemia inhibitory factor 
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receptor ablation were generated and characterised. Finally, the impact of a stem cell-
based regenerative therapy to promote endogenous testosterone production as a 
potential therapeutic strategy for the treatment of hypogonadism was determined. 
6.1 Primary Hypogonadism in Prematurely Ageing Cisd2-deficient Mice 
To date, the most widely used model for the study of age-related Leydig cell 
dysfunction has been the naturally aged brown Norway rat. This model has greatly 
increased our understanding of the changes occurring in aged Leydig cells including 
decreased LH-stimulated cAMP signalling and subsequent reduction in the expression 
and activity of enzymes involved testosterone biosynthesis. It has been suggested that 
these changes are partly mediated by cumulative cellular damage caused by reactive 
oxygen species (Beattie et al., 2015). Other models of premature ageing which display 
primary hypogonadism including the D-galactose model (Ahangarpour et al., 2014, 
Liao et al., 2016) and the senescence accelerated SAMP8 mouse (Flood et al., 1995, 
Smith et al., 2013, Wang et al., 2016a), both of which are associated with increased 
ROS production, provide support to this theory. However, one drawback with these 
models is that ageing occurs systemically, making it difficult to interpret cause and 
effect of specific testicular cell populations on Leydig cell dysfunction. To address 
this, the experiments detailed in Chapter 3 exploited the conditional potential of a 
novel Cisd2 premature ageing allele to, for the first time, age Leydig cells and Sertoli 
cells separately. Intriguingly, whilst constitutive Cisd2-deficient mice displayed a 
phenotype reminiscent of age-related compensated Leydig cell failure characterised 
by a reduction in Leydig cell number, reduced expression of mRNAs encoding 
steroidogenic enzymes and a reduction in circulating testosterone (without decreased 
luteinising hormone); neither conditional Cisd2-deficient models recapitulated this 
phenotype. These novel data are in agreement with the suggestion of Chen et al. (2015) 
that age-related reductions in testosterone biosynthesis may be mediated by factors 
extrinsic to Leydig cells in aged animals and further suggest that the ageing Sertoli cell 
population may not directly contribute to age-related Leydig cell dysfunction. 
Taking into account that conditional Cisd2-disruption, either in Leydig cells or in 
Sertoli cells alone, did not recapitulate the primary hypogonadism observed in 
constitutive CISD2-KO mice, the mechanisms underlying testicular degeneration and 
Chapter 6 General Discussion & Future Perspectives 
129 
 
Leydig cell dysfunction in this model of premature ageing are still unclear. At the 
cellular level, CISD2-loss causes endoplasmic reticulum and mitochondrial 
dysfunction and results in a pro-oxidative intracellular environment (Wiley et al., 
2013); processes which have been associated with impaired steroidogenesis (Allen et 
al., 2006, Kim et al., 2016, Huang et al., 2017, Yang et al., 2017a). Increased oxidative 
stress in the testes of constitutive Cisd2-KO mice, but not in either Leydig or Sertoli 
cell conditional Cisd2-KO, may explain the difference in phenotype between these 
models. Interestingly, Wiley et al. (2013) reported that the phenotype of Cisd2-
deficient MEFs could be reversed by treatment with the antioxidant N-acetylcysteine. 
Additionally, it has been reported that antioxidant treatment can ameliorate Leydig cell 
damage under conditions of oxidative stress (Chen et al., 2008, Ding et al., 2017). As 
such, an interesting next step would be to assess (i) whether testicular redox status 
differs between the three premature ageing models and (ii) if an antioxidant treatment 
could ameliorate Leydig cell dysfunction in constitutive Cisd2-deficient mice as a 
potential therapeutic strategy to treat age-related primary hypogonadism. 
A potential caveat to the prematurely aged Leydig cell model used herein is 
acknowledged. Whilst the lineage tracing studies using the Pdgfrb-Cre; tdTomato 
mice provide novel evidence that PDGFRb is a marker of adult Leydig stem/progenitor 
cells in fetal testis, this Cre targets only approximately 55 percent of adult Leydig cells. 
This observation adds weight to the suggestion that the adult testis harbours two 
distinct populations of Leydig cells (Payne et al., 1980). However, it also raises the 
possibility that reduced testosterone production by Cisd2-deficient Leydig cells in the 
conditional model may be compensated for by the untargeted (wild-type or ‘young’) 
population. To address this, Leydig cell Cisd2-KO mice were treated with hCG to 
assess maximal testosterone production but no difference in Leydig cell response was 
noted. As such, this, together with the observation that LH is unaltered to maintain 
baseline testosterone, strengthens the conclusion that testosterone production is normal 
when premature ageing is restricted to Leydig cells. 
Alterations in the wider endocrine milieu during ageing may result in diminished 
Leydig cell function. For example, increased circulating glucocorticoids have been 
reported in ageing rats (Sapolsky et al., 1983, Lo et al., 2000). It is well documented 
that glucocorticoids can modulate Leydig cell testosterone biosynthesis. 
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Administration of adrenocorticotrophic hormone (i.e. to stimulate adrenal 
glucocorticoid secretion) results in decreased circulating testosterone levels in men 
(Schaison et al., 1978). Similarly, administration of exogenous hydrocortisone was 
shown to reduce circulating testosterone (Cumming et al., 1983). Moreover, both these 
studies reported that the observed reduction in testosterone was not caused by altered 
LH secretion, suggesting a direct inhibitory effect of glucocorticoids on Leydig cells. 
Indeed, glucocorticoids have been shown to supress the expression and/or activity of 
LHCGR, StAR, CYP11A1, HSD3B and HSD17B in Leydig cells (Bambino and 
Hsueh, 1981, Badrinarayanan et al., 2006, Martin and Tremblay, 2008). Very 
preliminary data (thus not reported herein) suggest that circulating corticosterone may 
be elevated in the constitutive Cisd2-KO mice, but not in either conditional model. It 
is therefore tempting to speculate that increased Leydig cell glucocorticoid signalling 
may underlie the reduced testosterone production in constitutive Cisd2-KO mice. 
Further experiments are required to test this hypothesis. 
Degeneration of the seminiferous tubules is a common feature observed in the ageing 
testis. Previous reports suggest that Sertoli cell number and/or function declines with 
advancing age (Neaves et al., 1984, Tenover et al., 1988, Johnson et al., 1984a, 
Johnson et al., 1990, Mahmoud et al., 2000). Consistent with these reports, constitutive 
Cisd2-deficient mice displayed signs of testicular atrophy accompanied by reductions 
in seminiferous tubule diameter, Sertoli cell number and decreased numbers of sperm 
in the cauda epididymis. However, circulating FSH was not measured in these animals, 
which would provide additional insight into Sertoli cell function in this model of 
premature ageing. Sertoli cells play a critical role in supporting spermatogenesis and 
in regulating the activity of peritubular myoid cells that contribute to the architecture 
and function of the seminiferous tubules (Rebourcet et al., 2014b). As such, it was 
anticipated that prematurely aged Sertoli cells in the conditional model would result in 
a similar degeneration of the seminiferous epithelium. However, this was not the case 
thus questioning a direct role of ageing Sertoli cells on tubular degeneration. It is 
possible that the aged germ cells/and or peritubular cells mediate aspects of age-related 
seminiferous tubule degeneration in constitutive Cisd2-deficient mice. Additionally, 
Paniagua et al. (1991) suggested that age-associated involution of the seminiferous 
tubules may be related to altered testicular vascular function. As such, investigations 
Chapter 6 General Discussion & Future Perspectives 
131 
 
into peritubular myoid cell activity/function as well as the testicular microvasculature 
network in prematurely ageing Cisd2-deficient mice may be interesting avenues for 
future exploration. 
6.2 Sertoli Cells are a Major Target of Leukemia Inhibitory Factor Signalling 
in the Testis 
A complex paracrine signalling network supports overall testis function by facilitating 
crosstalk between various cellular components to orchestrate the processes of 
spermatogenesis and steroidogenesis. A detailed understanding of how testis 
homeostasis is regulated at the paracrine level could inform on how testis function fails 
in cases of reduced fertility, disease and during the ageing process. To this end, the 
experiments detailed in chapter 4 investigated the role of leukemia inhibitory factor 
signalling in the testis. Several reports have detailed the expression of LIF and 
LIFR/gp130 signalling subunits in the testis, both in fetal life and in adulthood (Jenab 
and Morris, 1998, Piquet-Pellorce et al., 2000, Molyneaux et al., 2003, Dorval-Coiffec 
et al., 2005). Interestingly, Piquet-Pellorce et al. (2000) reported that peritubular 
myoid cells are the principal source of LIF within the testis and proposed that LIF is a 
putative paracrine regulator of normal testicular development and function. However, 
to date, a definitive role for LIFR signalling in the testis in vivo has not been described.  
To address the question of how LIF/LIFR signalling contributes to testis function, 
novel models of conditional LIFR ablation were generated. Firstly, because LIFR has 
been detected in germ cells from the spermatogonial stage and LIF has been suggested 
to promote spermatogonial proliferation or survival ex vivo/in vitro (De Miguel et al., 
1996, Dorval-Coiffec et al., 2005), the effect of conditional germ cell LIFR ablation 
was investigated. Surprisingly, spermatogenesis appeared to proceed normally in germ 
cell LIFR-KO mice demonstrating that germ cell autonomous LIFR signalling is 
dispensable for fertility. As such, the question of how the previously suggested 
influence of LIF on spermatogonial proliferation/survival may be mediated remained 
open. Both in vitro systems utilised by De Miguel et al. (1996) and Dorval-Coiffec et 
al. (2005) contained Sertoli cells. This raised the possibility that the observed effects 
of LIF on spermatogonia are mediated via LIFR signalling in Sertoli cells as had 
previously been hypothesised by Jenab and Morris (1998). Indeed, conditional LIFR 
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ablation from the Sertoli cell population resulted in a reduction in spermatogonia and 
Sertoli cells and was accompanied by a progressive, degenerative phenotype 
characterised by abnormal germ cell loss, sperm stasis, seminiferous tubule distention 
and atrophy of the seminiferous tubules. Taken together, the results from both 
conditional LIFR ablation models provide novel in vivo evidence to support the 
hypothesis that the effect of LIF on germ cells are mediated via Sertoli cells. 
Further experiments are required to establish the mechanisms by which Sertoli cell 
LIFR signalling supports spermatogenesis. It has been demonstrated in vitro that the 
Jak/STAT pathway may function downstream of LIFR in Sertoli cells via 
phosphorylation of STAT3 (Jenab and Morris, 1998). Therefore, it would be 
interesting to assess whether disruption to this pathway underlies the phenotype 
observed in the Sertoli cell LIFR-KO testis. For example, a conditional STAT3 allele 
could be utilised to disrupt Sertoli cell STAT3 and the phenotype compared to that of 
the Sertoli cell LIFR-KO. Conversely, overexpression of STAT3 in the Sertoli cell 
LIFR-KO testis (i.e. using a Sertoli cell targeting lentivirus) may rescue the phenotype. 
Leukemia inhibitory factor receptor is also expressed in stem and adult Leydig cells 
(Jenab and Morris, 1998, Dorval-Coiffec et al., 2005, Ge et al., 2006, Jiang et al., 
2014). It has been reported previously that LIF can stimulate the proliferation of stem 
Leydig cells isolated from the neonatal rat testis (Ge et al., 2006) and Lif mRNA 
expression is transiently upregulated in the initial stages of Leydig cell differentiation 
following EDS-mediated Leydig cell ablation (O'Shaughnessy et al., 2008), together 
suggesting a role for LIFR in Leydig cell development. Additionally, in vitro studies 
have demonstrated LIF can have both inhibitory and stimulatory effects on Leydig cell 
and adrenal steroidogenesis (Mauduit et al., 2001, Bamberger et al., 2000, Mikhaylova 
et al., 2008, Wang et al., 2016b). However, a definitive role for LIFR signalling in 
Leydig cell development and function in vivo has not yet been described. An attempt 
was made during the course of this PhD project to ablate LIFR from the Leydig cell 
population using the Ap2-Cre which targets adult Leydig cells from the 
stem/progenitor stage (Kilcoyne et al., 2014, O’Hara et al., 2015). Unfortunately, this 
experiment was abandoned as it became apparent that disruption of Lifr using this Cre 
could possibly result in lethality due to off target effects in the nervous system 
(Martens et al., 2010). Recently, Penny et al. (2017) reported that adenoviral vectors 
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could transduce Leydig cells in vivo when injected into the mouse testis interstitium 
and, when packaged with Cre, could induce recombination of conditional alleles. As 
such, experiments are now underway in the lab to determine whether this approach 
could be used to disrupt Leydig cell Lifr expression in the testes of mice carrying the 
conditional Lifr allele. 
6.3 Regenerative Potential of Human Adipose-derived Perivascular Stem 
Cells to Support Leydig Cell Function 
The identity and behaviour of stem Leydig cells has been an area of intense research 
over recent years, particularly in relation to harnessing their regenerative properties as 
a potential treatment for androgen deficiency. The precise origin of stem Leydig cells 
within the testis is debated, with both peritubular and perivascular origins proposed. 
In relation to the latter, Davidoff et al. (2004) suggested that Leydig cells arise from 
perivascular pericytes (characterised by NG2 and PDGFRb expression) following 
EDS-mediated Leydig cell ablation. In attempt to clarify the identity of mesenchymal 
stem cells present in multiple tissues, Crisan et al. (2008) proposed a universal identity 
of perivascular stem cells in a wide panel of human organs. Specifically, the authors 
suggest that multipotent perivascular stem cells are identifiable by their expression of 
NG2, PDGFRb and CD146 as well as a number of mesenchymal stem cell markers 
including CD90. Interestingly, expression of each these markers has been documented 
in putative stem Leydig cells in the rodent testis (Davidoff et al., 2004, Jiang et al., 
2014, Li et al., 2016). Additionally, the Leydig cell lineage tracing carried out in this 
thesis (chapter 3) suggest that a sub-population of adult Leydig cells arise from 
PDGFRb expressing cells. As such, the experiments carried out in chapter 5 assessed 
whether perivascular stem cells isolated from human adipose tissue (hAd-PSCs) had 
the potential to promote Leydig cell regeneration following EDS-mediated ablation. 
A cocktail of growth factors and hormones have previously been reported to induce 
the differentiation of stem Leydig cells in vitro. This was first described by Ge et al. 
(2006) who suggested that a combination of LH, IGF-1, PDGF-B and T3 (which have 
been suggested to influence adult Leydig cell development) was sufficient to convert 
rat testicular stem cells into steroidogenic Leydig cells. This differentiation inducing 
medium (DIM) was subsequently reported to transform multipotent stem cells isolated 
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from the mouse testis into Leydig cells (Jiang et al., 2014, Zang et al., 2017). Whether 
this protocol could be used to differentiate multipotent human stem cells of an extra 
gonadal origin was addressed herein. Culturing hAD-PSCs in DIM was not sufficient 
to promote their differentiation into Leydig cells in vitro. However, STAR and 
CYP11A1 were upregulated, which may indicate commitment of these cells to a 
steroidogenic lineage. Further experiments are required to explore this possibility. For 
example, adding additional factors to the differentiation inducing media may promote 
the transformation of hAd-PSCs into Leydig cells. Both PDGF-A and DHH would be 
interesting candidates to test as both have been suggested to play a role in adult Leydig 
cell development (Clark et al., 2000, Gnessi et al., 2000, O'Shaughnessy et al., 2008). 
Importantly, Odeh et al. (2014) reported that whilst both PDGF-A and PDGF-B could 
stimulate stem Leydig cell proliferation, PDGF-A stimulated differentiation whereas 
PDGF-B was inhibitory. 
To further explore whether hAd-PSCs could form Leydig cells, they were transplanted 
into the rat testis following EDS-mediated Leydig cell ablation (i.e. in an environment 
conducive to stem Leydig cell differentiation). However, when hAd-PSC transplanted 
testes were analysed after 5 weeks, there was no evidence of engraftment. 
Interestingly, after 5 weeks, seminal vesicle weight (as a marker of peripheral 
androgen action) was similar between Vehicle+Sham control animals (i.e. no Leydig 
cell ablation and no cell transplant) and animals that received hAd-PSCs cultured in 
DIM. Additionally, DIM-exposed hAd-PSCs had a modest effect on circulating LH 
levels during the initial 2 weeks post EDS. This suggested that DIM-exposed hAd-
PSCs might promote Leydig cell regeneration. It would be interesting to repeat this 
experiment, harvesting testes at 7, 14 and 21 days post EDS to determine the 
mechanism by which DIM cultured hAd-PSCs may alter regeneration kinetics. For 
example, it may be the case that these cells differentiate into functional Leydig cells 
prior to being lost from the testis, or that they enhance the proliferation and/or 
differentiation of endogenously regenerating Leydig cells. 
 




The main hypothesis behind the experiments carried out in the context of this thesis 
was that manipulation of the paracrine network in the testis in vivo would provide 
significant novel insights into the regulation of testicular development and function, 
uncovering potential therapeutic targets to treat age-related testicular dysfunction. 
Several novel observations herein support this hypothesis: 
1. Intrinsic ageing in Leydig and Sertoli cells per se may not directly contribute 
to age-related testicular atrophy and Leydig cell dysfunction. As such, it is 
suggested that disruption to the testicular microenvironment and/or wider 
systemic effects of ageing play a significant role in age-related testicular 
dysfunction. 
2. Leukemia inhibitory factor receptor signalling is required in Sertoli cells but 
not in germ cells to support normal function of the seminiferous tubules (i.e. to 
maintain spermatogenesis). 
Additional novel observations reported herein include: 
1. Constitutive Cisd2-deficient mice represent a novel model of age-related 
primary hypogonadism with utility for the expedited study of age-related 
testicular dysfunction. 
2. A sub population of adult Leydig cells arise from PDGFRB positive 
stem/progenitor cells present in the fetal testis. 
3. Leukemia inhibitory factor receptor is dispensable for normal testicular 
development during fetal life. 
4. Human adipose-derived stem cells may promote Leydig cell regeneration 
following EDS-mediated ablation. 
In summary, the studies reported herein further refine our understanding of the 
complex crosstalk between individual cell types within the testis, which may have 
wider implications for the development of novel therapeutics to treat testicular 
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